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Abstract
Mathematical models, that depict the dynamics of a cancer cell population growing out of the human
body (in vitro) in unconstrained microenvironment conditions, are considered in this thesis. Cancer
cells in vitro grow and divide much faster than cancer cells in the human body, therefore, the effects
of various cancer treatments applied to them can be identified much faster. These cell populations,
when not exposed to any cancer treatment, exhibit exponential growth that we refer to as the balanced
exponential growth (BEG) state. This observation has led to several effective methods of estimating
parameters that thereafter are not required to be determined experimentally.
We present derivation of the age-structured model and its theoretical analysis of the existence
of the solution. Furthermore, we have obtained the condition for BEG existence using the Perron-
Frobenius theorem. A mathematical description of the cell-cycle control is shown for one-compartment
and two-compartment populations, where a compartment refers to a cell population consisting of cells
that exhibit similar kinetic properties. We have incorporated into our mathematical model the required
growing/aging times in each phase of the cell cycle for the biological viability. Moreover, we have
derived analytical formulae for vital parameters in cancer research, such as population doubling time,
the average cell-cycle age, and the average removal age from all phases, which we argue is the average
cell-cycle time of the population. An estimate of the average cell-cycle time is of a particular interest
for biologists and clinicians, and for patient survival prognoses as it is considered that short cell-cycle
times correlate with poor survival prognoses for patients.
Applications of our mathematical model to experimental data have been shown. First, we have
derived algebraic expressions to determine the population doubling time from single experimental
observation as an alternative to empirically constructed growth curve. This result is applicable to
various types of cancer cell lines. One option to extend this model would be to derive the cell-
cycle time from a single experimental measurement. Second, we have applied our mathematical
model to interpret and derive dynamic-depicting parameters of five melanoma cell lines exposed to
radiotherapy. The mathematical result suggests there are shortcomings in the experimental methods
and provides an insight into the cancer cell population dynamics during post radiotherapy. Finally, a
mathematical model depicting a theoretical cancer cell population that comprises two sub-populations
with different kinetic properties is presented to describe the transition of a primary culture to a cell
line cell population.
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Chapter 1
Introduction
1.1 Mathematics in cancer research
The role of mathematics in cancer research has steadily increased over time and the future of this
discipline is both exciting and critical as new patients are diagnosed with cancer every day. In New
Zealand, around 51 people are diagnosed with cancer every day and around 22 cancer deaths occur
(statistics provided by the Cancer Society of New Zealand, www.cancernz.org.nz). Multidisciplinary
collaboration in cancer research is essential and mathematical applications can contribute significantly
to many areas of cancer research. Mathematical models can provide insight and establish a framework
for understanding properties of cancer cells, e.g., by modelling the biochemical behaviour within a
single cancer cell or by modelling a tumour growth. This thesis presents the mathematical modelling
of the cancer cell population grown out of human body, called cell lines. Several mathematical mod-
els that have been derived in close collaboration with the Auckland Cancer Society Research Centre
serve as an additional tool for biologists. These models can be used to either give understanding of a
plausible dynamics of cancer cell populations or to gain more effective methods of estimating param-
eters depicting the dynamics of cancer cell populations. We shall continue by introducing biological
concepts that will be frequently referred to in the subsequent chapters.
1.2 Cell cycle and apoptosis
A cell cycle is a progression of a cell through steps of growth and chromosome duplication to complete
cell division. The cell cycle of a eukaryotic cell is traditionally divided in four phases - G1, S , G2
and M. Phases G1, S and G2 together are called the interphase. A gap phase G1 (G for gap) is an
interval before the DNA synthesis (S -phase) that is followed by another gap phase named G2, where
the cell keeps growing until mitosis takes place (M-phase). A cell cycle consists of various cyclins and
cyclin-dependent kinases that have to react at certain cell-cycle control checkpoints. During its cell
cycle, a cell makes two vital decisions: first, the decision of “entering into S -phase” is made in late
G1-phase, called G1 checkpoint. DNA replication begins when the cell is ready to undergo the entire
cell cycle. Second decision is the “entry into mitosis”, mitosis will proceed through all its stages once
initiated, called G2 checkpoint. The cell-cycle control system, the key proteins of the control system,
initiates and controls the progression of the cell cycle and can arrest it at specific checkpoints. Cells
in a cell cycle are called dividing or proliferating cell. If a cell is non-dividing or quiescent it is said to
be in G0-phase. A cell in G0-phase can return to the G1-phase again under the influence of mitogenic
signals (growth factors, tumour viruses etc.), see Alberts et al. (1994). A diagram outlining cell-cycle
1
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Figure 1.1: The cell-cycle control diagram. During G1-phase cell grows then DNA is replicated and
new chromatin is formed, denoted as S -phase. During G2-phase cell prepares for mitosis or M-phase,
where it divides into two daughter cells. A cell passing through the cell-cycle control checkpoints in
G1 and G2 phases and completing cell division is called proliferating. G0 depicts the non-proliferating
cell phase.
control with key checkpoints is shown in Figure 1.1. Some non-dividing cells like neurons and skeletal
muscle fibre cells are unable to re-enter the cell cycle. Others, like fibroblasts and lymphocytes are
ordinarily in the G0 - phase but can be activated by external agents.
Cells have the potential to undergo genetically programmed cell death, or apoptosis. Apoptosis
is the “tidy” breakdown and disposal of cells without causing an inflammatory response in the body.
Apoptosis is common during embryonic development, but also occurs in a response to severe cellular
damage, viral infections and somatic mutations. Apoptosis is a protective mechanism that eliminates
many virus-infected and genetically altered cells, Meisenberg & Simmons (1998).
We continue by introducing two parameters: doubling time and cell-cycle time. Doubling time is
defined as the time required to double in number. Cell-cycle time is the time required to complete a
cell cycle. For a single cell, doubling time and cell-cycle time are evidently equal. However, in the
case of a cancer cell population, this is not necessarily true, we investigate this closer in Chapter 2.
Cell-cycle length varies greatly during interphase from cell to cell with M-phase duration considered
to be short compared to the other phases.
1.3 Cancer cell population: primary culture and cell line
Gene mutation can turn a normal cell into a cancer cell. What cell mechanisms exactly trigger these
mutations is unclear. A cancer cell is considered to be more aggressive and faster growing than a
cell from normal tissue. Tumour cells divide without inhibition, i.e., they do not stop dividing after
they come into contact with neighbouring cells, and increasingly act as individuals with the goal of
maximizing their own proliferation, see Nagl (2006). Great variation in the duration of the G1-phase
among different cancer cells produces a variety of cell-cycle times of the cancer cells that, effectively,
influence the response to any type of cancer treatment.
In this thesis, our interest in cancer cell populations will be mainly focused on in vitro (out of
2
1.4 Mathematical modelling of the growth of a cell population
body) cell populations, and melanoma cell populations in particular. Cancer cells, taken from a tumour
tissue sample (removed at surgery), to be examined in vitro are called primary culture. Tumour tissue
can be grown in culture and measurements of primary culture cell-cycle times show a range of 3
days to several weeks, which is similar to that observed in vivo (in body), see Baguley & Marshall
(2004); Furneaux et al. (2008). After several months, by a variety of culture techniques designed to
preserve the viability of tumour cells and suppress the growth of host cells, particularly of fibroblasts,
which are naturally activated in the wounding response generated by the tissue disaggregation, the
clinical tumour material exhibits stable growth and is referred to as cell lines, Baguley et al. (2002).
Established cancer cell lines exhibit shorter cell-cycle times thus reacting to the treatment much faster
than cells in the primary cultures. It is considered that cells in cell lines divide indefinitely. The
patients from whom the tissue samples were collected are often outlived by cancer cell lines.
Human tumour cell lines have been used extensively in the discovery and characterisation of new
chemotherapeutic drugs, Baguley & Marshall (2004, 2008). A potential disadvantage of cancer cell
lines is that they may have lost important properties originally present in vivo. Cell-cycle times are
different between tumours and cell lines, and, as mentioned before, cell-cycle times of primary cul-
tures cover the same wide range as estimated in vivo cell-cycle times. Responses of primary cultures
to cancer treatment also differ from those of cell lines, suggesting that the process of developing a cell
line can result in the loss of important cellular responses. The identification of cell lines that preserve
potential targets is an important goal in cancer biology and research. Using primary cultures will help
in this identification, Baguley & Marshall (2004).
Mathematical models have been applied to cancer cell populations taken from cell lines in this
thesis. However, further work is necessary to extend the models presented in the subsequent chapters
to describe the dynamics of cells in a primary culture, thus giving more insight into in vivo population
growth and response to treatments.
Stem cells differ from other cells by two properties: firstly, stem cells has a self renewal property,
meaning they can go through cell division many times whilst preserving their undifferentiated state.
Secondly, stem cells have the potential to differentiate into other types of cells. It is hypothesised
that a small proportion of cancer stem cells drive the growth of cancer in humans Dittmat & Zanker
(2009); Schatton & Frank (2007); Sole et al. (2008). In Chapter 5, we develop a mathematical model
that describes the behaviour of system with two cell populations with different kinetic characteristics,
to provide a framework for understanding the behaviour of cancer tissue that is sustained by a minor
population of proliferating stem cells.
1.4 Mathematical modelling of the growth of a cell population
The mathematical models are often predetermined by the available experimental data. In Steel (1977),
G.G. Steel presented two principles that prevent unrestricted model-building. First, Occam’s Razor
states: “We should always choose the simplest model that will satisfactorily fit the data. Any increase
in sophistication beyond this takes us into the realm of imagination rather than science”. Second,
Principle of Analogy: “A model whose parameters relate to experimentally measurable quantities is
to be preferred to one that has abstract parameters. A model that is a close analogue to the actual cell
system more readily enables predictions to be made about as yet undetected responses”.
With an objective to model a cell population taken from a cell line, we first must observe that such
a population does not respond to spatial constraints, thus, it exhibits balanced exponential growth
(BEG), Bell (1968). We note here that cells in primary cultures do not exhibit exponential growth.
Applied mathematics presents various methods of examining exponentially growing populations such
3
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S -phase
G1-phase
G2M-phase
D-p 
D-p 
D-p 
rG1→S
rS→G2 M
rG2 M→G1
µG1
µS
µG2M
Figure 1.2: Diagram of the cell-cycle control of in vitro tumour cells showing the proportions in each
phase. Parameters described in the Glossary.
as discrete and continuous, deterministic and stochastic methods.
Our choice lies in continuous deterministic models, with a focus on age-structured population
models. Our mathematical model is initially designed to depict the growth of cancer cell population
in the BEG state, i.e., population that has not been exposed to any cancer treatment. We assume that
all cells in the population are proliferating and can be viewed as subdivided among phases G1, S , G2,
and M. Due to presented experimental data, explained in Section 1.5, we combine subpopulations in
G2 and M phases and refer to it as G2M-phase. Cells move from one phase to the next with a certain
transition probability rate (r). Age (τ) is considered to be the time spent by a given cell in its current
phase. Thus, each cell is at age zero when entering into a new phase of cell growth. No cells are in
the non-proliferating state or G0-phase. Although cells from cell lines exhibit immortality properties,
we have incorporated a probability of apoptosis in each phase (µ). Figure 1.2 presents a schematically
illustrated cancer cell population in BEG.
Apoptosis is genetically programmed cell death without inflammatory breakdown and disposal of
cells. Cell necrosis occurs due to physical or chemical damage. Throughout this thesis, we define
cell death or loss as a process of cells undergoing apoptosis. We declare that cells are proliferating or
non-proliferating until they undergo apoptosis. We remark that notions cell death, apoptosis and cell
loss are interchangeable in this thesis.
Detailed derivation of an age-structured model can be found in Chapter 2. Potential cancer treat-
ment effects can be incorporated into mathematical equations by examining the effect of the treatment
on the cell-cycle control. For example, a chemotherapeutic drug, that is said to stop mitosis, can be
incorporated into the mathematical model by setting the transition probability rate from M-phase to
4
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G1-phase to zero. Similarly, after ionised radiation DNA damage can occur and cells might repair it
and re-enter the cell cycle or might undergo apoptosis (the p53 protein - the product of tumour sup-
pressor gene - promotes apoptosis and thus helps to eliminate the defective cell). These effects can be
incorporated into our model by altering the transition rates between respective phases.
With the aim of providing “shortcuts” to estimate parameters that are experimentally unobtainable
or not sufficiently accurate, we have derived mathematical models in the following chapters that would
be beneficial for biologists and clinicians. We have kept in mind Occam’s Razor and Principle of
Analogy when simplifying a more general model in Chapters 3, 4, 5 in order to fit experimental data.
1.5 Flow cytometry
We have dedicated this section to introduce an experimental measurement technique with flow cytom-
etry apparatus. Analysis of a cell population in a state of replication can be achieved by fluorescence
labelling of the cell nuclei in suspension and subsequently analysing the fluorescence properties of
each cell in the population. G1-phase cells will have one copy of DNA and will therefore have 1x the
fluorescence intensity. Cells in the G2 and M phases will have two copies of DNA and, accordingly,
will have 2x the intensity. Flow cytometry cannot distinguish between G2 and M phases, therefore, we
combine them for our mathematical models, derived in the following chapters, and refer to it as G2M-
phase. Because the cells in the S -phase are synthesizing DNA, they will have fluorescence values
between 1x and 2x the population’s. The flow cytometry histogram shown in Figure 1.3 (in blue) is
obtained from labelled cells transiting through the laser beam and their fluorescence signal ultimately
generating a voltage pulse by the fluorescence detector (photomultiplier tube). The horizontal axis in
Figure 1.3 depicts the total cell fluorescence noted in the literature as FL2-A (“A” for area). The verti-
cal axis shows the number of cells with a respective total fluorescence value. We can extract estimates
of population proportions in each phase from the flow cytometry profiles. Population distribution in
the respective phases is shown in coloured-in segments. In this thesis, we analyse flow cytometry
profiles using Cylchred software provided by Cytonet, UK. When population is unexposed to the can-
cer treatment, i.e., exhibiting BEG, the flow cytometry profiles remain unchanged at all experimental
observation points. We discuss steady population-distribution conditions in Chapter 2.
1.6 Thesis outline
Chapter 2
In this chapter, we derive and analyse an age-structured cell population model. We show an implicit
analytical solution of the McKendrick-von Foerster partial differential equation (PDE) with side con-
ditions: an initial condition and a boundary condition. Moreover, we prove the existence of that
solution using methods developed for the Volterra integral equation of the second kind. We examine
two kinds of transition probability rates between two consecutive phases of the cell cycle: constant
and piecewise constant. A piecewise constant transition rate is biologically more relevant because
cells must grow (age) in particular phases of the cell cycle before being able to transit into the next
phase. Because a cancer cell population, when taken from a cancer cell line culture, exhibits the BEG
state, we demonstrate a condition for the existence of BEG by using the Perron-Frobenius theorem.
Later in this process, we derived formulae of the constant population proportions among cell cycle
phases at BEG state. We show the reduction of a PDE model to an ordinary differential equation
(ODE) system and a delay differential equation (DDE) system. A general PDE model allows us to de-
rive vital parameters in cancer research, such as population doubling time and average cell-cycle time.
5
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Figure 1.3: An example of a flow cytometryprofile of an unperturbed cell line population. The pro-
portions of cell population in the G1, S , and G2M phases are shown in the diagram. The horizontal
axis label FL2-A (“A” for area) depicts the total cell fluorescence. The vertical axis shows the number
of cells with a respective total fluorescence value.
Results of this chapter provide an insight into the relationship between population doubling time and
average cell-cycle time. A mathematical distinction is shown between two biological understandings:
the expected average age in the phase and the expected removal time from the phase.
Chapter 3
This chapter introduces a new approach of determining population doubling time using a single exper-
imental observation. A method for experimental estimation of cell-cycle times or doubling times of
cultured cancer cell populations, based on addition of paclitaxel (an inhibitor of cell division) has been
proposed in literature. We use a mathematical model to investigate relationships between essential pa-
rameters of the cell division cycle following inhibition of cell division. The reduction in the number
of cells engaged in DNA replication reaches a plateau as the concentration of paclitaxel is increased;
this can be determined experimentally. From our model, we have derived a plateau log reduction
formula for proliferating cells and established that there are linear relationships between the plateau
log reduction values and the reciprocal of doubling times (i.e. growth rates of the populations). We
have therefore provided theoretical justification of an important experimental technique to determine
cell doubling times. Furthermore, we have applied Monte Carlo experiments to justify the suggested
linear relationships used to estimate doubling time from 5-day cell culture assays. We show that our
results are applicable to cancer cell populations with cell loss present. Our mathematical model result
provides a shortcut for estimating the population doubling time and we hope to extend this model for
the cell-cycle estimation from a single experimental measurement.
Most of the results presented in this chapter have been published in Daukste et al. (2012).
Chapter 4
In this chapter, we examine the response of a cancer cell population to a one-time ionised irradiation
dose treatment. We show that, by changing the PDE system of the number density function to the
probability density function, our model tracks the variability of proportions in each phase of the cell
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cycle and is compatible with the experimental estimates of proportions in each phase after a variety
of cancer treatments. Our results agree with the previous studies of irradiated cancer cell lines, i.e.,
a cancer cell population undergoes little apoptosis after radiotherapy. Therefore, this study’s experi-
mentally observed decrease in the expected number of cells is due to the long-term arrest of the cell
cycle. Our model provides an interval of the initial surviving fraction of the cell population for each
cell line, i.e., the proportion of cells that keep proliferating after the application of radiotherapy. In the
discussion section, we explain why the survival fraction estimated via our mathematical model does
not agree with the experimentally estimated one.
Chapter 5
This chapter examines the application of the two-population model. This mathematical model de-
scribes the behaviour of a system with two cell populations with different kinetic characteristics. The
results provide a framework for understanding the growth behaviour of cancer tissue that is sustained
by a minor population of proliferating stem cells. The Perron-Frobenius theorem is used to prove the
existence of a BEG state of a two population model.
The results from this chapter have been published in Daukste et al. (2009).
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Chapter 2
One-Compartment Age-Structured
Model of Cancer Cell Population Growth
In this chapter, we derive and analyse an age-structured cell population model. We show an implicit
analytical solution of the McKendrick-von Foerster partial differential equation (PDE) with side con-
ditions: an initial condition and a boundary condition. Moreover, we prove the existence of that
solution using methods developed for the Volterra integral equation of the second kind. We examine
two kinds of transition probability rates between two consecutive phases of the cell cycle: constant
and piecewise constant. A piecewise constant transition rate is biologically more relevant because
cells must grow (age) in particular phases of the cell cycle before being able to transit into the next
phase. Because cancer cell population, when taken from the cancer cell line culture, exhibits the bal-
anced exponential growth (BEG) state, we demonstrate a condition for the existence of BEG by using
the Perron-Frobenius theorem. Later in the process, we derived formulae of the constant population
proportions among cell cycle phases at BEG state. This mathematical model allows us to derive vital
parameters in cancer research, such as population doubling time and average cell-cycle time. Results
of this chapter provide an insight into the relationship between population doubling time and aver-
age cell-cycle time. A mathematical distinction is shown between two biological understandings: the
expected average age in the phase and the expected removal time from the phase.
2.1 Introduction
Our objective is to mathematically model the dynamics of a cancer cell population taken from the
cancer cell line culture. The mathematical modelling of a cancer cell population taken from the
primary culture, which effectively exhibits in vivo properties, is of great interest in the cancer research;
however, because such a population does not demonstrate balanced exponential growth (BEG) Bell
(1968) properties, our main focus will stay on cell line cultures throughout this thesis.
The criteria for developing the mathematical models presented in the following chapters (such as
those posed in Metz & Diekmann (1986)) are the biological relevance and mathematical tractability.
Mathematical modelling has been applied to a large spectrum of the cancer cell proliferation prob-
lems, starting from the cycle-control biochemical modelling of a single cell to the modelling of the
cancer cell population, looking into both - in vivo and in vitro cases. A single cell growth models open
prospects for the multiscale modelling. Review papers Byrne (2010); Deisboeck et al. (2011) on can-
cer tumour modelling can be found in the literature. An overview paper on structured cell population
dynamics Arino (1995) stated that during the 1970s, mathematical modelling was more focused on
9
2. ONE-COMPARTMENT AGE-STRUCTURED MODEL OF CANCER CELL
POPULATION GROWTH
nonlinear equation (such as Gompertz equation) applications to cancer cell population growth. In the
1980s, focus switched to the linear age-structured models. Linear partial differential equations have
an advantage of being simple for analysis and are also applicable to the mathematical modelling of
the cancer cell population.
A cell compartment method can analyse the formation of cancer cells from stem cells. In Ganguly
& Puri (2006), it was concluded that mutations in stem cells rather than in early progeny cells lead
to faster growth of the abnormal progeny. Moreover, a model shows that a repeated insult to mature
cells leads to an increased growth rate of the abnormal progeny cells.
Compartmentalized cell population by cell kinetic properties, e.g. assuming that cells exit in one
of two kinetic states: proliferating and non-proliferating has been used to examine cell motion in the
tumour, Tindalla & Please (2007). It is assumed that the dominant mechanism for cell motion is due to
chemical gradients. Multicellular tumour spheroids are used in this study because they exhibit many
of the characteristics of in vivo tumours. The model in Tindalla & Please (2007) shows the commonly
held view of the cell cycle distributions within spheroids - proliferating cells are near the boundary
and the quiescent cells are in the core.
Cell compartment method has also been used to analyse the time- and dose-dependent effects of
antitumour agent RHPS4 on the cancer cell line HCT116, in Johnson et al. (2011). In this study,
experimental estimates of quite a few parameters have been used, i.e., the proportions in each phase
as well as the proportion of senescent cells, the total number of cells at certain time and the overall
population growth rate. In Johnson et al. (2011), telomerase inhibition RHPS4 increases the rate at
which cells become senescent state but, rather surprisingly, actually inhibits the rate of cell death
detects.
Mathematical models derived in this thesis have been previously examined to some extent in
Basse & Ubezio (2007); Basse et al. (2003, 2004a,b, 2005). In this chapter, we introduce a theoretical
background of the age-structured models and extend it beyond the analytical derivations published in
other literature including models by Basse & Ubezio (2007); Basse et al. (2003, 2004a,b, 2005). We
have derived analytical expressions for the average cell age in the phase and the average removal or
transit time through the phase, which is a novel result and has not been published before. The existence
and the uniqueness of the solution have been shown in the literature before just as the conditions for
the balanced exponential growth. We have shown results for the piecewise-constant transition rates
and analytically derived formulae for dynamical parameters. A DDE system has been derived from
an age-structured system as used by Simms et al. (2012).
As mentioned before, cancer cell population taken from the cancer cell line culture exhibits BEG
if unexposed to any cancer treatment methods. In the literature, BEG is also referred to as an asyn-
chronous exponential growth (AEG), the steady-state distribution (SSD), or steady age distribution
(SAD), but we will use notion BEG throughout the thesis. Age-structured models have the capacity
to describe the underlying structure of a cancer cell population at BEG and provide an opportunity to
estimate vital parameters in cancer research via mathematical models as an alternative to experimental
observations.
Solely for the purposes of the experimental data used in our research, we subdivide cell cycle into
the respective G1, S , and a combined G2M phases, as shown in Figure 1.2 in the Introduction. Our
models are to be utilised for flow cytometry profiles, and because the flow cytometry apparatus/method
cannot distinguish the difference between the G2 and M phases (due to the fact that DNA contents
in both phases are twice that of S -phase), phases G2 and M are combined in a G2M-phase in our
mathematical model.
In this chapter, we present the derivation of the one-population (also denoted as a one-compartment,
in this thesis term compartment does not refer to a phase of the cell cycle) age-structured model and
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the proof of the existence for the solution from the theory of the Volterra equations of the second kind.
Furthermore, the existence of the BEG state is proved by Perron-Frobenius theorem. Later, we express
parameters that depict the dynamics of a cancer cell population, such as population doubling time and
expected or average cell-cycle time of the cancer cell population, that have not been exposed to any
cancer treatment. From the results obtained in this chapter, we gain an insight into the relationship
between population doubling time and average cell-cycle time.
2.2 Age-structured model of a cancer cell population
Our objective is to model the dynamics of a cancer cell population in order to derive parameters that
describe the kinetics of the population, which has not been exposed to treatment, as well as parameters
that describe the effects of various cancer treatments.
A cell cycle of cancer cell population is modelled assuming that cells from this cancer cell pop-
ulation produce daughter cells with similar kinetic properties. In our model, cell cycle is subdivided
into three phases: G1, S , and G2M (with combined phases G2 and M because we apply our model
to flow cytometry [FC] profiles, and FC measurements cannot distinguish between G2 and M phases
because DNA contents in both phases are twice that of S -phase). Age is considered to be the time
spent by a given cell in its current phase. Thus, each cell has age zero when entering into a new phase
of cell growth.
Derivation of an age-structured partial differential equation is as follows. First, let us assume that
there is a continuous function n(t, τ) that represents the number density of the cancer cell population
and is a vector quantity, with
n(t, τ) = [nG1 (t, τ) nS (t, τ) nG2M(t, τ)]T . (2.2.1)
Here vector components np(t, τ) with p ∈ {G1, S ,G2M} are continuous functions, where np : [0,∞) ×
[0, T ) → [0,∞), that shows the number density of cells with age τ at time t in a cell cycle phase p. Age
τ states the duration of a cell in particular phase p. We impose a maximum age of cells, T > 0, after
which cells are assumed to have died. In fact, in vitro studies are seldom longer than 2 weeks, so most
of the time, T need not be larger than this number Baguley & Marshall (2004). The assumption of a
maximum age is for mathematical simplicity; T can be set arbitrarily large. Furthermore, derivatives
of np(t, τ) exist and are also continuous functions on [0,∞) × [0, T ). If time t is increased by h units
(and we assume that time unit h = 4t = 4τ), then cells have aged by h units. Given that function
np(t, τ) has a continuous derivative, then we obtain the following equation:
lim
h→0
np(t + h, τ + h) − np(t, τ)
h = limh→0
np(t + h, τ + h) − np(t, τ + h)
h +
np(t, τ + h) − np(t, τ)
h
=
∂
∂t
np(t, τ) + ∂
∂τ
np(t, τ).
Second, let us assume that the probability rate at which cells leave phase p is given by term bp(t, τ).
Assumptions that the transition probability depends on time t and age τ and is a non-negative piece-
wise continuous function, are comprehensible in biological terms. Here, transition rate bp(t, τ) with
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p ∈ {G1, S ,G2M} is defined as follows:
bG1(t, τ) = rG1→S (t, τ) + µG1(t, τ), (2.2.2)
bS (t, τ) = rS→G2M(t, τ) + µS (t, τ),
bG2 M(t, τ) = rG2M→G1 (t, τ) + µG2M(t, τ),
where rG1→S (t, τ), rS→G2M(t, τ), and rG2M→G1(t, τ) are the transition probability rates (probability per
time unit per cell) between two consecutive phases and µp(t, τ) depicts the death rate from the phase
p. Description of variables used in our mathematical model that has been schematically depicted
in Figure 1.2 have been explained in the Glossary. We have assumed, for now, that the transition
probability rates and death rates are dependent on time t and age τ. We also assume that cancer cells
taken from cancer cell lines have a potential undergoing apoptosis at any phase of the cell cycle. The
conservation law states that the variation of the population number density in p phase in time is caused
by a transition to the next phase or death; thus, the following linear partial differential equation can be
derived:
∂
∂t
np(t, τ) + ∂
∂τ
np(t, τ) = −bp(t, τ)np(t, τ). (2.2.3)
Conservation between the various phases and the death phase, which is not explicitly modelled, fol-
lows from the continuity of the derivatives on the domain. This is particularly important when con-
sidering proportions in each phase rather than number of cells.
Third, additional conditions for equation (2.2.3) are provided: the initial number density distribu-
tion and renewal condition (also called Lotka equation) for each phase. The initial age distribution is
defined as:
np(t = 0, τ) = n0p(τ), (2.2.4)
with the initial distribution n0p(τ) in (L1 ∩ L∞)[0, T ). Lotka showed Lotka (1922) that a boundary
condition expressed as an integral with respect to cell population age will then result in the solution
being depend on the boundary condition itself. The Lotka boundary condition turns the problem de-
scribed with (2.2.3) and (2.2.4) into a bounded and, subsequently, a compact problem. The boundary
or renewal condition states that cells in each phase start from age zero. Furthermore, all cells at age
zero have transferred from the previous phase and are expressed as follows:
np(t, τ = 0) =
∫ T
0
ap−1(t, τ)np−1(t, τ) dτ, (2.2.5)
where transition rate ap(t, τ) with p ∈ {G1, S ,G2M} is defined as:
aG1(t, τ) = rG1→S (t, τ), (2.2.6)
aS (t, τ) = rS→G2M(t, τ),
aG2 M(t, τ) = 2rG2 M→G1(t, τ).
Cells are presumed to be in the G1-phase immediately after division. Here, subscript p−1 in equation
(2.2.5) is taken to signify the following:
G1 − 1 = G2M; S − 1 = G1; G2M − 1 = S .
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We note that for the G1 - phase, the renewal condition (2.2.5) is as follows:
nG1(t, τ = 0) =
∫ T
0
2rG2M→G1 (t, τ)nG2 M(t, τ)dτ, (2.2.7)
where 2 refers to each cell that has completed mitosis producing two daughter cells.
It is assumed that rp→p+1, µp ∈ C−1([0,∞)× [0, T )) for all p ∈ {G1, S ,G2M}, and, in addition, they
are bounded and strictly positive. We also assume that derivatives of rp→p+1(t, τ) and µp(t, τ) for all
p ∈ {G1, S ,G2M} are bounded and piecewise continuous in t and τ. Finally, we assume that there ex-
ists a positive lower bound. Note that for biological realism, we also assume µp(t, τ) is non-negative.
The simplicity of the model is due to the linearity that is present when dealing with a cancer cell
population that grows in vitro exponentially without any environmental constraints. In the subsequent
sections, we provide the analytical solution of the problem (2.2.3) - (2.2.5) and show the condition for
the existence of such solution.
2.2.1 Analytical solution of an age-structured model
2.2.1.1 Single-phase model
We focus on a single-phase model in this section to demonstrate the derivation of the analytical solu-
tion via the method of characteristics. We impose change in variables: now arguments t and τ depend
on parameter z. Thus, the number density function can be rewritten as follows:
n¯p(z) = np(t(z), τ(z)). (2.2.8)
Hence, the derivative of n¯p(z) with respect to new variable z can be expressed as follows:
dn¯p
dz =
d
dznp(t(z), τ(z)) =
∂np
∂t
dt
dz +
∂np
∂τ
dτ
dz ,
where z varies along the following characteristic lines:
dt
dz = 1,
dτ
dz = 1, (2.2.9)
τ = z + t. (2.2.10)
Thus, equation (2.2.3) can be rewritten as
dn¯p
dz (z) + bp(t(z), τ(z))n¯p(z) = 0. (2.2.11)
We choose point (t0, τ0) along the characteristic lines (2.2.9). This point can be any point in the first
quadrant, as shown in Figure 2.1. Thus, the following expressions are derived:
t = t0 + z, τ = τ0 + z.
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t
τ t = τ
t > τ
t < τ
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np(t, τ = 0)
n
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=
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τ
)
Figure 2.1: Characteristic lines of McKendrick-von Foerster equation analytical solution, where num-
ber density function np(t, τ) on horizontal axis represents the renewal condition, and np(t, τ) on vertical
axis depicts the initial condition.
For simplicity, we define the number density function np at point (t0, τ0) as np(t0, τ0) = n0. Therefore,
equation (2.2.11) can be solved by integrating along the characteristic lines as follows:
n¯p(z) = n0 e−
∫ z
0 bp(t(ξ),τ(ξ)) dξ = n0 e−
∫ z
0 bp(t0+ξ,τ0+ξ) dξ =
= n0 e
−
∫ τ0+z
τ0
bp(s+t0−τ0 ,s) ds
, (2.2.12)
where s = τ0 + ξ. Further, we subdivide analysis of the solution into two cases: t < τ and t > τ, as
depicted in Figure 2.1. In the case of t < τ, we express solution of n¯p(z) as:
t = 0 + z, τ = τ0 + z,
n¯p(z) = np(z, τ0 + z) = np(0, τ0) e−
∫ τ0+z
τ0
bp(s−τ0 ,s) ds
.
Thus, the number density np(t, τ) for the case t < τ can be expressed as follows:
n(t, τ) = np(0, τ − t) e−
∫ τ
τ−t bp(s+t−τ,s) ds, t < τ. (2.2.13)
We note that the analytical solution of the problem (2.2.3) - (2.2.5), in the case of t > τ, portrays the
growth of the cancer cell population taken from the cancer cell line culture, i.e., the time it takes for
the cell population to grow is longer than the age τ that cells have spend in phase p. For the case t > τ,
solution of n¯p(z) is as follows:
t = t0 + z, τ = z,
n¯p = np(t0 + z, z) = np(t0, 0) e−
∫ z
0 bp(s+t0 ,s) ds.
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Here, the variable change gives us cell number density function np(t, τ), for the case t > τ, as:
np(t, τ) = np(t − τ, 0) e−
∫ τ
0 bp(s+t−τ,s) ds, t > τ. (2.2.14)
Thus, by using the renewal condition (2.2.5), equation (2.2.14) can be rewritten in its general form as
a representation of the asymptotic solution of the problem (2.2.3) - (2.2.5) as follows:
np(t, τ) =
∫ T
0
ap−1(t − τ, s) np−1(t − τ, s) ds e−
∫ τ
0 bp(s+t−τ,s) ds, t > τ. (2.2.15)
2.2.1.2 Multiple-phase model
For the purposes of mathematical analysis in the subsequent sections, we rewrite the problem of cancer
cell population growth with more general notation using vector function n(t, τ), as defined in (2.2.1).
The cancer cell population taken from the cancer cell line culture exhibits BEG state. Because
there are no environmental constraints on the cancer cell population growth, a linear partial differ-
ential equation is suitable for depicting such cell population dynamics. In more general notation,
McKendrick - von Foerster equation (2.2.3) can be rewritten as:
∂
∂t
n(t, τ) + ∂
∂τ
n(t, τ) = −Dout(t, τ)n(t, τ), 0 < t < ∞, 0 < τ < T, (2.2.16)
with respective side conditions defined as follows:
n(t = 0, τ) = n0(τ), initial age distribution, (2.2.17)
n(t, τ = 0) =
∫ T
0
Din(t, τ)n(t, τ) dτ, t > 0, renewal distribution. (2.2.18)
The matrix Dout represents the loss of cells from the various phases via death and transfer to other
phases, and is defined as:
Dout(t, τ) =

rG1→S + µG1 0 0
0 rS→G2M + µS 0
0 0 rG2 M→G1 + µG2M
 (t, τ). (2.2.19)
The renewal matrix Din represents the gain of cells at age τ = 0 in each phase and is caused by transfer
from other phases. Din is defined as:
Din(t, τ) =
 0 0 2rG2 M→G1rG1→S 0 00 rS→G2M 0
 (t, τ). (2.2.20)
Transition rates rp→p+1 and µp for p ∈ {G1, S ,G2M} are described in the Glossary, with the cell-
cycle control depicted in Figure 1.2. Solution to the governing differential equation (2.2.16) along
the characteristic lines, already expressed for each component of vector function n(t, τ) in equations
(2.2.13) and (2.2.14), is as follows:
n(t, τ) =
 exp
(
−
∫ τ
τ−t
Dout(s + t − τ, s) ds
)
n0(τ − t), 0 ≤ t ≤ τ,
exp
(
−
∫ τ
0 Dout(s + t − τ, s) ds
)
n(t − τ, 0), 0 ≤ τ < t. (2.2.21)
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2.3 Existence of a unique solution
Analytical solution of McKendrick-von Foerster equation (2.2.16) assumes that the solution on the
boundary τ = 0 has been given. However, in our problem, we are given the renewal boundary con-
dition (2.2.18). Substituting the formal solution from (2.2.21) into the boundary condition (2.2.18)
gives us a Volterra integral equation of the second kind for n(t, 0):
n(t, 0) = F(t) +
∫ t
0
K(t, s)n(s, 0) ds, (2.3.1)
where
F(t) =
∫ T
t
Din(t, τ) exp
(
−
∫ τ
τ−t
Dout(s + t − τ, s) ds
)
n0(τ − t) dτ, (2.3.2)
and kernel of integro-equation is defined as follows:
K(t, s) = Din(t, t − s) exp
(
−
∫ t−s
0
Dout(ξ + s, ξ) dξ
)
. (2.3.3)
By the assumptions made in our problem, we know that Dout(t, τ) and Din(t, τ) are piecewise continu-
ous: therefore, K(t, s) is piecewise continuous. Furthermore, because the components of n0(τ) are in
(L1 ∩ L∞)[0, T ) and the components of Din(t, τ) are bounded, we find that F(t) exists. We observe, by
the piecewise continuity of Dout and Din, that F(t) is continuous. Because kernel K(t, s) is piecewise
continuous, we use method of continuation to first establish existence and uniqueness in some interval
[0, T1], and then show that this solution can be continued to successive intervals [T1, T2], [T2, T3],
and so on. Eventually the whole interval [0, T ) is covered. We rewrite kernel K(t, s) as p(t, s)K˜(t, s),
where K˜(t, s) is continuous and p(t, s) represents the piecewise continuous part (effectively p(t, s) is
the same as equation (2.3.3)); thus, we may apply theorem from Linz (1985), showed in the Appendix
A.1, which tells us there is a unique continuous solution to equation (2.3.1) on [0, T ) for any T > 0.
Theorem 2.3.1. There exists a unique non-negative solution n(t, τ) (along characteristic lines) to
problem (2.2.16) such that each component of n(t, τ) belongs to (L1 ∩ L∞)([0,∞) × [0, T )) for any
T > 0, and each component of n(t, ·) belongs to (L1 ∩ L∞)[0,∞) for all t ≥ 0. The solution is given by
equation (2.2.21), where n(t, 0) is continuous for all t ≥ 0.
2.4 Steady age distribution at BEG state
We now show the existence of steady age distributions, given that problem (2.2.16)-(2.2.18) has age-
dependent transition probability rates. We note here that it would not be possible to show BEG state
for time-dependent transition rates. This corresponds to the unperturbed, i.e., unexposed to cancer
treatment, proliferating cancer cell line colonies that are exhibiting BEG, so Din and Dout are possible
functions of τ. We apply the results from Section 2.3 to show that steady age distributions, referred to
as n̂(τ), exist and are stable when Dout and Din are functions of age τ only. We find in Theorem 2.4.1
proved by the Perron-Frobenius theorem that given any initial conditions in ((L1 ∩ L∞)[0, T ))3, the
shape of the solution n(t, τ) to the problem will tend to a steady age distribution n̂(τ) (different methods
of proof can be found in Basse & Ubezio (2007); Begg et al. (2010)). As the renewal (boundary)
equation involves a compact operator, a consequence is, it is characterized by a discrete spectrum of
eigenvalues and the solution can be expressed as a superposition of eigenfunctions, Keyfitz & Keyfitz
(1997). A positive dominant eigenvalue depicts the asymptotic growth rate of the population, i.e., the
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population growth rate at BEG state. This will mean that there is a constant proportion of cells in
each phase: a fact that is observed experimentally in vitro. This result is important in showing our
mathematical model exhibits a unique steady age distribution, as is observed experimentally in vitro
via cell flow cytometry. In Figure 2.5, we show an example of such a steady age distribution structure.
Observe the exponential decay in the population as the age advances. It should be noted that by finding
stationary solutions to our problem, we are finding solutions to the problem of the following form:
n(t, τ) = eλtn̂(τ), (2.4.1)
and, therefore, n̂(τ) is a steady age distribution of the problem because the age distribution of cells,
n(t, τ), retains the same shape n̂(τ), whereas the overall number of cells may be growing or decaying
depending upon the sign of growth constant λ (also called Malthusian parameter). This scenario
corresponds to the unperturbed cancer cell line, where the transition and death probabilities in each
phase are purely a function of the age in that phase.
Theorem 2.4.1. There exists some double (λ0, n̂) such that λ0 is a real, positive dominant eigenvalue
to the characteristic equation Q(λ) = 1, and n̂(·) ∈ (L1 ∩ L∞)3[0, T ) is a strictly positive stationary
solution to (2.4.1).
When the ansatz (2.4.1) is substituted into equation (2.3.1), we obtain the following expression:[
A(λ) − IΛ
]̂
n(0) = 0, (2.4.2)
with F(t) → 0, as t → ∞ and Λ = 1. Thus, a necessary condition for the solution (2.4.1) to exist is
the existence of such λ that the nonlinear eigenvalue problem (2.4.2) admits an eigenvalue Λ = 1 for
some λ. The matrix A is defined as follows:
A =
∫ T
0
Din(s) exp
(
−
∫ s
0
[Dout(s′) + Iλ] ds′
)
ds. (2.4.3)
Thus, we need to know if there is a Λ = 1 for the parameter λ = λ0. Now it can be shown that the
structure of A ≥ 0 is as:
A =

0 0 κG2M
κG1 0 0
0 κS 0
 , (2.4.4)
where κp denotes a positive element and is defined as follows:
κp =
∫ T
0
ap(s) exp
(
−
∫ s
0
[bp(ξ) + λ] dξ
)
ds, (2.4.5)
with p ∈ {G1, S ,G2M} and ap, bp defined in equations (2.2.6) and (2.2.2), respectively. We note that
transition probability rates ap and bp are now assumed to be a function of τ only. A non-negative
matrix is irreducible if and only if its life cycle graph contains a path from every node to every other
node,Caswell (2001). We can see that matrix A is irreducible, as its strongly connected graph shows
in Figure 2.2. This matrix is imprimitive, see Section A.2 in the Appendix for more detail. Thus,
from the Perron-Frobenius theorem on irreducibe but imprimitive matrices A.2.1, there exists a real
positive eigenvalue λ0, which is a simple root of the characteristic equation det[A(λ) − IΛ] = 0 and
the associated eigenvector, namely n̂(0), is positive. Expression det[A(λ) − IΛ] = 0 reduces to the
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Figure 2.2: Diagram of irreducible matrix A.
following equality:
1 = Λ3 = Q(λ), (2.4.6)
where
Q(λ) =
∏
p
∫ T
0
ap(s) exp
(
−
∫ s
0
[bp(ξ) + λ] dξ
)
ds. (2.4.7)
The equation (2.4.6) states that the necessary condition for existence of a BEG is described by the
following characteristic equation:
Q(λ) = 1. (2.4.8)
Solution (2.2.21) with only age-dependent transition rates can be rewritten as follows:
n(t, τ) = exp
(
−
∫ τ
0
Dout(s) ds
)
n(t − τ, 0), τ < t. (2.4.9)
Taking into account equation (2.4.1), we can express the steady age distribution of the cancer cell
population at BEG state as:
n̂(τ) = exp
(
−
∫ τ
0
(Dout(s) + λI) ds
)
n̂(0). (2.4.10)
This shows that n̂(τ) will effectively have compact support provided Dout(s) + λI > 0. Later, we
derive a characteristic equation Q(λ) = 1 for constant and piecewise constant transition rates. In the
following sections, we show derivations of numerous parameters that are used frequently in the cancer
research.
2.5 Parameters: constant proportions, doubling time, and cell-cycle
time
For further analysis of the unperturbed cancer cell population exhibiting BEG, we assume that tran-
sition rates rp→p+1 and death rates µp are piecewise continuous functions with respect to τ only. On
the premise that each proliferating cell grows (ages) in G1, S and G2M phases before transferring into
the next phase, we find that by defining transition probability rates as piecewise constant adds to our
mathematical model viability. Further, we derive several vital parameters in the cancer research.
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Figure 2.3: Piecewise constant transition rate rp→p+1(τ).
2.5.1 The total number of cells
The total number of cells in each phase p, denoted by Np, is defined by integrating the number density
over the age as follows:
Np(t) =
∫ T
0
np(t, τ) dτ, (2.5.1)
where the total cell number of the population at any given time t, denoted as Ntot, is the sum of the
total cell number over the phases of the cell cycle, described as follows:
Ntot(t) =
∑
p
Np(t), with p ∈ {G1, S ,G2M}. (2.5.2)
We note here that at the total number of cell population at BEG state is as follows:
Ntot(t) = Ntot(0)eλt. (2.5.3)
2.5.2 Piecewise constant transition probability rates
We define piecewise constant transition probability rates, taking into account that cells have zero
transition probability while they grow (age) for a certain time (denoted as τp), as follows:
rp→p+1(τ) =
{
0, if τ < τp,
rp→p+1, if τ ≥ τp,
(2.5.4)
where p ∈ {G1, S ,G2M}, as depicted in Figure 2.3.
We have assumed that death probability rate µp is a piecewise constant function, i.e., cells may
undergo apoptosis only after growing for time τp in each phase, thus,
µp(τ) =
{
0, if τ < τp,
µp, if τ ≥ τp,
(2.5.5)
where p ∈ {G1, S ,G2M}.
19
2. ONE-COMPARTMENT AGE-STRUCTURED MODEL OF CANCER CELL
POPULATION GROWTH
We remark that transition rates ap and bp, defined in equations (2.2.6) and (2.2.2), respectively, are
then expressed as follows:
ap(τ) =
{
0, if τ < τp,
ap, if τ ≥ τp,
(2.5.6)
bp(τ) =
{
0, if τ < τp,
bp, if τ ≥ τp.
(2.5.7)
Although biologically age-dependent transition rates are a more realistic option, it is not simple
enough for numerical calculations with the experimental data provided. Thus, we do neglect this
in our model applications in Chapters 3, 4 and 5 because of the lack of experimental estimates that
would be needed if one would want to include a minimum time each cell averagely spends in a phase
before leaving the phase. By taking the limit when τp → 0, we can transfer from piecewise constant
transition rates rp→p+1(τ) to constant transition probability rates rp→p+1, thus stating that cells can
possibly transfer to the consecutive phase as soon as they enter present phase p.
2.5.3 Characteristic equation
Characteristic equation (2.4.8) is a condition imposed on our model that describes the population
at BEG state. In the case of the piecewise transition rates, we can show from equation (2.4.7) this
condition explicitly as the following nonlinear transcendental expression:
Q(λ) = aG1aS aG2M
(bG1 + λ)(bS + λ)(bG2M + λ)
exp
(
− λ[τG1 + τS + τG2 M]
)
= 1. (2.5.8)
We remind the reader that cells have a probability of transferring to the consecutive phase or die after
ages τG1 , τS , and τG2M in G1, S and G2M phases, respectively.
By taking potential aging times τp in every phase equal to zero, we can derive the BEG condition
for the constant transition probability rates, depicted in Figure 2.4, as follows:
Q(λ) = aG1aS aG2M
(bG1 + λ)(bS + λ)(bG2M + λ)
= 1. (2.5.9)
For the simplicity in numerical simulations later in thesis, we introduce new variable F(λ) and define
it as:
F(λ) = 1Q(λ) = 1. (2.5.10)
Examination of equation (2.5.10) shows the following evaluations:
lim
λ→∞
F(λ) → ∞, lim
λ→−∞
F(λ) = −∞, (2.5.11)
and because F(λ) is a continuous function, the intermediate value theorem shows that at least one
solution to the equation Q(λ) = 1 exists. Figure 2.4 illustrates the characteristic equation for three
theoretical cell lines with constant transition rates.
2.5.4 Constant proportions of cell population at BEG
To derive constant proportion formulae, we start by introducing a new notation: the probability density
function pi(t, τ) that depicts the probability density for a certain cell to be in the phase p of age τ at
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Figure 2.4: Characteristic equation F(λ) = 1 is plotted for three random sets of constant transition
rates, where rG1S < rS G2M . Here red dotted line depicts a cell line with transition rates rG1 = 0.025,
rS = 0.25 and rG2M = 1.9. Blue solid line rG1 = 0.009, rS = 0.11 and rG2M = 1.1. Green dashed line
rG1 = 0.02, rS = 0.35 and rG2M = 1.2.
time t. From equations (2.4.1) and (2.5.2), the probability density function, in the general case of
population growth, is defined as number density divided by the total mass of the system as follows:
pip(t, τ) =
np(t, τ)
Ntot(t) . (2.5.12)
From equations (2.5.1), (2.5.2), and (2.5.12), the proportion in p phase, denoted as Πp(t), is given by
the following expression:
Πp(t) =
∫ T
0
pip(t, τ) dτ =
∫ T
0 np(t, τ) dτ
Ntot(t) =
Np(t)
Ntot(t) , (2.5.13)
thus, the following identity (essential in our later models) arises:∑
p
∫ T
0
pip(t, τ)dτ =
∑
p
Πp(t) = 1, for t ≥ 0, (2.5.14)
where p ∈ {G1, S ,G2M}.
We continue by showing that, for the case of population in BEG state, from equations (2.5.12) and
(2.5.3), the probability density function, denoted as p̂ip(τ), is expressed as follows:
p̂ip(τ) =
n̂p(τ)
Ntot(0) , (2.5.15)
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observing that from equation (2.4.1), we can express numerical density function at BEG state in each
phase p as follows:
np(t, τ) = eλtn̂p(τ). (2.5.16)
We proceed by presenting the constant population formulae, from equations (2.5.13) and (2.5.14), for
the population at BEG as follows:
Πp =
∫ T
0
p̂ip(τ) dτ =
∫ T
0 n̂p(τ) dτ
Ntot(0) , where
∑
p
Πp = 1. (2.5.17)
We go on to explicitly show the number density, the probability density functions, and, subsequently,
formulae of the constant proportions in each phase on the cell cycle. Remembering that the transition
probability rates ap and bp are assumed to be piecewise constant functions, as discussed in Section
2.5.2.
We begin by rewriting general steady age-distribution equation (2.4.10) for each phase p of the
cell cycle separately, where p ∈ {G1, S ,G2M} as follows:
n̂p(τ) =
∫ T
0
ap−1(s) n̂p−1(s) ds e−
∫ τ
0 (bp(s)+λ) ds, t > τ. (2.5.18)
From Section 2.5.1, we show that the total cell number in the respective phase is as follows:
Np(t) =
∫ T
0
np(t, τ) dτ,
= eλt
∫ T
0
n̂p(τ) dτ,
=
∫ τp
0
np(t, τ) dτ +
∫ T
τp
np(t, τ) dτ,
= N˜p(t) + N p(t),
= eλt(N˜p + N p),
where we define N˜p =
∫ τp
0 n̂p(s)ds as the total cell number in phase p at age τ < τp and N p =∫ T
τp
n̂p(s)ds as the cell number in phase p at age τ ≥ τp, when T is assumed to be very large. Thus,
we can rewrite steady age-distribution equation (2.5.18) for each phase p of the cell cycle, depicted in
Figure 2.5 as:
n̂p(τ) = ap−1e−λτN p−1
1, τ < τpe−bp(τ−τp), τ ≥ τp. (2.5.19)
We note here that to obtain the number density function for the case of constant transition probability
rates, the growth age in each phase τp is set to zero, thus giving n̂p(τ) = ap−1N p−1e−(bp+λ)τ. By taking
into account that limτ→T e−τ = 0, where T is the maximum age in a phase (as would be seen in the
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Figure 2.5: A diagram showing the piecewise differentiable number density n̂p(τ) at the BEG state for
piecewise constant transition rates ap and bp.
case of T → ∞), the total number of cells in p phase at time t can be expressed as follows:
Np(t) = N˜p(t) + N p(t),
= eλtap−1N p−1
[1 − e−λτp
λ
+
e−λτp
λ + bp
]
. (2.5.20)
From equation (2.5.20), we can establish that N˜p = ap−1N p−1 1−e−λτpλ and N p = ap−1N p−1 e
−λτp
λ+bp
.
We proceed by writing out population number density functions for phases G1, S , and G2M as follows:
n̂G1 (τ) =
̂nG1 (0)e−λτ, τ < τG1 ,n̂G1 (0)e−λτe−bG1 (τ−τG1 ), τ ≥ τG1 , (2.5.21)
n̂S (τ) =
aG1 NG1 e−λτ, τ < τS ,aG1 NG1 e−λτe−bS (τ−τS ), τ ≥ τS , (2.5.22)
n̂G2 M(τ) =
aS NS e−λτ, τ < τG2M ,aS NS e−λτe−bG2 M(τ−τG2 M), τ ≥ τG2M , (2.5.23)
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where n̂G1(0) = aG2MNG2M , see Figure 2.5. Furthermore, we can express NG1 as:
NG1 =
∫ T
τG1
n̂G1 (s) ds,
= n̂G1 (0)
e−λτG1
bG1 + λ
, (2.5.24)
and then NS as follows:
NS = n̂G1 (0)
aG1
(bG1 + λ)(bS + λ)
e−λ(τG1+τS ). (2.5.25)
Thus, from equations (2.5.20), (2.5.24),(2.5.25) and taking into account that n̂G1 (0) = aG2MNG2M , the
total number in G1, S , and G2M phases for the population at BEG are given as follows:
NG1(t) = eλtn̂G1(0)
[1 − e−λτG1
λ
+
e−λτG1
λ + bG1
]
, (2.5.26)
NS (t) = eλtn̂G1(0)
aG1
λ + bG1
e−λτG1
[1 − e−λτS
λ
+
e−λτS
λ + bS
]
, (2.5.27)
NG2M(t) = eλtn̂G1(0)
aG1aS
(λ + bG1)(λ + bS )
e−λ(τG1+τS )
[1 − e−λτG2 M
λ
+
e−λτG2 M
λ + bG2M
]
. (2.5.28)
We remind here that transition rates are defined as aG1 = rG1→S , aS = rS→G2M, aG2M = 2rG2M→G1 and
bp = rp→p+1 + µp with p ∈ {G1, S ,G2M}. Because Ntot(t) = NG1 (t) + NS (t) + NG2M(t), we can rewrite
equation (2.5.3) as follows:
Ntot(t) = eλtn̂G1 (0)Cλ, (2.5.29)
observing that Ntot(0) = n̂G1 (0)Cλ and n̂G1 (0) = aG2MNG2M. Furthermore, our constant Cλ is defined
as follows:
Cλ =
1 − e−λτG1
λ
+
e−λτG1
λ + bG1
+
aG1
λ + bG1
e−λτG1
[1 − e−λτS
λ
+
e−λτS
λ + bS
]
+
+
aG1 aS
(λ + bG1)(λ + bS )
e−λ(τG1+τS )
[1 − e−λτG2 M
λ
+
e−λτG2 M
λ + bG2M
]
. (2.5.30)
We have to note here that by using characteristic equation (2.5.8), after some algebraic manipulation,
we can show that equation (2.5.30) can be simplified to the following identity:
Cλ =
1
2λ
. (2.5.31)
From equations (2.5.12) and (2.5.21) to (2.5.25), the probability density functions for G1, S , and G2M
phases can be expressed as follows:
piG1(τ) =
 1Cλ e−λτ, τ < τG1 ,1
Cλ e
bG1τG1 e−(bG1+λ)τ, τ ≥ τG1 ,
(2.5.32)
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piS (τ) =

1
Cλ
aG1
bG1+λ
e−λτG1 e−λτ, τ < τS ,
1
Cλ
aG1
bG1+λ
e−λτG1 ebS τS e−(bS+λ)τ, τ ≥ τS ,
(2.5.33)
piG2M(τ) =

1
Cλ
aG1 aS
(bG1+λ)(bS+λ)
e−λ(τG1+τS )e−λτ, τ < τG2M ,
1
Cλ
aG1 aS
(bG1+λ)(bS+λ)
e−λ(τG1+τS )ebG2 MτG2 M e−(bG2 M+λ)τ, τ < τG2M .
(2.5.34)
We introduce new variables Π˜p and Πp, where Π˜p shows the proportion of the population in a partic-
ular phase that is in the required phase growing state, and Πp denotes the proportion of the population
that is able to transition onto the next phase. These notions are defined as follows:
Π˜p =
∫ τp
0
pip(τ) dτ, (2.5.35)
Πp =
∫ T
τp
pip(τ) dτ, (2.5.36)
with the total proportion in each phase as Πp = Π˜p+Πp. Finally, the constant proportions in each cell
cycle phase for the population at BEG state are expressed as follows:
ΠG1 =
1
Cλ
[1 − e−λτG1
λ
+
e−λτG1
λ + bG1
]
, (2.5.37)
ΠS =
1
Cλ
aG1
λ + bG1
e−λτG1
[1 − e−λτS
λ
+
e−λτS
λ + bS
]
, (2.5.38)
ΠG2M =
1
Cλ
aG1aS
(λ + bG1 )(λ + bS )
e−λ(τG1+τS )
[1 − e−λτG2 M
λ
+
e−λτG2 M
λ + bG2M
]
, (2.5.39)
where Π˜p is the first term of the sum, and Πp is the second term of the summation in the square brack-
ets for corresponding phases p ∈ {G1, S ,G2M}.
We remind the reader here that in order to convert previous formulae for the population with constant
transition rates among phases, aging times τG1 , τS , and τG2M must be set to zero.
2.5.5 Population doubling time and average cell-age
We define the doubling time of the cell population, denoted by Td, as a time unit taken for a population
to double its cell number. When population is at the BEG state and grows at a constant rate λ, from
(2.5.3), we see that 2Ntot(0) = Ntot(0)eλTd . Thus, we express population doubling time as follows:
Td =
ln2
λ
. (2.5.40)
We continue by defining the expected cell age in each phase p, denoted as Tp, of the cell population
at BEG as follows:
Tp =
∫ T
0
τpip(τ)dτ =
∫ τp
0
τpip(τ)dτ +
∫ T
τp
τpip(τ)dτ. (2.5.41)
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We can express the average cell-age for phases G1, S , and G2M as follows:
TG1 =
1
Cλ
[1 − e−λτG1
λ2
−
τG1e
−λτG1
λ
]
+
1
Cλ
e−λτG1
λ + bG1
[
τG1 +
1
λ + bG1
]
, (2.5.42)
TS =
1
Cλ
e−λτG1
λ + bG1
[1 − e−λτS
λ2
−
τS e
−λτS
λ
]
+
1
Cλ
aG1e
−λ(τG1+τS )
(λ + bG1)(λ + bS )
[
τS +
1
λ + bS
]
, (2.5.43)
TG2 M =
1
Cλ
aG1e
−λ(τG1+τS )
(λ + bG1 )(λ + bS )
[1 − e−λτG2 M
λ2
−
τG2Me
−λτG2 M
λ
]
+
1
Cλ
1
aG2M
[
τG2M +
1
λ + bG2M
]
,
(2.5.44)
where the characteristic equation (2.5.8) was used to simplify the second term of TG2M . Thus, the
average cell-age of the cancer cell population at BEG, denoted as Ta, is the sum of the average cell-
age times of each phase of the cell cycle, defined as follows:
Ta = TG1 + TS + TG2M. (2.5.45)
We expect that the average age of cells in the population Ta is smaller than the population doubling
time Td. Since the relationship between average cell age Ta and population doubling time Td is not
explicitly observable from our formulae, we created a following simulation: we chose random (and
biologically realistic) transition rates rp→p+1, death rates µp and aging times τp, for p ∈ {G1, S ,G2M}.
The results shown in Figure 2.6. The relationship between the doubling time and average cell-age is
as follows:
Ta < Td. (2.5.46)
For the simulations shown in Figure 2.6, random uniformly distributed transition rates rp→p+1, ag-
ing times τp and death rates µp were chosen. The intervals picked were rG1→S ∈ [0.0001, 0.2],
rS→G2M ∈ [0.0001, 0.2], rG2M→G1 ∈ [0.05, 2], τG1 ∈ [3, 25],τS ∈ [2, 25], τG2M ∈ [0.01, 10], and
µp ∈ [10−4, 10−3], for p ∈ {G1, S ,G2M} with units for these variables presented in the Glossary. We
remark that for Figure 2.6, a constraint Td < 168 was imposed because population doubling time
for cells growing in vitro is rarely exceeds 168 hours (or 1 week). We observe that from equation
(2.5.8) the growth rate value λ is affected by transition rates rp→p+1, aging times τp and death rates
µp; therefore variations in the nine-dimension space of transition rates, aging times and death rates
results in stochastic like changes in doubling time Td values and the average cell age Ta, as can be
seen in Figure 2.6.
2.5.6 Expected cell removal time, i.e., cell-cycle time
We introduce a new parameter - the average (expected) age of cells removed from a phase, denoted as
T ∗p. A cell removed from a phase p is considered as either transferred to the next phase p + 1 or dead.
We note that the average cell-age in phase p, namely Tp, is not equal to the average cell removal-age
from phase p, T ∗p. We examine the relationship between these two terms in this section.
The removal time is the time cells at age zero in phase p, namely n̂p(0), take to transit through
phase p. Let us assign some constant σR to the magnitude of the cell number density at age zero that
we want to track, so σR = n̂p(0). This number density of cells will grow (age) for at least τp hours and
then transfer onto the next phase or die. Because the cell population continues to grow for time τp,
the initially observed number density σR will be reduced because the total number of cells in phase p,
namely Np, would have grown at a rate λ; thus, scaling the initially observed number density σR by
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Figure 2.6: Diagram representing relationship between cell doubling time Td and average cell-age Ta
for theoretical cancer cell populations. Transition rates rp→p+1, aging times τp, and death rates µp
are randomly chosen from uniform distribution from the following intervals: rG1→S ∈ [0.0001, 0.2],
rS→G2M ∈ [0.0001, 0.2], rG2M→G1 ∈ [0.05, 2], τG1 ∈ [3, 25],τS ∈ [2, 25], and τG2M ∈ [0.01, 10], with
death rates µG1 ∈ [10−4, 10−3], µS ∈ [10−4, 10−3], and µG2M ∈ [10−4, 10−3]. A constraint of Td < 168
hours is imposed for biological realism.
eλτp . Therefore, the number density equations (2.5.21)-(2.5.23) have to be scaled by eλτ when dealing
with the removal time expressions. These normalised number density functions for each phase are
referred as n̂∗p, so n̂∗p(τ) = n̂p(τ)eλτ. We define the number of cells leaving phase p per unit time at age
τ, denoted as Hp(τ), as follows:
Hp(τ) = n̂∗p(0) − n̂∗p(τ), p ∈ {G1, S ,G2M}, (2.5.47)
we remark to the reader that the initially observed/tracked total number of cells is n̂∗p(0), thus the total
cell number removed, denoted by Htotp , is Htotp = n̂∗p(0) when τ → T . From equations (2.5.21)-(2.5.23)
and the scaling factor n̂∗p(τ) = n̂p(τ)eλτ, we can derive n̂∗p(τ) as:
n̂∗p(τ) =
̂n∗p(0), τ < τp,n̂∗p(0) e−bp(τ−τp), τ ≥ τp, (2.5.48)
for p ∈ {G1, S ,G2M}. We remark that n̂∗p(0) = n̂p(0). We continue by introducing the rate at which
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the number density of cells changes due to removal from phase p, denoted by ĥp(τ), as follows:
ĥp(τ) = −
d̂n∗p(τ)
dτ . (2.5.49)
The function ĥp(τ) is piecewise differentiable with respect to τ. Furthermore, we introduce a variable
for the probability density function for cells that are removed at age τ, refer to it as γ̂p(τ), and define
as:
γ̂p(τ) =
ĥp(τ)
Htotp
= −
1
n̂p(0)
d n̂∗p(τ)
dτ , (2.5.50)
then the probability of being removed from phase p at age τ, denoted as Γp(τ), is defined as follows:
Γp(τ) =
∫ τ
0
γ̂p(s) ds, (2.5.51)
where limτ→T Γp(τ) = 1. Considering that the probability density function γ̂p is decreasing in interval
[τp, T ), we express the expected time of cell removal from phase p as follows:
T ∗p =
∫ T
0
τ̂γp(τ) dτ =
∫ τp
0
τ̂γp(τ)dτ +
∫ T
τp
τ̂γp(τ)dτ, (2.5.52)
=
∫ τp
0
τ
[
−
1
n̂p(0)
d n̂∗p(τ)
dτ
]
dτ +
∫ T
τp
τ
[
−
1
n̂p(0)
d n̂∗p(τ)
dτ
]
dτ.
For simplicity, we define normalised number of cells in each phase p as:
N˜∗p =
∫ τp
0
n̂∗p(τ) dτ, τ < τp, (2.5.53)
N∗p =
∫ T
τp
n̂∗p(τ) dτ, τ ≥ τp.
Finally, by integrating equation (2.5.52) and incorporating (2.5.53), we derive the following expres-
sion for the time of removal from phase p:
T ∗p =
N˜∗p
n̂p(0) +
N∗p
n̂p(0) . (2.5.54)
We proceed by deriving explicit formulae for expected removal times in each phase. Taking into
account equations (2.5.48) and (2.5.53), we obtain the following expressions:
T ∗G1 = τG1 +
1
bG1
, (2.5.55)
T ∗S = τS +
1
bS
, (2.5.56)
T ∗G2M = τG2M +
1
bG2M
. (2.5.57)
We remind the reader that cancer cell population is composed of proliferating cells with some un-
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dergoing cell death; thus, all cells in each phase will either transit to the next phase or die. When
comparing the average age in the particular phase Tp with the average removal age T ∗p, we can see
that the following is true :
T ∗p > Tp.
We have not shown this result analytically. Here we define the expected time of cell removal from all
phases, denoted as Trm, as the sum of the removal times of all three phases:
Trm = T ∗G1 + T
∗
S + T
∗
G2M = τG1 + τS + τG2M +
1
bG1
+
1
bS
+
1
bG2M
. (2.5.58)
The relationship between the population doubling time Td and the expected removal time from all
phases Trm (or expected transit time through all phases) is as follows:
Td ≤ Trm. (2.5.59)
We ran a Monte Carlo simulation for equation (2.5.58) versus population doubling time (see Figure
2.7) for theoretical cell lines with the same random values for the transition rates, aging times and
death rates as in Figure 2.6 and obtained the following expression:
Trm = θTd, with θ ∈ [1, 1.3]. (2.5.60)
If no cell death µp or aging times τp are incorporated in the model, the expression (2.5.60) would
still hold as the magnitude of the growth rate λ, calculated from the characteristic equation (2.5.8), is
affected by the apoptosis rate and aging time variations. Clearly, the average cell age in the phase Ta
is always smaller than the average removal time of the cell cycle Trm.
The notions, the average cell-removal time and the average cell-cycle time, are intertwined when
relating to cell growth times and can also be called the cell transit time through cell cycle. In the
following chapters of this thesis, we will assume that notions of expected cell-removal time, cell-
transit time and cell-cycle time are interchangeable and will refer to it as Tc, i.e., Trm = Tc.
As mentioned before, the estimation of the cell-cycle time of a cancer population is of a particular
interest for biologists as it relates to patients survival prognosis; shorter cell-cycle times relate to poor
prognoses for the cancer patient. Mathematical model that could evaluate the cell-cycle time from a
single experimental observation, would be valuable to clinicians.
In experimental observations, biologists often assume that the cell-cycle time is equal to the pop-
ulation doubling time, which is calculated from the constructed growth curve. This data is then used
for the empirical estimate of the transition rate probability between certain phases of the cell cycle.
We note that this empirical method does not take into account the possibility of cell death. Our math-
ematical model agrees that the population doubling time can be equal to the cell-cycle time for some
cell lines. However, in general case, the average cell-cycle time of the population is greater or equal
to the population doubling time.
Several mathematical methods of the cell-cycle time estimation for the cancer cell population at
the BEG state can be found in the literature. The identical expression for the average cell-cycle time
(Tc = Trm) derived from our model, shown in equation (2.5.58), can be found in Basse & Ubezio
(2007); Basse et al. (2005); Simms et al. (2012). However, in these publications, the cell-cycle time
expression has been guessed and then verified by using a discrete computational simulation Simms
et al. (2012). An alternative method for estimating cell-cycle time can be found in Chiorino et al.
(2001), where the desynchronization of the population growth has been incorporated into the age-
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Figure 2.7: Diagram representing relationship between cell doubling time Td and expected re-
moval time Trm for theoretical cancer cell populations. Transition rates rp→p+1, aging times τp,
and death rates µp are randomly chosen from uniform distribution from the following intervals:
rG1→S ∈ [0.0001, 0.2], rS→G2M ∈ [0.0001, 0.2], rG2M→G1 ∈ [0.05, 2], τG1 ∈ [3, 25],τS ∈ [2, 25], and
τG2M ∈ [0.01, 10], with death rates µG1 ∈ [10−4, 10−3], µS ∈ [10−4, 10−3], and µG2M ∈ [10−4, 10−3]. A
constraint of Td < 168 hours is imposed for biological realism.
structured model and then related to the mean cell cycle duration. The computational results of this
model showed that, for two cell lines examined, the population doubling times and the average cell-
cycle times are approximately the same in their magnitude, thus strongly agreeing with our model
result. We note that the model in Chiorino et al. (2001) requires many experimental observation
points to monitor the desynchronized population’s convergence to the exponential growth state. The
stochastic approach of the desynchronization rate method has been shown in Bronk et al. (1968);
Olofsson & McDonald (2009). In the classic work Steel (1977), analytical methods for estimating the
duration of particular phases have been derived from an age-structured model, where phases G1, S
and G2 have been combined into one, therefore the transition rate probabilities between these phases
have not been included into the model. For example, from this method, the duration of the S -phase
can be calculated from the experimental estimates of the doubling time, the growth rate and the la-
belling index (the number of cells in the S -phase of the growth cycle divided by the total cells in the
population, namely what we refer to as ΠS ). Many papers utilise analytical results from Steel (1977)
to estimate the transit times of the particular phases Fried (1973); Larsson et al. (2007); Terry & White
(2006); White & Terry (2000).
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2.6 Conversion of age distribution model to ordinary differential equa-
tion model
In further chapters of this thesis, we apply experimental data to several ODE models. Transition
from PDE to the ordinary differential equation (ODE) is done with the assumption of homogeneity
of individual cells within the particular phases p. Taking into account equation (2.5.1), we find by
integrating McKendrick-von Foerster equation (2.2.16) over 0 ≤ τ ≤ T the following ODE system:
dN(t)
dt = n(t, τ = 0) −
∫ T
0
Dout(t, τ)n(t, τ) dτ, 0 < t < ∞, (2.6.1)
=
∫ T
0
Din(t, τ)n(t, τ) dτ −
∫ T
0
Dout(t, τ)n(t, τ) dτ, (2.6.2)
where we used expression N(t, τ → T ) = 0 and the renewal condition (2.2.18) to derive the result
above.
The only possible form of the matrices {Din,Dout}, in order to convert this equation into an ODE
system, is to have these matrices independent of τ; then we obtain the following ODE system:
dN(t)
dt = BN(t), N(0) =
∫ T
0
n(0, τ) dτ, 0 < t < ∞, (2.6.3)
and for the Din, Dout matrices also independent of time t, we have the constant matrix
B = (Din − Dout),
=

−(rG1→S + µG1) 0 2rG2M→G1
rG1→S −(rS→G2M + µS ) 0
0 rS→G2M −(rG2M→G1 + µG2M)
 .
In Chapters 3 and 5, we use ODE systems as main modelling tools. In Chapter 4, we derive an
ODE system describing the variations of cell population proportions over time that with an additional
constraint, showed in equation (2.5.14), becomes a differential-algebraic equation (DAE) system.
2.7 Delay differential equation system
The transition from an age-structure model with piecewise constant transition rates to a DDE system
is done by integrating the corresponding PDE equations over the age (as shown in Section 2.6). Thus,
by integrating McKendrick-von Foerster equation (2.2.3) over interval τ ∈ [0, τp), we can obtain the
following expression:
∂
∂t
∫ τp
0
np(t, τ) dτ = −np(t, τp) + np(t, 0) −
∫ τp
0
bp(τ)np(t, τ) dτ,
dN˜p(t)
dt = −np(t, τp) +
∫ T
0
ap−1(τ)np−1(t, τ) dτ −
∫ τp
0
bp(τ)np(t, τ)dτ,
= −np(t, τp) + ap−1N p−1(t), (2.7.1)
with the initial condition N˜p(0) =
∫ τp
0 np(0, τ) dτ. We remind the reader from Section 2.5.4 notion
N˜p(t) is the total number of cells in phase p at time t between ages 0 and τp, and notion N p(t) is the
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total number of cells in phase p at time t after age τp. Integrating over interval τ ∈ [τp, T ], we get the
following:
∂
∂t
∫ T
τp
np(t, τ) dτ = −np(t, T ) + np(t, τp) −
∫ T
τp
bp(τ)np(t, τ) dτ,
dN p(t)
dt = np(t, τp) −
∫ T
τp
bp(τ)np(t, τ) dτ,
= np(t, τp) − bpN p(t), (2.7.2)
with the initial condition as follows N p(0) =
∫ T
τp
np(0, τ) dτ.
The number density of the population in phase p, from equation (2.2.15) when population is not
at BEG and transition rates are only age-dependent, is as follows:
np(t, τ) =
∫ T
0
ap−1(s)np−1(t − τ, s) ds e−
∫ τ
0 bp(s) ds, (2.7.3)
=
ap−1
∫ T
0 np−1(t − τ, s) ds, τ < τp,
ap−1
∫ T
0 np−1(t − τ, s) ds ebp(τ−τp), τ ≥ τp,
(2.7.4)
where, from equation (2.5.1), we can express the integral in equation (2.7.4) as N p−1(t − τ) =∫ T
0 np−1(t − τ, s) ds. Thus, we can conclude that the number density of cells at age τp, in phase p
at time t, can be calculated as follows:
np(t, τp) = ap−1N p−1(t − τp). (2.7.5)
A DDE model tracks, first, the total cell number that are in a required growth state, namely N˜p(t),
at time t in each phase p, and, second, the total cell number that are in transition to the next phase,
namely N p(t), at time t in each phase p. We continue by deriving a DDE system, by using equations
(2.7.1), (2.7.2), and (2.7.5) to express the cell number variations in time as follows:
dN˜G1
dt = aG2MNG2M(t) − aG2MNG2M(t − τG1), (2.7.6)
dNG1
dt = aG2MNG2M(t − τG1) − bG1 NG1(t), (2.7.7)
dN˜S
dt = aG1 NG1(t) − aG1 NG1(t − τS ), (2.7.8)
dNS
dt = aG1 NG1(t − τS ) − bS NS (t), (2.7.9)
dN˜G2M
dt = aS NS (t) − aS NS (t − τG2M), (2.7.10)
dNG2M
dt = aS NS (t − τG2M) − bG2MNG2M(t), (2.7.11)
where aG1 = rG1→S , aS = rS→G2M , aG2M = 2rG2M→G1 , and bp = rp→p+1 +µp, p ∈ {G1, S ,G2M}. With
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the following initial conditions:
N˜G1(0) = N˜0G1 , (2.7.12)
NG1(0) = N
0
G1 , (2.7.13)
N˜S (0) = N˜0S , (2.7.14)
NS (0) = N0S , (2.7.15)
N˜G2M(0) = N˜0G2M , (2.7.16)
NG2M(0) = N
0
G2M. (2.7.17)
Since, biologically, cells have to grow/age in certain phases before transferring to the next phase,
a mathematical model incorporating this property would be preferable to the ODE model, in the
literature linear DDEs. Such mathematical models often require estimates of aging times τp that
experimentally can be observed via mitotic selection method, a linear DDE model investigating the
breast cancer cell line growth dynamics can be seen in Simms et al. (2012). Mitotic selection is a
synchronization method that does not affect the cell cycle. Upon entering mitosis, cells are not firmly
attached to the surrounding medium and can be collected after agitation (by shaking a culture vessel
like petri dish). This method is applicable only to cells that grow in monolayer culture, see Pagano
(1995). Cells that are tightly adherent to the surface of the culture vessel or to each other cannot be
synchronized by mitotic selection.
The DDE model in Simms et al. (2012) depicts a cell-cycle that has been subdivided into seven
phases, our DDE system (2.7.6) verifies the model proposed in the literature as the model in Simms
et al. (2012) can be reduced to a six-phase DDE system. In system (2.7.6) three equations out of six
decouple, the total number of cells leaving the storage phases have been incorporated into the delay
terms of the transiting number of cells. Population dynamics described with the delay differential
equation system represents the population growth at BEG state.
We have not been provided with the experimental estimates of aging times τp from the mitotic se-
lection for the melanoma cancer cell lines. Thus in the following chapters, we utilise ODE systems
because the data that can be extracted from the flow cytometry profiles is not sufficient to apply the
DDE model.
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Chapter 3
Determination of Cell Population
Dynamics Using Plateau Log Reduction
Method
Cell-cycle times are vital parameters in cancer research and short cell-cycle times are often related to
poor survival of cancer patients. A method for experimental estimation of cell-cycle times or doubling
times of cultured cancer cell populations, based on addition of paclitaxel (an inhibitor of cell division)
has been proposed in literature. In this chapter, we use a mathematical model to investigate relation-
ships between essential parameters of the cell division cycle following inhibition of cell division. The
reduction in the number of cells engaged in DNA replication reaches a plateau as the concentration
of paclitaxel is increased; this can be determined experimentally. From our model, we have derived a
plateau log reduction formula for proliferating cells and established that there are linear relationships
between the plateau log reduction values and the reciprocal of doubling times (i.e., growth rates of
the populations). We have therefore provided theoretical justification of an important experimental
technique to determine cell doubling times. Furthermore, we have applied Monte Carlo experiments
to justify the suggested linear relationships used to estimate doubling time from 5-day cell culture
assays. We show that our results are applicable to cancer cell populations with cell loss present.
3.1 Introduction to the plateau log reduction method
In this chapter, we develop analytical methods to interpret the growth of cancer cells in culture, thus
providing insights into the measurement of cancer growth in vitro unexposed to any cancer treatment.
An age-structured model with constant transition rates (derived in Section 2.6) has been reduced to
the ODE model and used in study of the cell population dynamics.
We remind the reader that our mathematical model depicts the dynamics of cell population in BEG
state. Cancer cell population has no microenvironmental constraints when growing in vitro. As dis-
cussed before, mammalian cells proliferating in culture progress through a series of four phases during
the cell division cycle, namely G1, S (DNA replication), G2 and M (mitosis) phases. It seems rela-
tively straightforward to determine experimentally at least two of the basic parameters of proliferating
cells, namely population doubling time and the proportion of cells in each phase. The population dou-
bling time Td can be measured by counting the number of cells at different times to produce a growth
curve, and the proportion of cells in each phase can be measured by staining the DNA with a fluores-
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cent dye such as propidium iodide and analysing the population by flow cytometry. This latter method
does not distinguish G2 and M-phase cells (which have the same DNA content) and these analyses
therefore often measure three phases G1, S and a combined G2M-phase, as discussed in Section 1.5.
Determination of transit times for each of the phases and the cycle time of the overall population is
complicated by two issues:
1. Although the numbers of proliferating cells increase exponentially with time, the phase transit
times are not just simply related to the proportion of cells as determined by flow cytometry.
A direct relationship has been thought to be so in some of the literature Barnes et al. (2001);
Taylor et al. (1983).
2. The transit times of individual mammalian cells in individual phases are variable, particularly
in G1 phase. This has the effect that in a proliferating cell population, some cells may remain
for long periods in G1 phase and thus appear as non-proliferating cells. In previous studies, this
issue has been addressed by modelling the cell cycle using a system of differential equations and
incorporating transition probabilities from one phase to another for the onset of DNA replication
and cell division Basse et al. (2003, 2004b), and we utilise similar approach in this chapter.
A further practical issue in the determination of cell cycle parameters of a proliferating cell population
is the incidence of apoptosis Baguley (2011). Many, perhaps all, cell lines in culture have a finite
probability of undergoing this programmed cell death mechanism which begins within seconds with
blebbing of the cytoplasm and continues for about 3 hours Andrade et al. (2010), leading to complete
fragmentation of the cell and to loss of DNA, thus making them almost invisible to microscopy and
DNA-based flow cytometry. Therefore, simple counting of cells cannot estimate this cell loss factor,
which would lead to errors in the calculation of population doubling times.
An alternative method, from the method explained above, for the estimation of cell cycle parame-
ters is the so-called stathmokinetic method, where the cell cycle is blocked at a particular point (such
as mitosis) and the consequent changes in proportions in the cell phases are measured by flow cy-
tometry. Cell cycle can be blocked by using a mitotic inhibitor chemotherapy drug - paclitaxel. It
interferes with the normal breakdown of microtubules during cell division. Because the transition
to apoptosis is thought to be essentially independent of the cycle phase, this method provides a good
basis for calculating cell cycle parameters. This method has been previously applied by using the drug
paclitaxel, which arrests cells in mitosis and prevents cell division. A complication of this approach is
that cells arrested by paclitaxel subsequently enter a state, which we termed A-phase, where DNA is
slowly but progressively degraded. In Basse et al. (2004a), the A-phase is included to exhibit process
of slow DNA loss.
A simplification of the above stathmokinetic methodology is to measure the incorporation of ra-
dioactive labelled thymidine (3H-TdR) into cellular DNA at a selected time after addition of paclitaxel.
This method provides an estimate of the number of cells in the population that have recently (less than
6 hours) entered the S-phase. The method uses comparison of cell populations grown in the presence
and absence of labelled thymidine to derive the cell cycle data. Comparison of measurements of the
population doubling time (by cell counting) and the described thymidine incorporation following ad-
dition of paclitaxel provided a significant correlation in Baguley et al. (1995). This result has led to
the development of a technique to more accurately estimate doubling time of cell populations. More-
over, the derivation of population doubling time, by counting, does not take cell loss into account.
The method based on this simplification, as outlined in this chapter, overcomes this problem by use
of the measured uptake of 3H-TdR into DNA of cultured cells. Then a ‘plateau’ reduction value
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(PLR) for 3H-TdR incorporation, at paclitaxel concentrations above a value that completely inhibits
cell division, can be used to estimate doubling time.
We address the question here, of whether the transition probability model can be used to de-
rive a direct relationship between cell doubling time and thymidine incorporation data. This chapter
provides the theoretical justification and a further extension of this 3H-TdR technique, which was
pioneered in Baguley et al. (1995, 1999). Central to our results here, and in flow cytometry experi-
ments, is the determination of transition rates between the phases that are used in our mathematical
model from the measurement of percentages in each phase and the cell population doubling time. In
subsequent sections, we address the existence and uniqueness of this mathematical mapping and its
inverse map (from the transition rates to the cell proportions). We suggest the replacement of the
direct counting measurement of the doubling time for cultures of proliferating cells by its calculation
from the plateau logarithm reduction measurement discussed here.
We provide in Section 3.2 respective adjustments to our general mathematical model derived in
Chapter 2. In Section 3.2.1, we utilise the analytical formulae, from Chapter 2, for the relationships
between transition rates, total population growth rate and proportions in each phase at BEG state
in order to provide theoretical justification and extensions which are discussed in Section 3.3. We
show our results of a Monte Carlo simulation of the full equations to justify the linear reciprocal
relationship between PLR and Td derived asymptotically in in Section 3.3.2.1. In Section 3.3.4 we
summarise our results showing the simple affine relationship that exists between Td and PLR. This
result is particularly important for oncology.
3.2 The model for in vitro human tumour cell population kinetics
We reduce our age-structured model (introduced in Chapter 2) to the ODE model due to limited
amount of experimental estimates. In Section 2.6, it was shown that the dynamics of the total number
of cells in each phase are subsumed by the ODE model. In this case, transition rate probabilities are
not functions of age. In this chapter, transition rates are constant and we refer to them as rp→p+1
throughout this chapter with p ∈ {G1, S ,G2M} (in Chapter 2 we referred to them as rp→p+1). We
observe that mathematical model has to incorporate the effects of chemotherapy drug paclitaxel, thus
appropriate adjustments to the ODE model in Section 2.6 have been made. Consider a population of
cells, with structure classification as G1, S , G2M and A, according to their corresponding phase of
the cell cycle and with the probability that cells can transfer from one phase to the next according to
transition rates {rG1→S , rS→G2M, rG2 M→G1 , rA} between phases. A cell arrest or apoptosis phase A is
also included as a removal class, and this occurs from the G2M-phase so that it can model the effect of
paclitaxel. In case of an A-phase consisting of arrested cancer cells, we refer to it as non-proliferating
cells of the population. Whereas, for an A-phase representing apoptosis we refer to it as cell death.
The resulting dynamical system, depicted in Figure 3.1, can be described with three ODEs — one
equation for the number of cells in each phase {NG1(t), NS (t), NG2 M(t)} as a function of time (t) as
follows:
dNG1 (t)
dt = 2rG2 M→G1 NG2M(t) − rG1→S NG1(t), (3.2.1a)
dNS (t)
dt = rG1→S NG1(t) − rS→G2MNS (t), (3.2.1b)
dNG2 M(t)
dt = rS→G2MNS (t) − rG2 M→G1 NG2M(t) − rANG2M(t), (3.2.1c)
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parameter description units
rG1→S rate transition G1 to S -phase hours−1
rS→G2M rate transition S to G2M-phase hours−1
rG2M→G1 rate transition G2M to G1-phase hours−1
rA arrest or apoptosis rate hours−1
Table 3.1: Model parameters with descriptions and units. It should be observed for biological cell
lines that generally the transition probabilities satisfy 0 < rG1→S < rS→G2M < rG2M→G1 with the rare
exception of 0 < rS→G2M < rG1→S < rG2M→G1 .
where the transition between the phases (included the A-phase) is determined by the probability pa-
rameters as listed in Table 3.1. It should be noted that the 2 on the right-hand-side of equation (3.2.1a)
indicates that 2 daughter cells are produced for every cell leaving the G2M-phase. Each equation is
a conservation equation for the rate of change of the number of cells in that phase per unit time with
transition rates per unit time between phases. Furthermore, defining
Nproli f (t) = NG1(t) + NS (t) + NG2M(t), (3.2.2)
where we see that the total number of proliferating cells, Nproli f , in the three phases is not conserved
but grows or decays depending on the sign of (rG2M→G1 − rA). The total population, Ntot, in the four
classes satisfies
Ntot(t) = Nproli f (t) + NA(t), (3.2.3)
where the term NA represents the number of cells in the A-phase.
The number of cells removed from the proliferating cell population (NA) satisfies:
dNA
dt = rANG2M ,
NA(0) = 0,
(3.2.4)
where it follows that NA grows exponentially when rA , 0.
3.2.1 Phase solutions in BEG with constant transition rates
When a cell line is being cultured for flow cytometry experiments the cell population exhibits balanced
exponential growth of the form
Np(t) = N peλt, (3.2.5)
where N p, p ∈ {G1, S ,G2M} is a constant for each phase. The form of the expression (3.2.5) shows
that the cell phase population grows exponentially with a growth rate λ and asymptotically the popula-
tion has a stable phase distribution which is independent of the initial phase distribution. Furthermore,
it is asynchronous as the percentage of cells in each phase are not in general the same but depend upon
the transition rates. We have shown the characteristic equation for the population in the BEG state
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S -phase
G1-phase
G2M-phase
A-phase
rG1→S
rS→G2M
rG2M→G1
rA
Figure 3.1: A diagram of cell-cycle control of a cell line cell population. The population is subdivided
into G1, S , G2M and A phases with the possibility that cells can transfer from one phase to the
next according to transition rates (Table 3.1) between phases. Response of cancer cell population to
paclitaxel is shown when transition rate rG2M→G1 is equal to zero.
with constant transition rates in equations (2.5.9) and (2.5.10). The condition for the exponential
growth of population with parameters used in system (3.2.1) is as follows:
F(λ) = (rG2M→G1 + rA + λ)(rG1→S + λ)(rS→G2 M + λ)
2rG2 M→G1 rG1→S rS→G2M
= 1. (3.2.6)
The function F(λ) is a cubic polynomial with zeros at −rG1→S , −rS→G2M, and −(rG2M→G1 + rA), and it
intersects the ordinate at (1 + rA/rG2M→G1 )/2 and moreover1 F is monotone increasing for λ > 0. An
alternative proof has been discussed in Basse et al. (2004a).
Figure 2.4 in Chapter 2 shows a series of typical graphs of F(λ). Further considerations of the
graph of F shows that if rA < rG2M→G1 , then F(λ) − 1 always has just one positive root for λ, and
this value determines the cell population growth. The case r = rG2M→G1 , which defines constant
population growth, is the boundary value of λ leading to proliferating population (Nproli f ) decline
when rA > rG2M→G1 . In addition, it is seen that λ defines the doubling time of the population cell line
through the well known equation
Td =
ln(2)
λ
. (3.2.7)
This time is central to understanding the dynamics of the cell line in that it also defines the population
cell-cycle time (equivalent to the population cell transit time) as the time it takes 1 cell to become
2 cells etc. When the proliferating cell population is considered to be in BEG, as given by equation
(3.2.5), then we can easily calculate the proportions in each phase, which will become asymptotically
constant, as shown in equations (2.5.37)-(2.5.39) in Chapter 2. Constant proportions in the phases
1See Appendix B.1 equation (B.1.2a)
39
3. DETERMINATION OF CELL POPULATION DYNAMICS USING PLATEAU LOG
REDUCTION METHOD
are obtained experimentally in cell lines when the cell cultures are maintained in exponential growth.
For simplicity in the remainder of this section we consider rA ≡ 0, so that Ntot = Nproli f . We can
reduce the constant proportion formulae (2.5.37)-(2.5.39) for the case of constat transition rates by
taking τp → 0 for p ∈ {G1, S ,G2M}. Then let ΠG1 be the proportion of cells in the G1-phase, namely
ΠG1 = NG1(t)/Ntot, and similar notation for the other phases, then
ΠG1 =
1
Cλ(rG1→S + λ)
, (3.2.8a)
ΠS =
1
Cλ(rG1→S + λ)
rG1→S
rS→G2M + λ
, (3.2.8b)
1 = ΠG1 + ΠS + ΠG2M, (3.2.8c)
where from equation (2.5.30)
Cλ =
1
rG1→S + λ
+
rG1→S
(rS→G2M + λ)(rG1→S + λ)
+
rG1→S rS→G2M
(rS→G2M + λ)(rG2 M→G1 + λ)(rG1→S + λ)
, (3.2.9)
so that
ΠS
ΠG1
=
rG1→S
rS→G2M + λ
, (3.2.10a)
ΠG2M
ΠS
=
rS→G2M
rG2M→G1 + λ
, (3.2.10b)
1 = ΠG1 + ΠS + ΠG2M . (3.2.10c)
Now Nproli f satisfies
dNproli f
dt = (rG2 M→G1 − rA)NG2M, (3.2.11)
= (rG2 M→G1 − rA)ΠG2MNproli f , (3.2.12)
so that besides the characteristic equation (3.2.6) for the population growth rate we have λ = (rG2 M→G1−
rA)ΠG2M.
From the equations of this section for an established cell line we have a relationship between
proportions in each phase, the rate transitions between phases, the population doubling time. The
equations (3.2.6), (3.2.7), and (3.2.10) form a system of five equations in the eight variables
{rG1→S , rS→G2M, rG2 M→G1 , λ,ΠG1 ,ΠS ,ΠG2M, Td}
but two of these five equations are reducible in that ΠG2M can be eliminated with the last of equation
(3.2.10) and similarly Td can removed with equation (3.2.7). So we have an implicit three-system
of equations for the six variables in the three-groupings r = {rG1→S , rS→G2M , rG2M→G1}, and σ =
{ΠG1 ,ΠS , λ} hence the implicit three-system can be written
G(r,σ) = 0, (3.2.13)
where G : R3+ × R3+ → R3, as we are only interested in λ > 0. For the Monte Carlo simulation
considered in Section 3.3.3 the r’s are known and we wish to know whether this implicit function,
G, determines the σ uniquely. That is, given the three transition rates is there a unique mapping to
40
3.3 Results
the proportions and λ (effectively Td). We now show for this direct problem that we have a local
differentiable mapping, R, defined by σ = R(r) that uniquely determines the σ. Another important
question for determination of cell kinetics is: Does measurement ofσ uniquely determine the r? That
is, can we write r = R−1(σ)? Both these answers are proven in Appendix B.1 by the implicit function
theorem, and in the following statement of this result the matrices Jσ, Jr are defined as appropriate
sub-matrices of the jacobian of G. We can now express the results found for both maps in the following
theorem:
Theorem 3.2.1. (a) The mapping, R(r), exists locally as det Jσ > 0 on S , a bounded and open
subset of {rG1→S , rS→G2M, rG2 M→G1} ∈ R3+, and it is uniquely locally defined on S , and the local
maps are continuously differentiable.
(b) The mapping R−1(σ) exists locally as det Jr > 0 on S ′, a bounded and open subset of {ΠG1 ,ΠS , λ} ∈
R
3
+, and it is uniquely locally invertible on S ′, and the local maps are continuously differen-
tiable.
We observe that from the flow cytometry data the Πp, p ∈ {G1, S ,G2M} can be measured, and Td
can be determined by cell counting thus yielding λ. This means that the r’s are uniquely determined
by Theorem 3.2.1(b).
These results are central to our model’s usefulness in predicting the cell dynamics from flow
cytometry measurements.
3.3 Results
3.3.1 Experimental paclitaxel dose-response effects
The cell-cycle times of human tumour cells vary considerably among different individuals Prescott
(1987), and for several cancer types, where short cycle times are related to poor survival times of
patients Furneaux et al. (2008); Rew & Wilson (2000). Hence it is important to estimate cell-cycle
times of in vivo tumours. However, the determination of in vivo potential doubling times (Tpot) is
not currently ethically justifiable, since it involves the administration of a potential mutagen (bro-
modeoxyuridine an analogue of thymidine) and subsequent tumour biopsy. An alternative approach
to estimate cell doubling time is to culture clinical material in a short-term (7 day) assay Baguley
et al. (1999) and to measure the effect of cell division arrest, typically carried out by adding a mitotic
poison such as paclitaxel. On subsequent uptake of 3H-TdR into DNA of cultured cells, a measured
‘plateau’ reduction value for 3H-TdR incorporation, at paclitaxel concentrations above a value that
completely inhibits cell division Baguley et al. (1999); Furneaux et al. (2008) can be used to estimate
doubling time. The method relies on the intrinsic variability of cell-cycle time, much of which is in
the G1-phase of the cell cycle and thus occurs before the onset of DNA replication Prescott (1987).
The range of values determined using this method is surprisingly similar to that obtained using in vivo
the Tpot method. Previous studies have shown that the kinetic behaviour of cultured cells, as measured
by flow cytometry, can be modelled effectively by incorporating transition probabilities for the onset
of DNA replication and cell division Basse et al. (2003, 2004b). This technique is analysed here for
cell lines, but a further application of it would allow this method to be extended to cultured clinical
tumour material.
We observe that the chemotherapy drug paclitaxel is an antimitotic agent that stabilises the assem-
bly of microtubules by preventing depolymerisation, thus arresting cells prior to or during mitoses.
In Baguley et al. (1995), the chemosensitivity of cell lines to paclitaxel was assayed by exposing the
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Figure 3.2: Diagrammatic representation of the paclitaxel concentration-dependent phase of the dose-
response semilog-curves.
tumour cell lines to paclitaxel for 5 days and the remaining proliferative cells quantitated by 3H-TdR
incorporation. This subsequent incorporation of 3H-TdR is proportional to the number of proliferating
cells in the S -phase and the level of this incorporation is measured using a liquid scintillation counter.
The resulting measurement then is proportional to the amount of cell proliferation.
PS (t) is defined as the time dependent (t hours) percentage of the S -phase cells after exposure to
paclitaxel. We name this important quantity the plateau log reduction with the symbol, PLR, which
is log10 units of the normalised value of PS (t). In Baguley et al. (1995) experimental measurements
were made and various PLR values and their corresponding measurements of population doubling
time, Td were calculated for 21 cell lines (after exposing them to paclitaxel for 5 days) and it was
shown that when these quantities were plotted against each other they showed a significant linear
dependence. The wide range of PLR found shows how different cell lines can have a different responses
to chemotherapy, and this stems from the possible wide range of values for transition rates between
phases. In particular, it is the transition rate from G1 to S -phase that produces a wide range of G1-
phase transit times.
The dose-response curves, obtained in Baguley et al. (1995), were biphasic on a semi-logarithmic
plot with a linear decrease in incorporation up to a particular drug concentration, and above which no
further decrease was evident (see diagrammatic representation of dose-response curves in Figure 3.2).
The plateau defines the PLR measurement. We observe in Figure 3.2 that, firstly, the initial decreasing
region of the dose response curve as the paclitaxel concentration increases results in a decreasing
proportion of proliferating cells, hence fewer cells in the S-phase. Secondly, the plateau corresponds
to the concentration level where the cell is arrested in mitosis. Also we observe that the position of
the elbow in the curve is dependent upon the concentration because for a shorter exposure time to
paclitaxel the concentration must be higher to stop cells cycling. Thirdly, the plateau is a measure
of the remaining cells in the S -phase at the exposure time. Fourthly, we observe the depth of the
plateau is deeper with longer exposure times. This is because there are fewer remaining proliferating
cells, in the S -phase, with longer paclitaxel exposure times. This is borne out by our mathematics
in Section 3.3.2.1 where it is shown that once mitosis has been inhibited the number of cells in the
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S-phase declines exponentially as a function of exposure time.
Baguley et al. (1995) hypothesised a model for this dose-response behaviour as: firstly, the cell
killing in response to paclitaxel occurs only during metaphase arrest (i.e., in M-phase), while the rate
of progress through other phases in the cell cycle is close to normal. Secondly, that the number of
proliferating cells is proportional to the 3H-TdR incorporation. Then, their model of the experimen-
tal results was that during the linear reduction in number of cells, in the dose-response dependence
range, a proportion of the cells undergo paclitaxel induced irreversible arrest once they enter mitosis
while the remaining cells continue through mitosis to another cell cycle. Whereas, over the plateau
concentration range, where the dose-response is independent of concentration, all cells undergo irre-
versible paclitaxel-induced arrest or death once they enter mitosis. Furthermore, they suggested that
the plateau effect shows the number of S -phase cells, fixed at a time, which is resultant on the entry of
cells from the G1-phase and exit into the G2M-phase, and will be independent of paclitaxel concen-
tration. Moreover, the exact number of remaining S -phase cells will be strongly dependent upon the
exposure time to paclitaxel and this hypothesis is supported by their experiments. These behavioural
characteristics are shown in Figures 3.2. Our model, which is predicated upon the phase cycle of the
cell, further supports their hypothesis from our mathematical results in Section 3.3.2.
3.3.1.1 Previous experimental work results
In Baguley et al. (1995), it was shown that the cancer cell population doubling time significantly
correlated with the maximum plateau reduction. In particular, they postulated that if an exponential
rate of departure of cells from G1-phase is assumed, the proportion (PG1) of G1-phase cells at any time
after exposure to paclitaxel at concentrations high enough to block cell division will be described by
the relationship:
PG1 = P0e
−kt/T˜ , (3.3.1)
where P0 is the proportion of G1-phase cells at zero time, k is a constant and T˜ is the doubling time.
After an interval (corresponding approximately to the S -phase transit time) the proportion of S -phase
cells will have a similar dependence on t. So following Baguley et al. (1995), taking the logarithm of
equation (3.3.1), when in the plateau logarithmic reduction dose-response concentration we have
ln PS (t)
Ps(0) = −
k
T˜
t, (3.3.2)
where PS (t)/Ps(0) is the change in the proportion of cells in the S -phase. So their model predicts
that the logarithm of the remaining S -phase cells at time t after paclitaxel exposure should be linear
function of t/T˜ . This formula can be rewritten (without loss of generality) in logarithm to base 10
units, and observing that 100 × PS (t)/Ps(0) is the percentage of the S -phase fraction giving plateau
log reduction (which we denote by PLR) it implies that the logarithm reduction formula is:
PLR = log10
PS (0)
PS (t)
= − log10
PS (t)
PS (0) = log10 100 − log10
[
100 PS (t)
PS (0)
]
,
= k1t/T˜ , (3.3.3)
where k1 = k log10 e. Furthermore, they found that on their plotting the experimental data from 21
tumour cell lines, which were sub-cultured in exponential phase over 5 days with the doubling times
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estimated by counting the cells in a haemocytometer, and using a linear regression polynomial to this
data a positive correlation existed (with r = 0.90; p < 0.001). From this an empirical formula was
derived in Baguley et al. (1995) as
T˜ =
K1
PLR
, (3.3.4)
where K1 = k1t1, with k1 = 0.45, and t1 = 5 days, this value of k1 is our least squares fit from their
21 cell lines from the tabulated data in their Table 2 (in Baguley et al. (1995)), and thus K1 = 2.25
for these cell lines. Whereas, based on their Figure 6 (in Baguley et al. (1995)), which has 37 cell
lines, one can obtain a value k1 = 0.473, and with t1 = 5 days, get K1 = 2.365 for these cell lines.
We observe for reference, for primary cultures with a paclitaxel exposure time of 7 days, the value of
K1 is 3.78 (as cited in Furneaux et al. (2008)). Further application of formula (3.3.4) to short-term
cultures of tumour samples taken at surgery from patients with brain cancer in Furneaux et al. (2008)
yields a value of K1 up to 4.8. This formula between PLR and 1/T˜ , for a fixed time t, implies that for
cell cultures with a long doubling time (or cycle time) PLR is small. But for those cell cultures with a
short doubling time PLR is large. It should observed that this formula can be only valid over restricted
ranges of PLR and T˜ as will be made apparent in Section 3.3.3.
The fundamental experimental hypothesis made in Baguley et al. (1995) is that the plateau log
reduction value obtained, at high enough paclitaxel concentration, is directly proportional to the pa-
clitaxel exposure time and inversely proportional to the doubling time. We show similar correlations,
based on our theories, between T˜ = Td and PLR in Section 3.3.2.1
3.3.2 Deriving a simple empirical method of calculating the cell doubling time for cell
lines using a phase structured model
We use our mathematical model to derive a simple empirical method for calculating the cell population
doubling time Td for cell lines as follows. First, we model the response to the mitotic inhibitor
paclitaxel, by setting the transition rate from the combined G2M-phase to G1-phase equal to zero, and
deriving a temporal expression for the remaining S -phase cells. We then apply the model to a range
of theoretical cell lines and show that PLR is approximately proportional to the exposure time divided
by cell doubling time for a range of values.
In this section, we will justify mathematically the results of Baguley et al. (1995), namely equation
(3.3.3), and their hypotheses through our phase ODE system (3.2.1). Hence we now model the effects
of adding paclitaxel at a concentration to ensure entry into the plateau region of the dose-response. We
therefore note that in the plateau region there are no proliferating cells so we simulate the paclitaxel
concentration by setting the transfer rate from G2M to G1 phase to zero, i.e., rG2 M→G1 = 0. Then
BEG will be broken and there will be no constant proportions in the phases, so that the number of
cells in the various phases will be described by the equations in Appendix B.3. We aim to show
that the relationship described in equation (3.3.1) holds for our model. Namely, that after addition of
paclitaxel the proportion of cells in S -phase will decline exponentially:
NS (t)
Ntotal(0) =
NG1(0)
Ntotal(0)
rG1→S
rS→G2M − rG1→S
(
e−rG1→S t − e−rS→G2 M t
)
+
NS (0)
Ntotal(0)e
−rS→G2 M t. (3.3.5)
We observe that t = 0 corresponds to the paclitaxel concentration having just stopped cell division so
that Ntotal is given by equation (3.2.2), when rA = 0, for BEG at t = 0−. For the rest of the chapter
we will assume rG1→S , rS→G2M , in other words, the case rG1→S = rS→G2 M, considered in equation
(B.3.2), will not occur. This is true in our Monte Carlo simulations of Section 3.3.3, as this case has
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zero probability of occurring as it is a boundary case.
Using notation PS for the proportion of the total population of cells in the S -phase, equation
(3.3.5) can be simplified to:
PS (t) = PG1(0)
rG1→S
rS→G2 M − rG1→S
(
e−rG1→S t − e−rS→G2 M t
)
+ PS (0)e−rS→G2 M t. (3.3.6)
Furthermore, since PS (0) denotes the proportion of the total cell population in the S -phase at time
t = 0−, i.e. , just before paclitaxel incorporation, we can express the proportion of cells in the S -phase
as follows:
PS (t)
PS (0) =
PG1(0)
PS (0)
rG1→S
rS→G2 M − rG1→S
(
e−rG1→S t − e−rS→G2 M t
)
+ e−rS→G2 M t. (3.3.7)
As
PG1(0)
PS (0) =
ΠG1
ΠS
,
we can use equation (3.2.10) to simplify equation (3.3.7) to
PS (t)
PS (0) =
rS→G2M + λ
rS→G2M − rG1→S
(
e−trG1→S − e−trS→G2 M
)
+ e−trS→G2 M . (3.3.8)
Now to show the exponential decay of the percentage of cells in the S -phase, we must subdivide
expression (3.3.8) into two cases. Firstly, in case of the transition rate from the G1 to S -phase being
slower than from the S to G2M -phase, i.e., rG1→S < rS→G2M , we can express the percentage of the
total cell population in the S -phase after a linearisation time TL, where TL > Ts, as:
PS (t)
PS (0) =
rS→G2M + λ
rS→G2M − rG1→S
e−trG1→S + O
(
e−trS→G2 M
)
, 0 < rG1→S < rS→G2M, t > TL, (3.3.9)
where TL is large enough to ensure that the order term is exponentially small. Secondly, when rG1→S >
rS→G2M , we can see that the following is true:
PS (t)
PS (0) =
rG1→S + λ
rG1→S − rS→G2M
e−trS→G2 M + O
(
e−trG1→S
)
, 0 < rS→G2 M < rG1→S , t > TL. (3.3.10)
Thus, the percentage of cells in the S -phase is eventually exponentially decreasing regardless of the
relationship between the transition rates rG1→S and rS→G2M and this is illustrated in Figure 3.3(a). In
both of the cases previously considered, the graphs display simple exponential decay when TL > 50
hours; see the log plot in Figure 3.3(b) showing when proportion of S -phase PS decays in a linear
fashion on time t.
3.3.2.1 Deriving the plateau log reduction formula
Using our model, we will show a plateau log reduction formula similar to equation (3.3.3), i.e., there
is a direct relationship between population doubling time and the plateau log reduction value. From
equation (3.3.8) at measurement time t1 as
PLR = − log10
PS (t1)
PS (0) ,
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(a) Linear plot of proportion of cells in the S-
phase. Cell cycle transfer rates were chosen for
the case a: where rG1→S < rS→G2 M - rG1→S = 0.05,
rS→G2 M = 0.101, rG2 M→G1 = 1.5. In the case b:
where rG1→S > rS→G2 M - rG1→S = 0.15, rS→G2 M =
0.101, rG2 M→G1 = 1.5.
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(b) Logarithmic plot of proportion of cells in the
S-phase. Cell cycle transfer rates were chosen for
the case a: rG1→S < rS→G2 M - rG1→S = 0.05,
rS→G2 M = 0.101, rG2 M→G1 = 1.5. In the case b:
when rG1→S > rS→G2 M - rG1→S = 0.15, rS→G2 M =
0.101, rG2 M→G1 = 1.5.
Figure 3.3: Proportion of cells in the S-phase after paclitaxel application will decrease exponentially.
It can be seen that in cases of rG1→S > rS→G2M proportion in S -phase will decay faster than in cases
of rG1→S < rS→G2M .
it follows
PLR = − log10
(
rS→G2M + λ
rS→G2M − rG1→S
(e−rG1→S t1 − e−rS→G2 M t1 ) + e−rS→G2 M t1
)
. (3.3.11)
Now remember t1 is the end of the paclitaxel exposure time, and λ can be obtained from the solution of
equation (3.2.6). So that asymptotically when t1 > TL, we can obtain two linear plateau log reduction
formulae, and to this end add and subtract TL from t. The first case being of rG1→S < rS→G2M , and
from equation (3.3.9), it is
PLR ≈ − log10
(
rS→G2M + λ
rS→G2M − rG1→S
e−rG1→S TL
)
+ log10(e) rG1→S (t1 − TL), t1 > TL. (3.3.12)
The second equation applies for when rG1→S > rS→G2M , and it is
PLR ≈ − log10
(
rG1→S + λ
rG1→S − rS→G2M
e−rS→G2 MTL
)
+ log10(e) rS→G2M (t1 − TL), t1 > TL. (3.3.13)
These formulae show directly the linear dependence of PLR on t1 and the two transition probabilities.
Furthermore, in Figure 3.3(b) we plot an illustration of formulae (3.3.11) showing the linear depen-
dence, as represented in equations (3.3.12), (3.3.13), when t1 > TL for TL ≈ 50 hr. The formulae
illustrate a linear increase in PLR on the exposure time t1 and the two transition rates.
Equations (3.3.12) and (3.3.13) should be compared with equation (3.3.3) with the understanding
that the transition rates are related to k1/T˜ as is now shown. The remaining link with the results of
Baguley et al. (1995) to be shown is how PLR is approximately linearly dependent upon 1/Td. To
show this, we need the dependence of λ on the transition rates. This can be done by examination
of the nonlinear equation (3.2.6). In Appendix B.2, we show that there exists an approximate linear
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(b) Simulation to verify the linear dependence of
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rSG2 M . Transition rates were chosen as rS→G2 M ∈
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Figure 3.4: Simulations were carried out to verify statements postulated in equation (3.3.14).
dependence of λ on the two transition rates appearing in the above two equations as
λ ≈
rG1→S , rG1→S < rS→G2M,rS→G2M, rG1→S > rS→G2M. (3.3.14)
This result provides some mathematical justification of the often quoted approximation that the BEG
growth rate is rG1→S . It is seen here that this is only true with the asymptotic assumptions made in
Appendix B.2 and if rG1→S < rS→G2M . To further illustrate the approximate linear dependence of λ
on the appropriate transition probability, we show in Figure 3.4 both cases considered in expression
(3.3.14) of λ verses rG1→S , and rS→G2M from the nonlinear equation (3.2.6). This figure shows that
our analysis in Appendix B.2 holds true for an appropriate range of rG1→S . In Appendix B.2, a second
order approximation is estimated.
So remembering equation (3.2.7), it is seen that we can find one asymptotic formula for the plateau
log reduction formulae as
PLR ≈ − log10
(
rS→G2M + λ
rS→G2M − rG1→S
e−rG1→S TL
)
+
ln 2
ln 10
(t1 − TL)
Td
, t1 > TL. (3.3.15)
Equation (3.3.15) is essential to our results as it shows that PLR is approximately linearly dependent
upon 1/Td as it was proposed in the paper Baguley et al. (1995).
We note that to get agreement with Baguley et al. (1995), as given in equation (3.3.4) for K1 = 2.25
the above equation implies that TL = 2.47 days or 59.4 hours which is fairly close to our previously
mentioned linearity estimate.
It is seen that equation (3.3.15) provides theoretical justification from our model of the experimental
postulate of Baguley et al. (1995), for equation (3.3.3). In the next section, we provide a Monte Carlo
simulation of the full equation (3.3.11) further justifying these conclusions.
3.3.3 Monte Carlo simulations
In this section, we present simulations of our model that were carried out in order to verify the linearity
of logarithmic plateau reduction values and exposure times over cell doubling time. This simulation
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uses the full equation (3.3.11), not the asymptotic equations, and so it will not only show justification
of the experimental results of Baguley et al. (1995), but will also verify the asymptotic analysis of
Section 3.3.2.
We chose approximately 500 random uniformly distributed transition rates within the intervals 0.0001 <
rG1→S < 0.12, 0.0001 < rS→G2M < 0.12, 0.99 < rG2M→G1 < 2 and 0.000001 < rA < 0.0001, which
are appropriate to many cell lines and were provided by biologists. For the biologically significant
case rG1→S < rS→G2M, in Figure 3.5(a) we show the results from equation (3.3.11) of our simulation
from the randomly generated transition rates, with the abscissa depicting the ratio of exposure time to
cell doubling time. Superimposed on the simulated data is our least squares affine regression line. In
Figure 3.5(b), we incorporate a constant death rate in our simulations that results in cell loss of 2%-
20% of the total population. The simulation uses the numerical solution of the ODE system (3.2.1) to
determine the ratio PS (t)/PS (0) as in this case the formula on the right-hand-side of equation (3.3.11)
is not correct. When solving the ODE system, the term rA is chosen from a uniform random distribu-
tion to result in the appropriate cell loss. We observe that our model with apoptosis Figure 3.5(b) gives
the least square affine regression line equivalent to the second decimal place to the affine regression
line of our model without apoptosis in Figure 3.5(a).
In our remaining simulations, we use the model without apoptosis effects in order to simplify
the derivation of the analytical formulae. For the less biologically significant case where rS→G2M <
rG1→S , we show in Figure 3.5(c) the results of our simulation from the randomly generated transition
rates, with the abscissa the ratio of exposure time and cell doubling time. Also shown in this figure
is the least squares affine regression line. Furthermore, we show for comparison in Figure 3.5(d), a
reproduction of the experimental and least squares affine regression line from Baguley et al. (1995).
To compare this figure with our results we must observe a few points. First, the experimental values
of Td in this figure are obtained by cell counting so that any apoptosis that occurs will ensure that the
experimental value of Td is too large. Second, the small number of data points in the experimental fit
leads to considerable variability in the coefficients of the fit when compared to our final results shown
in Figure 3.6.
We observe from equation (3.2.6) that the value of λ is affected by all three transition rates rG1→S ,
rS→G2M , rG2 M→G1 , and thus changes in the three-dimensional space of transition rates result in a
stochastic like changes in values of the doubling time Td in the three simulated plots of Figure 3.5. It
should be remembered that the doubling time is an inverse of λ. This will mean that all our simulation
graphs will have stochastic-like appearance.
The nonlinear map R was used to map the randomly chosen r’s onto λ the Π’s with the subsequent
calculation of Td, and then PLR through equations (3.2.7) and (3.3.11) to produce the results shown in
Figures 3.5-3.6. The map R was solved numerically by use of the damped Newton method.
It is observed from the simulated graphs in Figure 3.5 that a wide range of Td has been offered;
this range is in excess of what is found biologically. So in Figure 3.6 we reject simulations that offer
Td outside the interval: 1.3 < 5Td < 4.5 (here Td is in days). Figure 3.6(a) shows the results of
our simulation from the randomly generated transition rates when used in equation (3.3.11), with the
abscissa the ratio of exposure time to cell doubling time. Superimposed on the simulated data is our
least squares affine regression line. In Figure 3.6(b) we invert the plots of Figure 3.6(a) by plotting
the doubling time against the exposure time divided by the plateau log reduction value. Furthermore,
a least square affine regression line is shown. These regression lines show that we can express the
doubling time values through the reciprocal of the plateau log reduction values as follows:
Td = c1
t
PLR
+ c2. (3.3.16)
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(a) The biologically more plausible case of rG1→S <
rS→G2 M and rA = 0. From this plot it can be con-
cluded that doubling time can be obtained from lin-
ear expression PLR = m1t/Td + m2,where m1 =
0.608, m2 = −0.4844 and t = 120 hours, thus
Td = 72.96/(PLR + 0.4844).
0 1 2 3 4 5 6 7 8
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Exposure time (120h) / doubling time
Pl
at
ea
u 
Lo
g 
Re
du
ct
io
n 
r G
1S
<
r S
G
2M
 
w
ith
 a
po
pt
os
is
 
 
Arbitrary generated data
y=0.6077*x−0.4853
(b) The biologically more plausible case of rG1→S <
rS→G2 M with apoptosis present after treatment with
paclitaxel. The population doubling time can be
obtained from linear expression PLR = m3t/Td +
m4,where m3 = 0.6077, m4 = −0.4853 and t = 120
hours, thus Td = 72.924/(PLR + 0.4853).
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(c) For the case of rG1→S > rS→G2 M , with rA = 0,
it be can see that the doubling time can be cal-
culated using expression PLR = n1t/Td + n2 with
n1 = 0.5993, n2 = −0.4477 and t = 120 hours, thus
Td = 71.916/(PLR + 0.4477).
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(d) An experimental cell line data and the experi-
mental data in Table 2 from Baguley et al. (1995) is
plotted for the comparison with the previous three
figures. The doubling time can be estimated from
the equation PLR = n3t/Td + n4 with n3 = 0.4503,
n4 = 0.3013 and t = 120 hours, thus Td =
54.036/(PLR − 0.3013).
Figure 3.5: Plateau log reduction value is plotted against the exposure time/doubling time in order
to show the linearity. Two cases - rG1→S < rS→G2M and rG1→S > rS→G2M were analysed. It can be
concluded that the relation between transition rates rG1→S and rS→G2M has no effect on affine formula
of the doubling time. Cases of no apoptosis and apoptosis present after paclitaxel addition are analysed
and it can be seen that apoptosis presence has no effect on the affine formula of the doubling time.
Each dot represents a cell line either experimental or theoretical.
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(a) Plateau log reduction values versus exposure time/ cell doubling time for cell
line data, when rG1S < rSG2 M . We can see that the doubling time can be calculated
using expression PLR = a1t/Td + a2 with a1 = 0.5609, t = 120 hours and a2 =
−0.4374, thus we can express population doubling time through the plateau log
reduction value as Td = 67.308/(PLR + 0.4374).
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(b) Population doubling time values versus exposure time/ plateau log reduction for cell
line data, when rG1S < rSG2 M . We can see that the doubling time can be calculated using
expression Td = c1t/PLR + c2 with c1 = 0.253, t = 120 hours and c2 = 14.29 thus
Td = 30.36/PLR + 14.29.
Figure 3.6: Simulations for estimating cell population doubling time for cell lines are shown. We
have only considered case of rG1→S < rS→G2M since there is no effect on choosing the opposite and
also rA = 0. From arbitrary generated data we have chosen only those that fall within the range
1.3 < 5Td < 4.5 for cell lines, here Td is in days.
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Cell line Cell line Cell line
Exposure time (hours) 120 144 168
(days) 5 6 7
Doubling time (hours) Td = 30.36PLR + 14.29 Td = 36.288PLR + 16.42 Td = 42.2184PLR + 19.16
Table 3.2: Affine formula for the cell doubling time calculation. Figure 3.6(b) was used to obtain the
affine relation values. Observe that Td is in hours.
We have derived a linear relationship between the plateau log reduction value and the cell doubling
time (as found in Baguley et al. (1995)) of a cell line after being exposed to paclitaxel. The coefficient
c1 (c1t = K) is directly dependent on the exposure time, therefore the linear method is applicable only
for the fixed exposure time of 5 to 7 days. Our simulations show that the linear relationship between
Td and PLR exists. We have used the asymptotics in Section 3.3.2 on PLR × Td to show that for any
random transition rates the coefficient c1 value is the approximately the same.
3.3.4 Determination of population cell dynamics from plateau log reduction
We first observe that determination of λ from the experimentally obtained doubling time is problematic
as it involves cell counting. The use of the experimental method analysed in this chapter to determine
PLR and then the use of the least squares regression line between PLR and Td, of the previous subsec-
tion, overcomes this difficulty. This then enables the determination of the transition probabilities with
λ calculated from the doubling time and the nonlinear map described in Theorem 3.2.1(b). However,
a superior method for short term assays to determine Td is:
1. Find the plateau log reduction, PLR, from the assay.
2. Use the results in Table 3.2 to find Td from PLR.
In Table 3.2, we list our overall affine regression results.
3.3.5 Population doubling time formulae in literature
A variety of methods of the doubling time estimation can be found in the literature. Table 3.3 depicts
many crucial features that distinguish between different methods - firstly, whether or not cell death
is taken into account when calculating population doubling time. Td describes population doubling
time with cell death present and Tpot is a measurement of cell population doubling time with no cell
loss Steel (1977). Secondly, whether or not one needs to estimate apoptosis rate experimentally
since cell death evaluation has come to be known as somewhat problematic Rew & Wilson (2000).
Thirdly, whether experimental estimates used in population doubling time formulae are single time-
point observations or multiple time-point observations.
We have included references to formulae of doubling times and short descriptions of variables used
in theses formulae. For more detailed information, we ask readers to look at papers Baguley et al.
(1995); Bertuzzi et al. (2002); Rew & Wilson (2000); Steel (1977); Terry & White (2006) as shown
in Table 3.3.
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Formula Cell death Cell death Experimental Authors Variables Single (ST) or multiple (MT)
included measurement methods time-point observation
Td = c1 tPLR + c2 Yes No Stathmokinetic Our method PLR - plateau log reduction value ST
3H − TdR, Flow cytometry Baguley et al. (1995) c1, c2 -constant
t - exposure time to paclitaxel
Td = ln(2)rc Yes Yes Relative motion (RM) Terry & White (2006) r - fraction of labelled cells completing division MT
BrdUrd, Flow cytometry c - progression rate of labelled cells towards division
Td = ln(2)λ No N/A Growth curve Many papers λ - growth rate MT
Tpot = ln(2)TSν No N/A Relative motion (RM) Steel (1977); Terry & White (2006) TS - duration of S -phase MT
BrdUrd, Flow cytometry Bertuzzi et al. (2002); Rew & Wilson (2000) ν- labelling index
Table 3.3: Population doubling time estimation methods in the literature. Second column indicates whether or not a particular method takes
cell loss into account when estimating doubling time. Third column shows if cell death has to be determined experimentally (N/A stands for
not applicable), fourth column provides key words of the experimental techniques applied. Fifth column points to references in literature. Sixth
column briefly describes variables used in the particular formulae. Seventh column shows whether or not the particular method requires a single
time-point measurement.
52
3.4 Conclusions
3.4 Conclusions
We have addressed the question here of whether the transition probability model can be used to derive
a direct relationship between cell population doubling time and 3H-TdR incorporation data. We have
shown that indeed it can, and furthermore we can derive a direct relationship between cell doubling
time and 3H-TdR incorporation data.
In Baguley et al. (1995), a cell doubling time formula (3.3.4) was estimated using a simple model
for cell growth. We use a more complicated phase structured model and obtain a similar linear de-
pendence for the cell doubling time Td. We have verified by asymptotics that the linear relationship
between Td and PLR exists. We have derived that the coefficient Kt is dependent on the time a cell
line has been exposed to paclitaxel. We have applied Monte Carlo experiments to justify and quantify
the linear relationships used to estimate doubling time from 5-day cell culture assays, and we suggest
these equations be used for application of the experimental technique. Furthermore, we have incorpo-
rated apoptosis in our simulations that would result in a cell loss of 2%-20% of the total population,
through a constant death rate. We observed that our model with apoptosis and no apoptosis after pa-
clitaxel incorporation had no difference in the least square affine regression lines. This implies our
techniques are applicable to cell line populations with a small percentage of non-proliferating cells.
We also observe that the wide range of PLR show how different cell lines can have a different
responses to chemotherapy and this stems from the possible wide range of values for transition rates
between phases, in particular the transition rate from G1 to S -phase which produces to a wide range of
G1-phase transit times is a major factor in this. A further extension of this model for cancer cell lines
would involve: first, incorporating aging times τp in each phase of the cell cycle to increase biological
realism of the model. Second, derive expressions for estimating the cell-cycle time (or removal time
in Chapter 2) from single experimental observation of the plateau log reduction value, similar to the
ones presented in Table 3.2 for the doubling time.
We should point out that currently this type of linear relationship can be derived only for the cell
lines, although it has been suggested in Baguley et al. (1999) such a relationship holds for primary
cultures. The above model and method could be applied to primary cultures by using an extension of
the model described Daukste et al. (2009). Further work would include deriving such formulae for
primary cultures.
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Chapter 4
Modelling Cancer Cell Population
Perturbed by Irradiation
In this chapter, we examine the response of a cancer cell population to a one-time irradiation dose.
We show that, by changing the PDE system of the number density function to the probability density
function, our model tracks the variability of proportions of cancer cell population in each phase of the
cell cycle and is compatible with the experimental estimates of proportions in each phase after a variety
of cancer treatments. Our results agree with the previous studies of irradiated cancer cell lines, i.e.,
a cancer cell population undergoes little apoptosis after radiotherapy within the given experimental
observation times. Therefore, we show that the experimentally observed decrease in the expected
number of cells is due to the long-term arrest of the cell cycle. Our model provides an interval of
the initial proliferating fraction of the cell population for each cell line, i.e., a proportion of cells that
keeps proliferating after the application of radiotherapy. In the discussion section, we explain why
the proliferating fraction estimated via our mathematical model does not agree with experimentally
estimated surviving fraction.
4.1 Introduction
Radiation therapy is one of the main cancer treatment methods due to its ability to control cell growth:
it causes DNA damage, leading to long-term cell cycle arrest and cell death. The aim of the model
in this chapter is to determine the proliferating proportion of a cancer cell population of human
melanoma cell lines after a one-time irradiation dose. It is considered that cell death or apoptosis
takes place within a few hours of an irradiation dose Illidge (1998); Kerr et al. (1994); Meyn (1997).
We observe here that, in biological nomenclature, cells are considered dead if they have lost ability to
divide indefinitely. Cells that divide indefinitely are called clonogenic. Throughout this thesis, we de-
fine cell death or loss as process of cells undergoing apoptosis. We declare that cells are proliferating
or non-proliferating until they undergo apoptosis. We remark that notions cell death, apoptosis and
cell loss are interchangeable in this chapter. The difference between programmed cell death, apopto-
sis, and necrosis occurring after radiotherapy has been discussed in paper Illidge (1998). However,
we do not differentiate between these notions in our mathematical model.
Numerous mathematical models have been developed to analyse the effects of radiotherapy Baraz-
zoul et al. (2010); Basse et al. (2010); Enderling et al. (2006); Rockne et al. (2009). Many of the
proposed methods involve the construction of a mathematical model to explain the flow cytometry
data of cancer cell lines after irradiation. In this chapter, we are going to address and elaborate on
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the methods derived in paper Basse et al. (2010). The model presented in Basse et al. (2010) demon-
strated that an irradiation dose of 9 Gray (Gy) induced long-term cell cycle arrest. While a cancer cell
population unperturbed by any treatment remains in balanced exponential growth (BEG) Bell (1968),
a cancer cell population after exposure to any cancer treatment does not exhibit BEG.
We note here that, for various cancer types, cancer patients are given radiotherapy in fractions of
1.8 − 2.0 Gy daily on weekdays for 5 − 7 weeks Kim & Tannock (2005). Radiation dose 2 Gy is
considered to cause a sub-lethal radiation damage to normal tissue. The total weekly radiation dose
9− 10 Gy is broken down to multiple smaller doses along the week to give time for a normal tissue to
recover, which is named as one of the reasons of radiotherapy failures for some cancer types, see Kim
& Tannock (2005). Our mathematical model is applied to five melanoma cell lines that have been
exposed to one-time irradiation of 9 Gy. Cancer patients never receive radiation dose of total 9 Gy in
a day due to potential sever toxic reactions.
We start by deriving an age-structured mathematical model of a cell population response to radi-
ation therapy to analyse experimental data of human melanoma cell lines from the Auckland Cancer
Society Research Centre. Identical data has been analysed in paper Basse et al. (2010), see Basse et al.
(2010) for details on cell line derivation and experimental methods applied. Here we undertake the
method presented in paper Guiotto & Ubezio (2000), i.e., we normalise the numerical density function
(previously discussed in Chapter 2) and deal with the proportion density function in our age-structured
model. We then apply our mathematical model to experimental data extracted from flow cytometry
profiles. Such profiles show proportion distribution among cell cycle phases at different time points.
The existence of the age-structured model solution has been discussed in Guiotto & Ubezio (2000).
Later, we reduce the model to a nonlinear differential - algebraic equation (DAE) system in order
to determine the arrest and cell loss impact on the transition rates between the cell cycle phases. We
use the DAE system because normalisation of the system, i.e., dealing with the varying proportions
at each time step, leads to a constraint that the sum of proportions in all phases combined is equal
to one at every time step. The aim of this model is to determine the initial proliferating fraction and
proportion of a cancer cell population that continues proliferating for more than 96 hours after the
irradiation of 9 Gy. Experimental data was provided for various time points up to 96 hours. We
initially assume that, within 96 hours after irradiation, full effects of cancer treatments, i.e., the arrest
of the transition rates and cell death, can be detected. The flow cytometry profile data of human
melanoma cell lines has been provided. These data include flow cytometry profiles of unperturbed
cancer cell lines, cancer cell lines treated by paclitaxel at a concentration of 200 nM, cancer cell lines
treated by 9 Gy strength irradiation, and a combined treatment of paclitaxel and 9 Gy irradiation.
We cannot extract enough information from radiation data alone; thus, paclitaxel and the combined
treatment flow cytometry profiles are vital. Flow cytometry data of cell lines treated with paclitaxel,
in addition to that of radiation, are used to provide the uniqueness of the calculated values of arrested
transition rates.
In Basse et al. (2010), theoretical profiles generated by the mathematical model are compared with
the experimental flow cytometry profiles at various time points. Flow cytometry profiles of irradiated
cell lines and irradiated cell lines with applied paclitaxel are used to determine if arrest occurs in the
G1 or G2 phase. Authors of paper Basse et al. (2010) concluded that apoptosis does not occur after
irradiation of the cell lines.
In this chapter, we estimate the proportion of the cancer cell population in each of the cell cycle
phases (G1, S, and combined G2M) from flow cytometry profiles and then use this estimate as input
data for our optimization routine. Since the flow cytometry method cannot distinguish the difference
between the G2 and M phases (due to the fact that DNA contents in both phases are twice that of the
S -phase), we used a combined G2M-phase in our mathematical model. We have assumed that cancer
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cells can respond to radiation by cell cycle arrest, senescence, and cell death. There is evidence that
radiation at lower doses produces damage that can lead to cell death but it can also be fairly rapidly
repaired, while higher doses produce damage that is irreparable, and cells go into long-term cell cycle
arrest Pawlik & Keyormarsi (2004). After radiation, some cells are lost by cell death (which makes
no contribution to the flow cytometry profiles) and some by senescence (which contributes to the
flow cytometry profiles), while others proliferate. We aim to estimate the proportion of proliferating
cells. It is known that a small fraction of the initial population (0.1-10%, depending on the cell line)
survives radiation (also called the surviving fraction) and that this fraction is the population that grows
in a surviving colony assay Baguley (2011). Ultimately, we expect that our model will provide similar
arrest values, as in Basse et al. (2010), if the cell loss (death) rate is not included. Moreover, in
advance to Basse et al. (2010), we estimate the proportion of proliferating cells after the irradiation
dose of 9 Gy. The main difference between the model presented in this chapter and the one examined
in Basse et al. (2010) is that in our model does not require experimentally estimated transition rate
values, apoptosis rates and doubling times as input variables. We used a DAE system as oppose to
the ODE/PDE system used in Basse et al. (2010). Furthermore, we have estimated the surviving
fraction of the population exposed to a single dose of irradiation and the transition rates between the
consecutive phases.
This chapter presents several mathematical models that were constructed to utilise the experimen-
tal data of a cancer cell population that was first, unperturbed by any treatment, second, perturbed
by 200 nM paclitaxel, third, perturbed by a combined treatment of 200 nM of paclitaxel and 9 Gy
irradiation, and, four, perturbed by the irradiation of 9 Gy. Derivation of the mathematical model of
radiation effects on cancer cell population dynamics is shown by introducing a general model with
modifications made to fit the provided experimental data.
4.2 Mathematical model of cycling population. Cancer cell population
dynamics after radiotherapy.
The following model is constructed to track the proliferating proportion of the cell population after
radiation therapy. It describes temporary varying proportions observed after the irradiation of cancer
cell lines.
4.2.1 Age-distribution system
Our mathematical model, presented in this chapter, shows the response to ionising radiation treatment
(senescence, arrest, and cell death) by including the arrest and senescence phases that branch from G1
and G2M phases and the cell loss rate arising from the G2M - phase, as depicted in Figure 4.1, where
Senk with k ∈ {1, 2} represents the senescence phase and Ak defines the arrest state for the appropriate
cell cycle phase. The transition rates between phases are described in Table 4.1.
We proceed with defining the partial differential equation (PDE) system for our model. Later,
we simplify it in order to apply the experimental data from flow cytometry profiles. Flow cytometry
profiles illustrate the proportion of the cell population in each of the G1, S , and combined G2M phases.
An example of a flow cytometry profile can be seen in Figure 1.3.
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Figure 4.1: Diagram of the cell-cycle control of in vitro tumour cells perturbed by radiation. Transition
rates are explained in Table 4.1.
We define a general age-structured model as follows:
∂nG1(t, τ)
∂t
+
∂nG1(t, τ)
∂τ
= −[rG1→S (t, τ) + rA1(t, τ) + rS en1 (t, τ)]nG1 (t, τ) + rA2(t, τ)nA1(t, τ), (4.2.1a)
∂nS (t, τ)
∂t
+
∂nS (t, τ)
∂τ
= −rS→G2M(τ)nS (t, τ), (4.2.1b)
∂nG2M(t, τ)
∂t
+
∂nG2M(t, τ)
∂τ
= −[rG2 M→G1(t, τ) + rA3(t, τ) + rS en2 (t, τ) + rD(t, τ)]nG2 M(t, τ)
+ rA4(t, τ)nA2(t, τ), (4.2.1c)
∂nA1(t, τ)
∂t
= rA1(t, τ)nG1 (t, τ) − rA2(t, τ)nA1 (t, τ), (4.2.1d)
∂nS en1 (t, τ)
∂t
= rS en1 (t, τ)nG1 (t, τ), (4.2.1e)
∂nA2(t, τ)
∂t
= rA3(t, τ)nG2 M(t, τ) − rA4(t, τ)nA2(t, τ), (4.2.1f)
∂nS en2 (t, τ)
∂t
= rS en2 (t, τ)nG2 M(t, τ), (4.2.1g)
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with the renewal distribution conditions:
nG1 (t, τ = 0) = 2
∫ ∞
0
rG2M→G1 (t, τ)nG2M(t, τ) dτ, (4.2.2a)
nS (t, τ = 0) =
∫ ∞
0
rG1→S (t, τ)nG1 (t, τ) dτ, (4.2.2b)
nG2M(t, τ = 0) =
∫ ∞
0
rS→G2M(τ)nS (t, τ) dτ, (4.2.2c)
and the initial age distribution:
nG1 (t = 0, τ) = n0G1(τ), (4.2.3a)
nS (t = 0, τ) = n0S (τ), (4.2.3b)
nG2 M(t = 0, τ) = n0G2M(τ), (4.2.3c)
nA1(t = 0, τ) = n0A1(τ), (4.2.3d)
nS en1 (t = 0, τ) = n0Sen1(τ), (4.2.3e)
nA2(t = 0, τ) = n0A2(τ), (4.2.3f)
nS en2 (t = 0, τ) = n0Sen1(τ), (4.2.3g)
where nm with m ∈ {G1, S ,G2M, A1, A2, Sen1, Sen2} represents the number density function at age τ
at time t in a respective phase. Transition rates are shown in Table 4.1. Throughout this chapter, it is
assumed that the maximum cell age T → ∞. We have taken into account that cells in the senescent
phase do not age; this assumption has also been made for cells in the arrest phase. Our model keeps
track of the proportion of cells lost due to apoptosis, because system (4.2.1) expresses the dynamics
of the cell population with a removal class (or cell death rate rD). Flow cytometry profiles do not track
the proportion of cells lost due to treatment; thus, one advantage of our model is that we estimate
cell loss via mathematical means. Observe that the number two on the right-hand-side of the renewal
equation (4.2.2a) is due to the fact that two daughter cells are produced after mitosis is complete.
We have defined problem (4.2.1)-(4.2.3) for a broad range of parameters that may vary with time
and age. Although, in biological terms, this definition is a more realistic option, it is not simple
enough for numerical calculations with the experimental data provided. Thus, as a first step, we make
all transition rates between phases independent of age τ. While each cell has to age (grow) biologically
within the G1-phase before moving to the S -phase that also applies for S and G2M phases, we neglect
it in our model. This neglect is due to the lack of experimental estimates that would be needed to
include a minimum time that each cell, on average, spends in a phase before leaving it. However,
transition rates dependent on time t are necessary due to the effects of irradiation. Without any loss of
generality, we impose that all transition rates after the treatment are piecewise linear functions with
respect to time t. The total number of cells in a phase m, Nm(t), was previously defined in Chapter 2
as follows:
Nm(t) =
∫ ∞
0
nm(t, τ) dτ, (4.2.4)
where m ∈ {G1, S ,G2M, A1, A2, Sen1, Sen2}. The total number of cells in all of the phases Ntot(t) is
defined as follows:
Ntot(t) =
∑
m
Nm(t). (4.2.5)
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parameter description units
rG1→S rate transition G1 to S -phase hours−1
rS→G2M rate transition S to G2M-phase hours−1
rG2M→G1 rate transition G2M to G1-phase hours−1
rA1 arrest rate G1 to A1-phase hours−1
rA2 rate transition A1 to G1-phase hours−1
rS en1 senescence rate G1 to Sen1-phase hours−1
rA3 arrest rate G2M to A2-phase hours−1
rA4 rate transition A2 to G2M-phase hours−1
rS en2 senescence rate G2M to Sen2-phase hours−1
rD apoptosis rate from G2M-phase hours−1
Table 4.1: Radiation model parameters with descriptions and units.
In addition, we derive formulae for a change in the total number of cells in phase p at time t using
equations (4.2.1)-(4.2.2), identity (4.2.4), and expression limτ→∞ nm(t, τ) = 0. For the G1-phase, the
formula can be written as follows:
dNG1 (t)
dt =
∫ ∞
0
∂nG1 (t, τ)
∂t
dτ,
=
∫ ∞
0
(
−
∂nG1(t, τ)
∂τ
− [rG1→S (t) + rA1(t) + rS en1 (t)]nG1 (t, τ) + rA2(t)nA1 (t, τ)
)
dτ,
= n(t, τ = 0) − [rG1→S (t) + rA1(t) + rS en1 (t)]
∫ ∞
0
nG1(t, τ)dτ + rA2(t)
∫ ∞
0
nA1(t, τ)dτ,
= 2rG2 M→G1(t)NG2M(t) − [rG1→S (t) + rA1(t) + rS en1 (t)]NG1 (t) + rA2(t)NA1(t). (4.2.6)
Similar ordinary differential equations (ODE) can be derived for the rest of the phases. An additional
equation needs to be derived for the next section. The equation representing the change of the total
number of cells over time, i.e., a time-dependent growth rate for the total number of cells, is defined
as follows:
dNtot(t)
dt =
∑
m
dNm(t)
dt = [rG2M→G1 (t) − rD(t)]NG2 M(t). (4.2.7)
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4.2.2 Probability density system
We have to normalise the age-distribution system in order to use irradiated cancer cell population flow
cytometry data at different time points. We previously defined the probability density function of cells
in Chapter 2 and express it here again for a phase m as:
pim(t, τ) = nm(t, τ)Ntot(t) . (4.2.8)
Implying the probability of finding the random variable in nm at time t between τ and τ + dτ is pim dτ.
Therefore, the proportion of cells in phase m at a given time is Πm(t) and is defined as follows:
Πm(t) =
∫ T
0
pim(t, τ)dτ = Nm(t)Ntot(t) . (4.2.9)
We can then transform problem (4.2.1)-(4.2.3) to a probability density system, given that:
∂pim(t, τ)
∂t
=
∂
∂t
nm(t, τ)
Ntot(t) =
1
Ntot(t)
∂ nm(t, τ)
∂t
− pim(t, τ)
N′tot(t)
Ntot(t) . (4.2.10)
We can replace the first term on the right-hand-side of equation (4.2.10), namely, term ∂
∂t nm(t, τ), by
using system (4.2.1) and then, by taking into account that transition rates are independent of age τ, we
can write the probability density equation system as follows:
∂piG1(t, τ)
∂t
+
∂piG1(t, τ)
∂τ
= −[rG1→S (t) + rA1(t) + rS en1 (t)]piG1 (t, τ) + rA2(t)piA1(t, τ) − piG1(t, τ)
N′tot(t)
Ntot(t) ,
(4.2.11a)
∂piS (t, τ)
∂t
+
∂piS (t, τ)
∂τ
= −rS→G2MpiS (t, τ) − piS (t, τ)
N′tot(t)
Ntot(t) , (4.2.11b)
∂piG2M(t, τ)
∂t
+
∂piG2M(t, τ)
∂τ
= −[rG2 M→G1(t) + rA3(t) + rS en2 (t) + rD(t)]piG2 M(t, τ) + rA4(t)piA2(t, τ)
− piG2M(t, τ)
N′tot(t)
Ntot(t) , (4.2.11c)
∂piA1(t, τ)
∂t
= rA1(t)piG1(t, τ) − rA2(t)piA1(t, τ) − piA1(t, τ)
N′tot(t)
Ntot(t) , (4.2.11d)
∂piS en1(t, τ)
∂t
= rS en1 (t)piG1(t, τ) − piS en1(t, τ)
N′tot(t)
Ntot(t) , (4.2.11e)
∂piA2(t, τ)
∂t
= rA3(t)piG2M(t, τ) − rA4(t)piA2(t, τ) − piA2(t, τ)
N′tot(t)
Ntot(t) , (4.2.11f)
∂piS en2(t, τ)
∂t
= rS en2 (t)piG2M(t, τ) − piS en2 (t, τ)
N′tot(t)
Ntot(t) , (4.2.11g)
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with the renewal distribution conditions as:
piG1(t, τ = 0) = 2
∫ ∞
0
rG2 M→G1(t, τ)piG2M(t, τ)dτ, (4.2.12a)
piS (t, τ = 0) =
∫ ∞
0
rG1→S (t, τ)piG1(t, τ)dτ, (4.2.12b)
piG2M(t, τ = 0) =
∫ ∞
0
rS→G2M(τ)piS (t, τ)dτ, (4.2.12c)
and the initial age distribution as:
piG1(t = 0, τ) = pi0G1(τ), (4.2.13a)
piS (t = 0, τ) = pi0S (τ), (4.2.13b)
piG2M(t = 0, τ) = pi0G2M(τ), (4.2.13c)
piA1(t = 0, τ) = pi0A1(τ), (4.2.13d)
piS en1(t = 0, τ) = pi0Sen1(τ), (4.2.13e)
piA2(t = 0, τ) = pi0A2(τ), (4.2.13f)
piS en2(t = 0, τ) = pi0Sen2(τ). (4.2.13g)
Using equations (4.2.7) and (4.2.9), we define the growth rate function λ(t) as:
λ(t) = N
′
tot(t)
Ntot(t) = [rG2 M→G1(t) − rD(t)]ΠG2M(t). (4.2.14)
We observe that λ(t) is the time-dependent growth function and the total population grows as:
Ntot(t) = Ntot(0)e
∫ t
0 λ(s)ds. (4.2.15)
This equation is an important parameter in our population model.
By using similar techniques as in equation (4.2.6), we can reduce the PDE system (4.2.11) to an ODE
system as the transition rates are independent of age, τ,. Thus, the cell population proportion system
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is as follows:
dΠG1(t)
dt = 2rG2 M→G1(t)ΠG2 M(t) − [rG1→S (t) + rA1(t) + rS en1 (t)]ΠG1 (t) + rA2(t)ΠA1(t) − λ(t)ΠG1(t),
(4.2.16a)
dΠS (t)
dt = rG1→S (t)ΠG1(t) − rS→G2MΠS (t) − λ(t)ΠS (t), (4.2.16b)
dΠG2M(t)
dt = rS→G2 MΠS (t) − [rG2 M→G1(t) + rA3(t) + rS en2(t) + rD(t)]ΠG2 M(t) + rA4(t)ΠA2(t)
− λ(t)ΠG2M(t), (4.2.16c)
dΠA1(t)
dt = rA1(t)ΠG1 (t) − rA2(t)ΠA1(t) − λ(t)ΠA1(t), (4.2.16d)
dΠS en1 (t)
dt = rS en1 (t)ΠG1(t) − λ(t)ΠS en1(t), (4.2.16e)
dΠA2(t)
dt = rA3(t)ΠG2M(t) − rA4(t)ΠA2(t) − λ(t)ΠA2(t), (4.2.16f)
dΠS en2 (t)
dt = rS en2 (t)ΠG2M(t) − λ(t)ΠS en2 (t), (4.2.16g)
with the following initial conditions:
ΠG1(t = 0) = Π0G1 , (4.2.17a)
ΠS (t = 0) = Π0S , (4.2.17b)
ΠG2M(t = 0) = Π0G2M, (4.2.17c)
ΠA1(t = 0) = Π0A1 , (4.2.17d)
ΠS en1(t = 0) = Π0Sen1 , (4.2.17e)
ΠA2(t = 0) = Π0A2 , (4.2.17f)
ΠS en2(t) = Π0Sen2 . (4.2.17g)
Equations (4.2.5) and (4.2.9) let us derive the following algebraic expression:∑
m
Πm(t) = 1, ∀t ≥ 0, (4.2.18)
where m ∈ {G1, S ,G2M, A1, A2, Sen1, Sen2}. Thus, a cell cycle dynamics problem expressed with
an ODE system (4.2.16) with respective initial conditions (4.2.17) and a constraint equation (4.2.18)
becomes a DAE system. Equation (4.2.18) is a constraint expression that has to be satisfied for all t
greater or equal to zero, i.e., the proportions in each phase of the cell cycle add up to a value of one
at any time. We remind here that ODE system (4.2.16) does not include the proportion of cells dying
due to the treatment because flow cytometry method does not track cell loss.
4.2.3 DAE system for experimental data
For the purposes of the analysis involved in the next section, and in order to formulate the use of the
experimental data, we rearrange system (4.2.16) by combining the proliferating and non-proliferating
cells (arrested and senescent cells) into one phase (as would be seen in the flow cytometry profiles).
We add together the proliferating and non-proliferating fractions of the cell population in G1 and G2M
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phases and denote this variable as Pp with p ∈ {G1, S ,G2M}:
PG1(t) = ΠG1(t) + ΠA1(t) + ΠS en1(t),
PG2M(t) = ΠG2M(t) + ΠA2(t) + ΠS en2(t),
where we see the non-proliferating proportions of G1 and G2M phases as the fractions ΠA1(t)+ΠS en1 (t)
and ΠA2(t) + ΠS en2 (t), respectively. Although subdivision in proliferating and non-proliferating cell
subpopulations is desirable, our experimental data do not differentiate between proliferating and non-
proliferating subpopulations. We note that the whole proportion of the cell population in S -phase
detected in flow cytometry is considered to be proliferating, thus ΠS = PS . Thus, system (4.2.16)
becomes, through the addition of appropriate equations, as follows:
dPG1(t)
dt = 2rG2 M→G1(t)ΠG2 M(t) − rG1→S (t)ΠG1(t) − λ(t)PG1(t), (4.2.19a)
dPS (t)
dt = rG1→S (t)ΠG1 (t) − rS→G2MPS (t) − λ(t)PS (t), (4.2.19b)
dPG2 M(t)
dt = rS→G2MPS (t) − [rG2 M→G1(t) + rD(t)]ΠG2M(t) − λ(t)PG2 M(t), (4.2.19c)
with initial conditions provided from the flow cytometry profiles of the unperturbed cancer cell line
populations:
PG1(t = 0) = P0G1 , (4.2.20a)
PS (t = 0) = P0S , (4.2.20b)
PG2M(t = 0) = P0G2M, (4.2.20c)
where new proportions combining the proliferating and non-proliferating populations are defined as
follows:
PG1(t) = ΠG1(t) + ΠA1(t) + ΠS en1(t), (4.2.21a)
PS (t) = ΠS (t), (4.2.21b)
PG2M(t) = ΠG2M(t) + ΠA2(t) + ΠS en2(t). (4.2.21c)
This system still incorporates knowledge of the proliferating proportions: ΠG1(t) and ΠG2M(t). The
constraint (4.2.18) arising in cancer cell population proportion dynamics can be rewritten as follows:∑
p
Pp(t) = 1, ∀t ≥ 0, (4.2.22)
where p ∈ {G1, S ,G2M}. From equations (4.2.21), we can introduce the following identities:
ΠG1(t) = α(t)PG1 (t), (4.2.23a)
ΠG2M(t) = β(t)PG2 M(t), (4.2.23b)
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with α(t), β(t) ∈ [0, 1] for all t ≥ 0. We then substitute equations (4.2.23) into the system (4.2.19) as
follows:
dPG1(t)
dt = 2rG2 M→G1 (t)β(t)PG2M(t) − rG1→S (t)α(t)PG1 (t) − λ(t)PG1 (t), (4.2.24a)
dPS (t)
dt = rG1→S (t)α(t)PG1 (t) − rS→G2MPS (t) − λ(t)PS (t), (4.2.24b)
dPG2 M(t)
dt = rS→G2MPS (t) − [rG2 M→G1(t) + rD(t)]β(t)PG2 M(t) − λ(t)PG2 M(t), (4.2.24c)
where the population growth rate λ(t) (note that cancer cell population after irradiation or any cancer
treatment does not exhibit BEG) from equation (4.2.14) can be rewritten as follows:
λ(t) = [rG2 M→G1(t) − rD(t)]ΠG2M(t) = [rG2 M→G1 (t) − rD(t)]β(t)PG2 M(t). (4.2.25)
We then introduce new transition rates:
r∗G1→S (t) = α(t)rG1→S (t), (4.2.26a)
r∗G2M→G1 (t) = β(t)rG2 M→G1 (t), (4.2.26b)
r∗D(t) = β(t)rD(t). (4.2.26c)
This means the transition rates r∗G1→S (t), r∗G2 M→G1(t) and r∗D(t) have been modified from those of Table
4.1 and an asterisk in superscript ∗ has been added to highlight the difference. From equations (4.2.23)
and (4.2.26), the following three identities, linking subdivided (namely, Πm ) and not subdivided (Pp)
proliferating subpopulations in G1 and G2M phases, arise:
r∗G1→S (t)PG1 (t) = rG1→S (t)ΠG1(t), (4.2.27a)
r∗G2M→G1 (t)PG2M(t) = rG2 M→G1(t)ΠG2M(t), (4.2.27b)
r∗D(t)PG2M(t) = rD(t)ΠG2M(t). (4.2.27c)
We subsequently can express the DAE system that is used for numerical calculations as shown in the
next section.
4.2.4 DAE for calculations
We consider a model involving combined proliferating and non-proliferating proportions, as shown in
Figure 4.2. Transition rates that have not been affected by the treatment are notified with tilde above
the transition rate symbol. We have assumed that transition probability rate from the S -phase to the
G2M-phase has not been affected by irradiation, thus rS→G2M = r˜S→G2M . Using equations (4.2.24),
(4.2.25), and (4.2.26), we can present the DAE system that is then used for our numerical simulations,
as follows:
dPG1 (t)
dt = 2r
∗
G2 M→G1(t)PG2 M(t) − r∗G1→S (t)PG1(t) − λ(t)PG1 (t), (4.2.28a)
dPS (t)
dt = r
∗
G1→S (t)PG1 (t) − r˜S→G2 MPS (t) − λ(t)PS (t), (4.2.28b)
dPG2 M(t)
dt = r˜S→G2MPS (t) − [r
∗
G2 M→G1(t) + r∗D(t)]PG2M(t) − λ(t)PG2M(t), (4.2.28c)
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S -phase
G1-phase
G2M-phase
D-p 
r∗G1→S (t)
r˜S→G2M
r∗G2M→G1(t)
r∗D(t)
Figure 4.2: Diagram of the cell-cycle control of in vitro tumour cells perturbed by radiation, showing
the proportions in each phase. This diagram is compatible with flow cytometry data. We note that
flow cytometry profiles do not track cell loss/death proportion.
with the following constraint equation:
1 = PG1(t) + PS (t) + PG2M(t), t ≥ 0. (4.2.29)
From equation (4.2.25), we can see that the cancer cell population after irradiation grows at rate
λ(t) = [r∗G2 M→G1(t) − r∗D(t)]PG2M(t), with the initial population distributed among phases as follows:
PG1(t = 0) = P0G1 , (4.2.30a)
PS (t = 0) = P0S , (4.2.30b)
PG2M(t = 0) = P0G2M. (4.2.30c)
The model investigates the DAE system rather than an ODE one because constraint equation (4.2.29)
must be satisfied at every internal calculation point. In our calculation, we use system (4.2.28) with
side conditions (4.2.29) and (4.2.30) and the methods shown in Section 4.3 to estimate transition rates
r∗G1→S (t), r∗G2 M→G1(t), and r∗D(t). Since cell death cannot be estimated successfully after radiotherapy
via experimental means, we use a mathematical model describing the effects of the combined treat-
ment of radiotherapy and paclitaxel to determine cell loss. In subsequent sections, we replace the
estimation of transition rate r∗D(t) with cell death rate λR(t) = −r∗D(t)PG2 M(t), as explained in Section
4.3.
It should be noted here that we simplified system (4.2.16) in order to be able to use the experimen-
tal data. We aim with our model, which contains a removal class, to recreate results from paper Basse
et al. (2010); moreover, we aim to estimate the proportion of cells that keeps proliferating after irra-
diation.
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S -phase
G1-phase
G2M-phase
DTx-phase
r˜G1→S
r˜S→G2MrDTx
Figure 4.3: Diagram of the cell-cycle control of in vitro tumour cells perturbed by paclitaxel.
4.3 Non-cycling population models. Estimating arrested transition rate
r∗G1→S (t) and cell loss due to paclitaxel and radiation treatments
The following models are introduced for the purposes of applying the experimental data of the can-
cer cell population treated by paclitaxel and a combination of the paclitaxel and irradiation that are
schematically depicted in Figures 4.3 and 4.4, respectively. We observe that the experimental data of
the cancer cell population’s response to irradiation alone is not sufficient to ensure the uniqueness of
problem (4.2.28) - (4.2.30) parameters, namely transition rates r∗G1→S (t), r∗G2M→G1 (t), and death rate
λR(t). Therefore, the experimental data of the cancer cell population perturbed by paclitaxel and pacli-
taxel with radiation is used. Since, in subsequent sections, we compare the proportion in the G1-phase
for different treatments, we will use superscripts Tx for paclitaxel, TxR for the combined treatment of
paclitaxel and radiotherapy, and R for radiotherapy, e.g., ΠTxRG1 (t) depicts the proliferating proportion
in G1-phase after a combined radiation and paclitaxel treatment at time t. The relationship between
notions Π and P for each phase are shown in equation (4.2.21).
4.3.1 The paclitaxel model
The response of the cancer cell population to paclitaxel was analysed in Chapter 3. Here, we introduce
a DAE system describing the dynamics of proportions of the cancer cell population after treatment
with paclitaxel. The aim of the paclitaxel treatment response mathematical model is to estimate the
death rate of the cancer population after exposure to paclitaxel. We start by introducing a conservation
system that includes a death phase DTx. Terms ˘Pw with w ∈ {G1, S ,G2M, DTx} represent the propor-
tion distribution of the population among the phases and can be expressed as ˘Pw(t) = ˘Nw(t)/ ˘NT (t),
where ˘Nw(t) is a number of cells in w phase and ˘NT (t) = ∑w ˘Nw(t). Cell loss proportion of population
˘PDTx is considered to be a part of the total population, thus the growth (or death in the case of non-
cycling population) rate λ(t) is equal to zero at all times. Transition rates r˜G1→S and r˜S→G2M notify
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the transition probability rate between the respective phases of the population that is unperturbed by
any treatment. Paclitaxel interferes with the normal breakdown of microtubules during cell division,
cells in mitosis are arrested and prevented from dividing; therefore, this effect is incorporated into our
model by setting the transition rate from the G2M-phase to the G1-phase to zero. So the resulting
conservation system, schematically depicted in Figure 4.3, is as follows:
d ˘PG1 (t)
dt = −˜rG1→S
˘PG1(t), (4.3.1a)
d ˘PS (t)
dt = r˜G1→S
˘PG1(t) − r˜S→G2M ˘PS (t), (4.3.1b)
d ˘PG2 M(t)
dt = r˜S→G2M
˘PS (t) − rDTx(t) ˘PG2 M(t), (4.3.1c)
d ˘PDTx (t)
dt = rDTx(t)
˘PG2 M(t), (4.3.1d)
with a constraint equation:
1 = ˘PG1(t) + ˘PS (t) + ˘PG2M(t) + ˘PDTx(t), t ≥ 0. (4.3.2)
The initial conditions are:
˘PG1(t = 0) = P0G1 , (4.3.3a)
˘PS (t = 0) = P0S , (4.3.3b)
˘PG2M(t = 0) = P0G2M, (4.3.3c)
˘PDTx(t = 0) = 0. (4.3.3d)
Since, in the case of a conservation system approach, we require experimental estimates of cell loss
proportion, but experimental estimates of cell loss after exposure to paclitaxel are not reliable, so
we have to use a DAE system with a removal class similar to problem (4.2.28) - (4.2.30). From
equations (4.2.5) and (4.2.9), we can express proportions in G1, S , and G2M phases (namely, Pp(t)
with p ∈ {G1, S ,G2M}) for the case in which the cell loss phase is not included in the sum of the total
cell number as Pp(t) = Np(t)/Ntot(t). Notions of the number of cells in phases Np(t) and ˘Nw(t) are
interchangeable with those of phases - G1, S , and G2M. We can then express proportion ˘Pp(t) in p
phase with p ∈ {G1, S ,G2M}, in the case of a conservation system approach, or with the proportion
Pp(t) in the case of a system with a removal class, as follows:
˘Pp(t) = Pp(t)[1 − ˘PDTx(t)], where p ∈ {G1, S ,G2M}. (4.3.4)
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Equation (4.3.4) is substituted, using the appropriate phase index, into problem (4.3.1) - (4.3.3) and
the following result is derived:
dPG1 (t)
dt = −˜rG1→S PG1(t) − λTx(t)PG1(t), (4.3.5a)
dPS (t)
dt = r˜G1→S PG1(t) − r˜S→G2MPS (t) − λTx(t)PS (t), (4.3.5b)
dPG2 M(t)
dt = r˜S→G2MPS (t) − rDTx(t)PG2 M(t) − λTx(t)PG2M(t), (4.3.5c)
1 = PG1(t) + PS (t) + PG2M(t), t ≥ 0. (4.3.5d)
Here, λTx(t) = −rDTx(t)PG2 M(t), with the following initial conditions:
PG1(0) = P0G1 , (4.3.6a)
PS (0) = P0S , (4.3.6b)
PG2M(0) = P0G2M . (4.3.6c)
The initial conditions are provided by the proportion distribution of the unperturbed population ob-
tained from flow cytometry profiles. We note that solution of problem (4.3.5)-(4.3.6) will be marked
as PTxp (t) to notify paclitaxel treatment. We can see from system (4.3.5) that the proportion of the
G1-phase after paclitaxel exposure can be written as follows:
PTxG1(t) = PG1(0)e−
∫ t
0 [˜rG1→S+λTx(s)]ds. (4.3.7)
We impose that the death rate, λTx(t), is a piecewise constant function. In our numerical simulations,
we utilise the paclitaxel treatment response data to estimate the cell death from this treatment. The
proportion of the initial cancer cell number that undergoes apoptosis after paclitaxel treatment can
be evaluated using equations (4.3.1d), (4.3.4) and taking into account that λTx(t) = −rDTx(t)PTxG2M(t).
Thus, we rewrite equation (4.3.1d) as follows:
d ˘PDT x (t)
dt = rDTx (t)PG2M(t)[1 −
˘PDT x(t)], (4.3.8)
= −λTx(t)[1 − ˘PDT x(t)]. (4.3.9)
By integrating the ODE above with the initial condition (4.3.3d), we get the following expression:
˘PDT x(t) = 1 − e
∫ t
0 λTx(s)ds, (4.3.10)
where λTx(t) = −rDTx(t)PTxG2M(t). We observe that, since the cell population after paclitaxel treatment
does not undergo arrest and is considered to be proliferating, notions PTxG1(t) and ΠTxG1(t) are inter-
changeable, i.e., all cells in G1-phase are proliferating.
4.3.2 Radiation with the paclitaxel model
Cancer cell population growth perturbed by a combined paclitaxel and radiation treatment is depicted
in Figure 4.4. A combined treatment model has been constructed for the purposes of estimating
transition rate r∗G1→S (t) and death rate after combined treatment. The effects of radiotherapy alone
on cells in G1-phase, i.e., r∗G1→S (t) can be derived from the combined treatment. We use problem
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(4.2.16)-(4.2.18) as a base for the following combined treatment model. Since paclitaxel interferes
with the mitosis stage of the cell cycle, we incorporate this into our model by setting rG2 M→G1 = 0.
We assume that for the combined treatments of paclitaxel and radiation all cells in the population
have stopped cell division, namely rG2M→G1 = 0. Observe that the population growth rate λ(t) have
changed. In combined treatment model, we refer to growth rate as λTxR. Then we can rewrite problem
(4.2.16)-(4.2.18) as follows:
dΠG1 (t)
dt = −[rG1→S (t) + rA1(t) + rS en1 (t)]ΠG1 (t) + rA2(t)ΠA1(t) − λTxR(t)ΠG1(t), (4.3.11a)
dΠS (t)
dt = rG1→S (t)ΠG1(t) − rS→G2MΠS (t) − λTxR(t)ΠS (t), (4.3.11b)
dΠG2 M(t)
dt = rS→G2MΠS (t) − [rA3(t) + rS en2 (t) + rD1(t) + rD(t)]ΠG2 M(t) + rA4(t)ΠA2(t)
− λTxR(t)ΠG2M(t), (4.3.11c)
dΠA1(t)
dt = rA1(t)ΠG1(t) − rA2(t)ΠA1(t) − λTxR(t)ΠA1(t), (4.3.11d)
dΠS en1 (t)
dt = rS en1 (t)ΠG1 (t) − λTxR(t)ΠS en1(t), (4.3.11e)
dΠA2(t)
dt = rA3(t)ΠG2M(t) − rA4(t)ΠA2(t) − λTxR(t)ΠA2(t), (4.3.11f)
dΠS en2 (t)
dt = rS en2 (t)ΠG2M(t) − λTxR(t)ΠS en2 (t). (4.3.11g)
Furthermore, we express the death probability rate in two parts rD1 (t) and rD(t) to show the potential
effects of each treatment separately. We note that system (4.3.11) is a conservation system, so adding
the seven equations yields λTxR(t) = −[rD1(t)+ rD(t)]ΠG2M(t). The proportion dynamics of cancer cell
population depicted in ODE system (4.3.11) has the following constraint equation :∑
m
Πm(t) = 1, ∀t ≥ 0, (4.3.12)
where m ∈ {G1, S ,G2M, A1, A2, Sen1, Sen2}. The respective initial conditions are as follows:
ΠG1(t = 0) = Π0G1 , (4.3.13a)
ΠS (t = 0) = Π0S , (4.3.13b)
ΠG2M(t = 0) = Π0G2M, (4.3.13c)
ΠA1(t = 0) = Π0A1 , (4.3.13d)
ΠS en1(t = 0) = Π0Sen1 , (4.3.13e)
ΠA2(t = 0) = Π0A2 , (4.3.13f)
ΠS en2(t) = Π0Sen2 . (4.3.13g)
Solution of problem (4.3.11)-(4.3.13) is denoted as ΠTxRm (t). We now examine the growth rates
N′tot/Ntot. The death rate of the population treated with a combination of paclitaxel and irradiation,
namely λTxR(t), is assumed to be a piecewise constant function. Now, if we consider model for
radiotherapy without the paclitaxel, the population dynamic equations are as system (4.2.28) but the
death rate is now λR(t). Death rate λR(t) is incorporated in the growth rate N′tot/Ntot, denoted as λ(t) in
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Figure 4.4: Diagram of the cell-cycle control of in vitro tumour cells perturbed by paclitaxel and
radiation, with proliferating and non-proliferating cancer cell population subdivision.
system (4.2.28). Again, we impose that the death rate of the population affected by an irradiation dose
alone is a piecewise constant function, namely λR(t). We have assumed that cell death rate λTx(t) from
the paclitaxel treatment is unaffected by irradiation and has the same value as the one for the paclitaxel
treatment alone. Therefore, the growth (death) rate λTxR(t) of the population treated by paclitaxel and
irradiation can be presumed to be:
λTxR(t) = λTx(t) + λR(t), (4.3.14)
where λTx(t) = −rD1(t)ΠG2M(t) and λR(t) = −rD(t)ΠG2M(t). Thus, the following statement is true:
|λTxR(t)| ≥ |λTx(t)| f or t ≥ 0. (4.3.15)
Next, we proceed with the derivation of the relationship between transition rates of unperturbed and
perturbed by treatment population. Term ‘unperturbed’ refers to a cell population that has not been
affected by any treatment and ‘perturbed’ to a population that has been exposed to cancer treatment.
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For the simplicity of further analysis, we introduce a new variable, rQ1 (t), a transition rate indicating
the probability of a proliferating cell in the G1-phase to enter a non-proliferating state. We replace
terms −[rA1(t) + rS en1 (t)]ΠG1(t) + rA2(t)ΠA1(t) in equation (4.3.11a) with a new notion rQ1(t)ΠG1(t) as
follows:
dΠG1(t)
dt = −[rG1→S (t) + rQ1(t)]ΠG1 (t) − λTxR(t)ΠG1(t). (4.3.16)
We assume that rQ1(t) is non-negative, and define it as follows:
rQ1 (t) = rA1(t) + rS en1 (t) − rA2(t)
ΠA1(t)
ΠG1 (t)
. (4.3.17)
We then solve equation (4.3.16) using the initial condition (4.3.13a) and show that the proliferating
proportion of the G1-phase after the combined radiation and paclitaxel treatment can be expressed as
follows:
ΠTxRG1 (t) = Π0G1e−
∫ t
0 [rG1→S (s)+rQ1 (s)+λTxR(s)]ds. (4.3.18)
We have assumed that the proportion of the proliferating cells in the G1-phase after the combined
treatment (namely, ΠTxRG1 (t)) is equal to the proliferating cell proportion in the G1-phase after paclitaxel
treatment ΠTxG1(t) that has been scaled down by cell loss from radiotherapy with death rate λR(t), and
can be expressed as:
ΠTxG1(t)eλR(t)t = ΠTxRG1 (t). (4.3.19)
Thus, from equations (4.3.7), (4.3.18), and (4.3.19), we can see that the following is true:
r˜G1→S ≥ rG1→S (t) f or t ≥ 0. (4.3.20)
A similar inequality can be derived for the transition rate: r˜G2M→G1 . A different therapeutic agent such
as carboplatin, which interferes with DNA replication without affecting mitosis, can be used to derive
the following inequality:
r˜G2M→G1 ≥ rG2M→G1 (t) f or t ≥ 0. (4.3.21)
We proceed to derive a DAE system that is used in the numerical simulations for transition rate
r∗G1→S (t) and death rate λTxR estimation. Since flow cytometry profiles do not distinguish between
proliferating and non-proliferating cells within a particular phase, we rearrange problem (4.3.11) -
(4.3.13) by using techniques from Section 4.2.3, to the following problem and use it for the numerical
simulations discussed in Section 4.4.4:
dPG1 (t)
dt = −r
∗
G1→S (t)PG1 (t) − λTxR(t)PG1(t), (4.3.22a)
dPS (t)
dt = r
∗
G1→S (t)PG1 (t) − r˜S→G2 MPS (t) − λTxR(t)PS (t), (4.3.22b)
dPG2 M(t)
dt = r˜S→G2MPS (t) − [rDTx (t) + r
∗
D(t)]PG2M(t) − λTxR(t)PG2M(t), (4.3.22c)
1 = PG1(t) + PS (t) + PG2M(t), t ≥ 0, (4.3.22d)
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where λTxR(t) = −[rDTx (t) + r∗D(t)]PG2M(t) and with the initial conditions:
PG1(0) = P0G1 , (4.3.23a)
PS (0) = P0S , (4.3.23b)
PG2M(0) = P0G2M . (4.3.23c)
Similar identities to equations (4.2.27) can be derived from systems (4.3.11) and (4.3.22):
rDTx (t)PG2M(t) = rD1(t)ΠG2M(t), (4.3.24a)
r∗D(t)PG2M(t) = rD(t)ΠG2M(t). (4.3.24b)
The proportion of the cell population that underwent apoptosis after paclitaxel and radiation treatment
(similarly derivable as equation (4.3.10)) can be calculated by the following expression:
PDTxR(t) = 1 − e
∫ t
0 λTxR(s)ds, (4.3.25)
where the death rate λTxR(t) = −[rDTx (t) + r∗D(t)]PG2 M(t).
4.4 Experimental data and calculations
We have five different types of experimental data available. These terms will be explained in the
following subsections:
1. for the flow cytometry data of unperturbed cell lines, see subsection 4.4.2;
2. for the plateau logarithmic reduction values for each cell line, see subsection 4.4.2;
3. for the flow cytometry data of cell lines perturbed by paclitaxel, see subsection 4.4.3;
4. for the flow cytometry data of cell lines perturbed by paclitaxel and then irradiated, see subsec-
tion 4.4.4;
5. for the flow cytometry data of cell lines perturbed by radiation, see subsection 4.4.5.
In order to track the proliferating proportion of the cell population after treatment with radiotherapy,
we have to monitor the proportion of the cell population that enters the G1-phase (hence, having
undergone mitosis). We cannot extract sufficient information from the flow cytometry profiles of the
irradiated population alone; therefore, we need extra information from the rest of the data provided.
The flow cytometry profiles are analysed using the Cylchred software program provided by Cytonet,
UK, and we obtain estimates of the population proportions subdivided between phases G1, S , and
G2M at time points - 0, 18, 48, 72, and 96 hours for each cell line for every treatment.
4.4.1 Experimental data extracted from flow cytometry profiles
The flow cytometry profiles were analysed using Cylchred software provided by Cytonet, UK. We
have extracted estimates of population proportions in each phase from the flow cytometry profiles (an
example of a flow cytometry profile is shown in Figure 1.3) for all provided treatments and cell lines.
An example of such data collected for cell line NZM3 can be seen in Table 4.2 that shows variations
of percentages in the G1, S and G2M phases for every treatment at experimental time points from 0 up
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treatment hours %G1 %S %G2M
Paclitaxel 200 nM 0 52.25 29.69 18.06
18 4.9546 28.2548 66.7906
48 4.5587 21.8494 73.5919
72 5.3123 36.7733 57.9144
96 5.1227 42.0292 52.8481
Radiation 9 Gy and 0 52.25 29.69 18.06
paclitaxel 200 nM 18 16.8273 27.6499 55.5228
48 7.235 21.497 71.268
72 5.9558 37.4681 56.5761
96 7.1407 36.3593 56.5
Radiation 9 Gy 0 52.25 29.69 18.06
18 19.05 31.34 49.61
48 30.79 38.91 30.3
72 45.09 32.97 21.94
96 45.42 26.93 27.65
Table 4.2: Data extracted from the flow cytometry profiles of cell line NZM3. In paper Basse et al.
(2010), the transition rate from the G1-phase to the S -phase for the unperturbed cell lines is not esti-
mated from mathematical model but rather provided by experimentalists (rG1→S = 0.051). The first
column shows the treatment used. The second column represents the hours at which flow cytometry
profiles were generated for each treatment. Last three columns show the percentages in G1, S , and
G2M phases for every experimental hour for every treatment.
to 96 hours after treatment applications. Percentages in each phase of the NZM3 cell line unperturbed
by any treatment (i.e., in BEG state) are shown in Table 4.2 at hour zero for every treatment.
4.4.2 Unperturbed data and plateau log reduction value
The flow cytometry data of unperturbed cell lines gives us information about the proportion of the cell
population in each phase (G1, S , and the combined G2M). Unperturbed data refers to a cell population
that has not been affected by any treatment. In Daukste et al. (2012), we have shown that having
estimates of the proportions in each phase at BEG state and a plateau log reduction value allow us
to calculate unique constant transition rate values between phases (˜rG1→S , r˜S→G2M and r˜G2 M→G1) and
the growth rate of the population (˜λ). We can then express population doubling time Td, from Chapter
2, Td = ln(2)/˜λ. For more information on the plateau log reduction value method, see Chapter 3.
Observe we use a tilde to denote the unperturbed transition values and the growth rate. Calculations:
A system of four nonlinear algebraic equations is solved using damped Newton’s method (as showed
in Chapter 3).
Estimated variables thus far are transition rates r˜G1→S , r˜S→G2M, r˜G2M→G1 , and the growth rate of the
unperturbed population λ˜.
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4.4.3 Paclitaxel data
Paclitaxel is a mitotic inhibitor chemotherapy drug. The changes in flow cytometry data in the pro-
portion of the G1-phase are used to determine the cell loss due to the treatment (noted as our variable
λTx(t), introduced in Section 4.3). Since we have estimated the r˜G1→S value as shown in Section 4.4.2,
we use the equation (4.3.10) showed in Section 4.3 to determine the proportion of cells lost after ex-
posure to paclitaxel.
Calculations: Exponential equation (4.3.7) is solved to acquire the estimate of cell loss shown in
Section 4.3.
Estimated variables from Section 4.4.2 are the transition rates r˜G1→S , r˜S→G2M , r˜G2M→G1 , and the
growth rate of the unperturbed population λ˜. Paclitaxel data provides an estimate of the death rate
λTx(t).
4.4.4 Radiation with paclitaxel data
A response of cell lines to radiation results in senescence, arrest, and apoptosis in both the G1 and G2M
phases. Furthermore, a cell line subsequently exposed to paclitaxel stops dividing, i.e., rG2M→G1 (t) = 0
for t ≥ 0.
Calculations: Built-in MatLab functions ode15s and fmincon are used to solve the DAE problem
(4.3.22) - (4.3.23). Optimization function fmincon determines transition rate r∗G1→S (t). There are four
inputs for the optimization function. The first is derived from the proportions in each phase at the
two consecutive time points. Second is transition rate r˜S→G2M, where we assume that the transition
rate from the S -phase to G2M-phase is unaffected by paclitaxel or radiation treatment and has been
determined from the unperturbed data and the plateau log reduction value, as discussed in Section
4.4.2. Third is that the cell death from the paclitaxel treatment λTx(t) is unaffected by irradiation and
has the same value as for the paclitaxel treatment alone. We assume that paclitaxel treatment has
not affected the transition rate from the G1-phase to S -phase, but irradiation has. We impose that
r∗G1→S (t), if reduced after the irradiation dose, is expected to recover piecewise linearly, as shown in
Figure 4.5(a). The solution converges quickly to the optimal value.
Known variables so far are the transition rates r˜G1→S , r˜S→G2M, r˜G2 M→G1 , and cell death from the
paclitaxel treatment λTx(t). Thus, we can estimate the transition rate r∗G1→S (t) and the cell death from
irradiation λR(t) (this variable has been introduced in Section 4.3) from the provided data.
4.4.5 Radiation data
A response of cell lines to radiation results in respective senescence, arrest and apoptosis in the G1
and G2M phases.
Calculations: Built-in MatLab functions ode15s and fmincon are used to solve the DAE problem
(4.2.28) - (4.2.30). Optimization routine fmincon determines transition rate r∗G2M→G1 (t). There are
four inputs for the optimization function. The first is derived from the proportions in each phase at the
two consecutive time points. Second is transition rate r∗G1→S (t), which has been determined from the
data of the cell population treated through a combination of paclitaxel and irradiation, as discussed in
Section 4.4.4. Third is the cell death λR(t) from irradiation, as determined in Section 4.4.4. Fourth is
transition rate r˜S→G2M, where we assume that the transition rate from the S -phase to the G2M-phase is
unaffected by the paclitaxel or radiation treatment and has been determined from the unperturbed data
and the plateau log reduction value, as discussed in Section 4.4.2. We also assume that the transition
rate from the G2M-phase to the G1-phase, if reduced in value after the irradiation dose, is expected to
recover piecewise linearly, as shown in Figure 4.5(b). The solution converges quickly to the optimal
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value.
Known variables are transition rates r˜G1→S , r˜S→G2M , r˜G2 M→G1 , r∗G1→S (t), and λR(t). From the provided
radiotherapy data, we estimate the transition rate: r∗G2 M→G1(t).
4.5 Estimating the initial proliferating fraction
The aim of this model is to estimate the initial proliferating fraction of the cancer cell population after
a one-time irradiation dose of 9 Gy of five cell lines.
It is known that a small fraction of the initial population (0.1-10%, depending on the cell line)
survives radiation (called a surviving fraction in biological terminology), and that this is the population
that grows into a surviving colony assay. Just where these surviving cells come from is unclear, but it
is thought that they will sustain DNA damage and move ultimately to the G2-phase until DNA repair is
complete, whereupon they will divide and re-enter the cell cycle. This re-entry will be asynchronous,
so the surviving population will be distributed through all cycle phases.
4.5.1 Initial proliferating fraction interval
Our model has limitations in estimating the initial proliferating fraction. We can only calculate an
interval where such fraction is located. We introduce a variable Φinit and refer to it throughout this
chapter as the initial proliferating fraction. We define initial proliferating fraction Φinit as a sum of
proliferating proportions in G1, S and G2M phases at time 0 as follows:
Φinit = ΠG1(0) + ΠS (0) + ΠG2M(0). (4.5.1)
When calculating the initial proliferating fraction, we assume that cells in the S -phase at hour zero
are all proliferating; therefore, the initial proportion of the cell population in S -phase (as mentioned
before, notions ΠS (0) and P0S are interchangeable) is added to the proliferating fraction. We assume
that the proportion of the cell population after combined radiation and paclitaxel treatment in the G1-
phase that has moved from the G1-phase to the S -phase within the first 18 hours is the proliferating
fraction of the population in the G1-phase. Since there is radiation induced apoptosis present, we
calculate the proliferating fraction in the G1-phase as follows:
ΠG1(0) = [PTxRG1 (0) − PTxRG1 (18)]eλR18. (4.5.2)
The initial proliferating fraction in the G2M-phase (namely, ΠG2M(0)) is not detectable without dif-
ferent chemotherapeutic agents that interfere with DNA replication without affecting mitosis. Thus,
from equations (4.2.27b) and (4.3.21), we can express only the following inequality:
ΠG2M(t) =
r∗G2 M→G1(t)
rG2 M→G1(t)
PG2M(t) ≥
r∗G2M→G1 (t)
r˜G2M→G1
PG2M(t), ∀t ≥ 0. (4.5.3)
Therefore, we can estimate only an interval of the proliferating fraction in the G2M-phase, denoted
by FG2M, as follows:
FG2M ∈
[
r∗G2 M→G1(0)
r˜G2 M→G1
PG2M(0), PG2M(0)
]
, (4.5.4)
where the initial arrest of the division rate r∗G2M→G1 (0) and the unperturbed value r˜G2M→G1 have been
shown in Figures 4.5-4.9. We observe that for cell lines NZM3, NZM4 and NZM13 cell division has
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briefly stopped r∗G2 M→G1(0) = 0. Using our model, we estimate the initial proliferating fraction of the
population treated with radiotherapy as follows:
Φinit ∈ [ΠG1(0) + ΠS (0) + FG2M]. (4.5.5)
Intervals of initial proliferating fraction estimates of five cancer cell lines are shown in Table 4.3 in
column two.
4.5.2 Proliferating fraction interval 96 hours post irradiation
In this section, we estimate the proliferating fraction, named Φend, of the cancer cell population at the
final experimental observation time (tend = 96 hours). We define proliferating fraction Φend as a sum
of proliferating proportions in the G1, S , and G2M phases at time tend as follows:
Φend = ΠG1(tend) + ΠS (tend) + ΠG2M(tend). (4.5.6)
As discussed in Section 4.5.1, our model is limited to estimating intervals of proliferating proportions
for each cell line. The lower bound, denoted by LB, of the proliferating population proportion after 96
hours post the irradiation enables us to say that at least LB per cent of the population is proliferating.
It follows that our mathematical model supports that the effect of the irradiation dose is the arrest of
the transition rates, i.e., a decrease in their numerical values.
Taking into account equations (4.2.27), we can rewrite (4.5.6) as:
Φend =
r∗G1→S (tend)
rG1→S (tend)
PG1(tend) + PS (tend) +
r∗G2 M→G1(tend)
rG2 M→G1(tend)
PG2M(tend), (4.5.7)
where tend = 96 hours. Measurement of the transition rates, rG1→S (tend) and rG2 M→G1(tend), is not
possible. Thus, we can only provide the lower bound of the proliferating proportion of the population
after irradiation. Using equations (4.3.20) and (4.3.21), we rewrite equation (4.5.7) as:
Φend ≥
r∗G1→S (tend)
r˜G1→S
PG1(tend) + PS (tend) +
r∗G2M→G1 (tend)
r˜G2M→G1
PG2M(tend) = LB, (4.5.8)
where tend = 96 hours, and the right-hand-side of inequality (4.5.8) is referred to as our variable LB.
Our model estimates the interval of the proportion that continues proliferating after 96 hours post
radiotherapy as:
Φend ∈ [LB, 1]. (4.5.9)
Intervals of the proliferating fraction 96 hours post radiotherapy of five cancer cell lines are shown in
Table 4.3 in column three.
4.6 Results: transition rate arrest and proliferating fractions
We impose that transition rates r∗G1→S (t) and r∗G2M→G1(t), if reduced in value after irradiation, will
recover piecewise linearly. Radiotherapy effects on the transition rates are shown in Figures 4.5 - 4.9.
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(a) The arrest of transition rate r∗G1→S for cell line
NZM3. The dashed line represents the value of tran-
sition rate r˜G1→S of an unperturbed population. The
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(b) The arrest of transition rate r∗G2 M→G1 (t) for cell
line NZM3. The dashed line represents the value of
transition rate r˜G2 M→G1 of an unperturbed population.
The solid line shows the arrested value of r∗G2 M→G1 (t).
Figure 4.5: Arrest of the transition rates after the irradiation of cell line NZM3. The mathematical
optimization function discussed in Section 4.4 produced piecewise linear functions for the transition
rates: r∗G1→S (t) and r∗G2M→G1(t), shown in subfigures (a) and (b), respectively.
4.6.1 NZM3 cell line
From our model, we estimated that after the irradiation cancer cell population taken from cell line
NZM3 initially stopped cell division for 18 hours, as can be seen in Figure 4.5(b), but recovered
within 96 hours to 75% of its unperturbed value. Radiotherapy had no impact on the cell population
transition probability from the G1 - phase to S - phase, as can be seen in Figure 4.5(a). Apoptosis
induced by irradiation was close to 1%. An experimental estimate for the recovering fraction of 6%.
We present the initial proliferating interval calculated via our model in Table 4.3.
4.6.2 NZM4 cell line
Our model predicted an initial decrease in transition rate r∗G1→S (t) to 63% of its unperturbed value and
full recovery to its unperturbed value within 48 hours after irradiation, as shown in Figure 4.6(a). The
cell division rate was estimated to drop to zero abut started to recover immediately and reached its
unperturbed value over 96 hours after irradiation, as shown in Figure 4.6(b). The death rate induced
by irradiation was close to zero.
4.6.3 NZM5 cell line
Irradiation had not stopped cell division for the NZM5 cell line, as shown in Figure 4.7(b). It initially
reduced transition rate r∗G2 M→G1(t) to 31% of its unperturbed value and 49% of its unperturbed value
after 96 hours. Transition rate r∗G1→S (t) was not affected, as can be seen in Figure 4.7(a). Apoptosis
induced by irradiation was estimated at 4%.
4.6.4 NZM6 cell line
Numerical simulations proposed an initial drop in the value of transition rate r∗G1→S (t) to 57% of its
unperturbed value with full recovery within 72 hours, as shown in Figure 4.8(a). Cell division rate
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(a) The arrest of transition rate r∗G1→S for cell line
NZM4. The dashed line represents the value of tran-
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solid line shows the arrested value of r∗G1→S (t).
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(b) The arrest of transition rate r∗G2 M→G1 (t) for cell
line NZM4. The dashed line represents the value of
transition rate r˜G2 M→G1 of an unperturbed population.
The solid line shows the arrested value of r∗G2 M→G1 (t).
Figure 4.6: Arrest of the transition rates after the irradiation of cell line NZM4. The mathematical
optimization function discussed in Section 4.4 produced piecewise linear functions for the transition
rates: r∗G1→S (t) and r∗G2M→G1(t), shown in subfigures (a) and (b), respectively.
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(a) The arrest of transition rate r∗G1→S for cell line
NZM5. The dashed line represents the value of tran-
sition rate r˜G1→S of an unperturbed population. The
solid line shows the arrested value of r∗G1→S (t).
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(b) The arrest of transition rate r∗G2 M→G1 (t) for cell
line NZM5. The dashed line represents the value of
transition rate r˜G2 M→G1 of an unperturbed population.
The solid line shows the arrested value of r∗G2 M→G1 (t).
Figure 4.7: Arrest of the transition rates after the irradiation of cell line NZM5. The mathematical
optimization function discussed in Section 4.4 produced piecewise linear functions for the transition
rates: r∗G1→S (t) and r∗G2M→G1(t), shown in subfigures (a) and (b), respectively.
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(a) The arrest of transition rate r∗G1→S for cell line
NZM6. The dashed line represents the value of tran-
sition rate r˜G1→S of an unperturbed population. The
solid line shows the arrested value of r∗G1→S (t).
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(b) The arrest of transition rate r∗G2 M→G1 (t) for cell
line NZM6. The dashed line represents the value of
transition rate r˜G2 M→G1 of an unperturbed population.
The solid line shows the arrested value of r∗G2 M→G1 (t).
Figure 4.8: Arrest of the transition rates after the irradiation of cell line NZM6. The mathematical
optimization function discussed in Section 4.4 produced piecewise linear functions for the transition
rates: r∗G1→S (t) and r∗G2M→G1(t), shown in subfigures (a) and (b), respectively.
r∗G2M→G1 (t) initially underwent arrest to 9% of its unperturbed value and reached a new plateau value
at 51% of the unperturbed rate within 24 hours after irradiation. Apoptosis caused by the treatment
was close to 1%.
4.6.5 NZM13 cell line
Our model suggests that cell division r∗G2 M→G1(t) was initially stopped due to irradiation, with imme-
diate recovery reaching 44% of the unperturbed value, as shown in Figure 4.9(b). We remark that it
a new plateau value has not been reached during 96 hours as can be seen for other cell lines. Tran-
sition rate r∗G1→S (t) initially dropped to 19% of the unperturbed value and recovered to 86% of the
unperturbed value but also seems not have reached a new plateau value, as shown in Figure 4.9(a).
We note that population doubling time Td has been experimentally estimated as 76.8 hours (see Table
4.4). This cell line’s Td is longer compared to the other four cell line population doubling times. This
suggests that the transition rate recovery duration is correlated to the population doubling time. Our
model suggests that cell death due to irradiation was close to 1%. Cell number measured 96 hours
after radiation at 9 Gy was 75% of that expected, and our model suggests that it is 68%, due solely to
cell cycle arrest and not cell death, see Table 4.4.
4.6.6 Proliferating cell population proportions
We present the proliferating proportion interval for each cell line in Table 4.3. For example, the pro-
liferating proportion of cell culture Φend taken from cell line NZM3 can be calculated with equation
(4.5.8) as follows: firstly, estimate ratios r∗G1→S (tend)/˜rG1→S and r∗G2M→G1 (tend)/˜rG2 M→G1 from Figure
4.5 and, secondly, use Table 4.2, which contains the values of the proportions of populations in each
phase after 96 hours post-irradiation. From Table 4.3, we can see that following 96 hours after expo-
sure to the radiation of 9 Gy, the cell population of the NZM3 cell line culture will be composed of at
least 93.2% of proliferating cells.
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(a) The arrest of transition rate r∗G1→S for cell line
NZM13. The dashed line represents the value of
transition rate r˜G1→S of an unperturbed population.
The solid line shows the arrested value of r∗G1→S (t).
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(b) The arrest of transition rate r∗G2 M→G1 (t) for cell
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Figure 4.9: Arrest of the transition rates after the irradiation of cell line NZM13. The mathematical
optimization function discussed in Section 4.4 produced piecewise linear functions for the transition
rates: r∗G1→S (t) and r∗G2M→G1(t), shown in subfigures (a) and (b), respectively.
The recovering survival fraction, denoted by Φexperim , was experimentally measured for every cell
line. It is an estimate of colonies counted after 1-3 weeks over the initial number of cells seeded.
We have shown in Table 4.3 the proliferating proportion intervals of the cancer cell populations
taken from five cell lines. The second column, Φinit , shows the interval of the initial proliferating
fraction after a one-time irradiation dose (at t = 0) for each cell line estimated by our model. The third
column, Φend , presents the interval of the proliferating cell proportion of each cell line after 96 hours
following irradiation. Column four, Φexperim, shows the experimental estimates of the proliferating
fraction for each cell line.
4.6.7 Cell loss and expected number of cells
Table 4.4 shows the parameters of cell cycle dynamics for five cell lines. We have calculated the
population doubling times using the plateau log reduction method (discussed in Chapter 3) for cell
lines NZM5 and NZM6. For the rest of the cell lines, we used the experimental estimates of the
population doubling times, which were obtained by constructing a growth curve. The transition rates
between respective phases, calculated with methods described in Section 4.4.2, have been shown in
columns three to five in Table 4.4. We have estimated from equation (4.3.10) the initial proportion
of the population lost within 18 hours following the paclitaxel treatment application for each cell line
from. We refer to it as T xLoss and present in column six. By utilising the arrested rates r∗G1→S (t)
and r∗G2 M→G1(t) in Figures 4.5 - 4.9, we have calculated from system (4.2.28) the proportion of cell
number expected after 96 hours, e.g., cell line NZM13 has 68% of the expected number of cells after
96 hours following irradiation; and refer to as EMod. Column eight in Table 4.4, EExperim, shows the
experimental estimate of the expected proportion of cell number measured 96 hours after irradiation
at 9Gy.
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Cell line Φinit Φend Φexperim
NZM3 [0.67, 0.85] [0.93, 1] 0.06
NZM4 [0.55, 0.76] [1, 1] 0.20
NZM5 [0.23, 0.32] [0.83, 1] 0.20
NZM6 [0.32, 0.44] [0.82, 1] 0.02
NZM13 [0.35, 0.51] [0.75, 1] 0.08
Table 4.3: Proliferating proportion intervals of the cancer cell population taken from five cell lines.
The second column, Φinit , shows the interval of the proliferating fraction after a one-time irradiation
dose (at t = 0) for each cell line estimated by our model. The third column, Φend, indicates the interval
of the proliferating cell proportion of each cell line after 96 hours following irradiation. Column four,
Φexperim , shows the experimental estimates of the proliferating fraction for each cell line.
4.7 Discussion
We used optimization methods in order to estimate the initial proliferating fraction and the proliferat-
ing proportion of the population after 96 hours following a one-time irradiation dose.
We analysed five cell lines, identical to the ones in paper Basse et al. (2010), and our mathematical
model results agreed with the model presented in paper Basse et al. (2010), i.e., cancer cell population
growth undergoing arrest and little cell death occurring due to irradiation. We imposed that the tran-
sition rates from the G1-phase to the S -phase and from the G2M-phase to the G1-phase, if decreased
in value, would recover in a piecewise linear mode after radiotherapy.
A significant difference between our mathematical model and that in Basse et al. (2010) is in es-
timation of transition rates. We estimated the unperturbed population transition rates (namely, r˜G1→S ,
r˜S→G2M and r˜G2M→G1) by applying a mathematical model rather than using values provided by experi-
mentalists. We used the plateau log reduction value (discussed in Chapter 3) to calculate all transition
rates of the unperturbed cancer cell population; therefore, our numerical values differed from those
given in Basse et al. (2010).
After an irradiation dose, the cell division rates (i.e., the transition rate from the G2M - phase to
the G1 - phase) for cell lines NZM3, NZM5, and NZM6 plateaued at a lower value than they did in
the unperturbed state. The cancer cell population taken from cell line NZM4 recovered from radiation
within the 96 hours after treatment and reached the original unperturbed BEG state. A one-time
irradiation dose of 9 Gy for some cell lines did not induce a long-term cell cycle arrest, as we can see
in Table 4.3, the proliferating proportion Φend after 96 hours post-irradiation is equal to 1. For cancer
cell line NZM13, transition rates did not plateau within 96 hours. From Figures 4.5 - 4.9 and Table
4.4, we can see that the transition rate speed of recovery is related to the doubling time: the shorter
the doubling time, the faster the recovery to the unperturbed value or a new plateau value.
Cell loss induced by irradiation is approximately 1% for every cell line apart from NZM5, which
produced a 4% cell loss within 96 or 72 hours. Our mathematical model estimates of the proportion of
cells expected after 96 hours (EMod) are shown in the seventh column of Table 4.2. An experimental
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Cell Line Td r˜G1→S r˜S→G2M r˜G2 M→G1 Tx Loss EMod EExperim
(hours) (hours−1) (hours−1) (hours−1)
NZM3 41∗ 0.04781 0.06723 0.09361 0 1 n.a.
NZM4 46∗ 0.05105 0.05406 0.07258 0 1 n.a.
NZM5 31.2 0.06215 0.09782 0.11129 0.32 0.54 n.a.
NZM6 27.5 0.05583 0.12967 0.16426 0.18 0.75 n.a.
NZM13 76.8∗ 0.02297 0.04254 0.04889 0.12 0.68 0.75
Table 4.4: Parameters of cell cycle dynamics for five cell lines. Column two, Td, shows the popu-
lation doubling time of each cell line: asterisks indicate the doubling times that are experimentally
estimated; Td values with no asterisks show that the doubling time is calculated from the plateau log-
arithmic reduction value. Columns three to five show the transition rate values from respective phases
of the unperturbed cancer cell population calculated with the methods discussed in Section 4.4.2. Col-
umn six shows the calculated value of the proportion of the initial population number lost within 18
hours after the paclitaxel treatment application of each cell line, which are the methods discussed in
Section 4.4.3. Column seven, EMod, indicates the proportion of cell number expected after 96 hours.
Column eight, EExperim, shows the experimental estimate of the expected proportion of cell number
measured 96 hours after irradiation at 9 Gy; n.a. indicates that this data is not available.
observation for that, which was expected for cell line NZM13 is shown in 75%. In comparison, our
mathematical model derived the expected cell number at 68% of that initial. No experimental data
was available for the other cell lines. Thus, our mathematical estimate was very good for the observed
data point.
Loss of clonogenical survival was experimentally estimated for every cell line and was in a range
of 90 − 99%: this percentage of population has lost capability to reproduce indefinitely. We argue
that within 96 hours following irradiation flow cytometry method cannot detect this loss. The initial
proliferating fractions Φinit and the proliferating proportions of the cell population Φend for five cell
lines are shown in Table 4.3. The initial proliferating fraction interval estimated via our mathemat-
ical model is much higher in value than experimentally estimated ones, because, after irradiation,
some cells do divide once or twice before dying. These cells have lost the capability to reproduce
indefinitely and are considered dead in biological terminology but not in our mathematical approach.
Experimental observations stopped at 96 hours for cells lines NZM3, NZM4, NZM5, and NZM13,
and at 72 hours for cell line NZM6. These times are at most the length of three average cell cycles
times for some cell lines (we presumed here that the average cell-cycle time is similar to that of pop-
ulation doubling, see Chapter 2). A proportion of the population that is not a part of the survival
fraction divides once or twice or more before undergoing apoptosis; thus, our model cannot estimate
the surviving fraction successfully, as experimental observations stop too soon. Our model results do
not agrees with the following statement from Basse et al. (2010): “the long-term cell cycle arrest,
rather than apoptosis, accounts for much of the loss of viability observed in clonogenicity assays”.
This statement implies that flow cytometry profiles could differentiate what proportion of arrested cell
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population would eventually undergo apoptosis, which is not the case.
The flow cytometry profiles of cell populations perturbed by paclitaxel and paclitaxel in combina-
tion with irradiation were very noisy after certain experimental observation points, and measurements
with Cylchred method seemed very inaccurate.
We note that our data readings, i.e., slight variations in the plateau log reduction value or in
estimates of proportions in each phase from flow cytometry profiles via different methods (Cylchred
or others), affect the result of the unperturbed population transition rates that then affect the results of
the optimization routine. However, it does not affect the conclusions derived from our model that the
transition rates undergo arrest, little cell death occurs within 96 hours, and that the initial proliferating
proportion is much larger in value than the surviving fraction due to the fact that more cells die after
96 hour observation point.
Since little apoptosis is detected via our mathematical model, and the one presented in Basse et al.
(2010) during the first 96 hours after radiotherapy and the entire initial proportion in the S -phase after
irradiation is assumed to be proliferating, the instant result is the proliferating fraction calculated with
our model to be larger than the experimental estimates of the initial surviving fraction.
For successful estimation of the surviving fraction via mathematical modelling, we require ex-
perimental data beyond the observation point of 96 hours. With our mathematical model, we could
then estimate cell loss that occurs beyond 96 hours, thus leading us to more precise calculation of the
surviving fraction of the cancer cell population after the one-time irradiation dose.
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Chapter 5
Application of the Two-Population Model
There is increasing evidence that the growth of human tumours is driven by a small proportion of tu-
mour stem cells with self-renewal properties. Multiplication of these cells leads to loss of self-renewal
and after division for a finite number of times the cells undergo programmed cell death. Cell-cycle
times of human cancers have been measured in vivo and shown to vary in the range from two days and
several weeks, depending on the individual. Cells cultured directly from tumours removed at surgery
initially grow at a rate comparable to the in vivo rate but continued culture leads to the generation
of cell lines that have shorter cycle times (1-3 days). It has been postulated that the more rapidly
growing sub-population exhibits some of the properties of tumour stem cells and are the precursors
of a slower growing sub-population that comprise the bulk of the tumour. We have previously devel-
oped a mathematical model to describe the behaviour of cell lines and we extend this model here to
describe the behaviour of a system with two cell populations with different kinetic characteristics and
a precursor-product relationship. The aim is to provide a framework for understanding the behaviour
of cancer tissue that is sustained by a minor population of proliferating stem cells.
5.1 Introduction
Stem cells for normal tissues in the human body are thought to act as a reservoir of self renewing cells
and are supported within a spatially constrained microenvironment called a niche Moore & Lemis-
chka (2006); Watt & Hogan (2000). It is hypothesised that proliferation, apoptosis, senescence, and
differentiation of stem cells are inhibited within the niche, but that once stem cells leave the niche they
are able to proliferate (via a controlled number of cell divisions), migrate to surrounding tissue and
differentiate, constituting the bulk of normal tissue (as illustrated in Figure 5.1). There is increasing
evidence that the growth of human tumours is also driven by a population of tumour stem cells that
have the property of self-renewal and are located in a spatially constrained niche microenvironment
Dittmat & Zanker (2009); Lindeman & Visvader (1999); Schatton & Frank (2007); Sole et al. (2008)
but with unlimited proliferation potential, giving rise to progeny outside the niche that are not spatially
constrained but have limited proliferation potential. While retaining the property of self-renewal in the
niche, tumour stem cells have in many cases lost the ability to respond to niche signals and therefore
continue to proliferate Baguley (2006). When these cells leave the niche, they (i) lose self-renewal
capacity, (ii) continue to proliferate, (iii) fail to differentiate properly and (iv) undergo programmed
cell death after a finite number of cell divisions. These cells form the majority of the tumour tissue.
Their average cell-cycle time can be measured in vivo and various studies have shown cycle times to
vary in the range from two days to several weeks, depending on the individual Wilson et al. (1988).
85
5. APPLICATION OF THE TWO-POPULATION MODEL
b
b
b b
r
r
r
r
r
r
r
rbC bC
bC
rs
rs
rs
rs
rs rs rs
rs rs
rs
rs
rs
rs
rs
rs
rs
Niche
Body tissue
Non dividing stem cell
Dividing stem cell
Dividing progeny
Normal tissue cell
Figure 5.1: Schematic diagram of a niche in a human tissue. Stem cells, located in a spatially con-
strained niche microenvironment but with unlimited proliferation potential, normally divide asymmet-
rically with one daughter cell remaining in the niche and one, once triggered by demand, migrating
from the niche to surrounding tissue. Stem cell progenies proliferate in surrounding body tissue and
eventually (after proliferation ceases) differentiate to become normal tissue cells.
Tumour tissue removed at surgery can be grown in culture and measurements of primary culture
cycle time show a range of 3 days to several weeks, which is similar to that observed in vivo Baguley
& Marshall (2004); Furneaux et al. (2008). Continued culture of clinical tumour material results in
death of the majority of the cells but in the emergence after several months of stably growing cells
called cell lines, as shown by the scheme in Figure 5.2. These lines have shorter cell-cycle times than
those of the primary cultures with a range, depending on the individual, of 1-3 days. Notably, the
cell-cycle times of cell lines are correlated to the cell-cycle times of the primary cultures from which
they were initially derived and it has been postulated that cell lines exhibit some of the properties of
tumour stem cells Baguley & Marshall (2008).
Mathematical models describing the kinetic behaviour of cell lines, both under steady state be-
haviour and following perturbation with radiation and cytotoxic drugs can be found in the literature
Basse & Ubezio (2007); Basse et al. (2003, 2005); Begg (2007). In Johnston et al. (2006), a math-
ematical model is used to describe stem and semi-differentiated cells in the colonic crypt. In this
chapter, we have combined aspects of these models with our model in Chapter 2 to describe the be-
haviour of the tumour tissue in terms of the above stem cell model, where the tumour comprises two
sub-populations with different kinetic properties. One small sub-population of recently migrated stem
cells from the niche exhibits rapid growth (we term this sub-population the ‘rapid sub-population
cells’) and the other slower growing sub-population of partially differentiated stem cell progeny mak-
ing up the bulk of the tumour (termed the ‘slow sub-population cells’). Cell-cycle times and percent-
ages in each phase of the cell cycle have been determined experimentally in cell lines as described in
Section 5.2 and these measurements are used to establish estimates of model parameters. It should
be noted here that the term growth refers to the number of cells in the population or sub-population
increasing and not to the actual size of individual cells.
When tumour cells from a surgical sample are placed into culture, the niche structure is destroyed
so that no new stem cells migrate from the niche. The more slowly growing, partially differentiated
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Figure 5.2: Schematic diagram of a primary culture of tumour tissue (left), comprising mainly of
relatively slowly growing sub-population of cells (cycle times of 3 days to several weeks) and a small
sub-population with the potential for more rapid growth (cell-cycle times of 1 to 3 days). With contin-
ued culture of the primary culture for several months, the more slowly growing sub-population cells
die and are replaced by more rapidly growing sub-population cells, termed a cell line.
progeny tumour cells, which form the majority of the population, continue to proliferate and to un-
dergo apoptosis. However, the small population of rapidly growing tumour ‘ex stem’ cells continues
to proliferate and is resistant to apoptosis, such that with continuing culture, the proportion of slowly
growing sub-population of cells decreases while that of the more rapidly growing sub-population
increases. Eventually, the proportion of slowly growing sub-population of cells is negligible and vir-
tually the entire population is composed of more rapidly growing sub-population of cells and may be
termed a cell line (Figure 5.2).
The aim of this communication is to construct a mathematical model that reproduces the main
elements of this scheme for tumour cells in primary cultures and established cell lines, and apply
this to in vivo tumour growth. In Section 5.2, we describe the experimental procedure for measuring
cell-cycle times and cell cycle phase percentages of cell lines. Section 5.3 outlines the mathematical
model for the two sub-populations of growing cells and also shows the equilibrium result of the switch
from a high percentage of ‘slow sub-population cells’ (the primary culture case) to a high percentage
of ‘rapid sub-population cells’ (the cell line case). Cell death via time dependent apoptosis is added
to the model in Section 5.4. Section 5.5 describes two applications of the model. The first compares
model results to experimental cell-cycle times of primary cultures and established cell lines. The
second looks at in vivo tumour cell population growth where a population of slow sub-population
cells is maintained by a fixed number of stem cells in a niche.
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5.2 Experimental procedure
5.2.1 Derivation of cell lines from primary cultures
The derivation of the cell lines from melanoma specimens has been reported in several publications
and two references are provided here Marshall et al. (1993); Parmar et al. (2000). More than 150 cell
lines have now been derived from clinical samples, and of these, 31 have corresponding cell cycle data
from primary cultures. It is from this set that the correlation between the cycle time of the primary
culture and the corresponding cell lines has been obtained Baguley & Marshall (2004).
5.2.2 Determining cell-cycle times of established cell lines
This has been described in detail in other publications Baguley et al. (1995); Furneaux et al. (2008).
Growth of cultured cells can be measured by direct counting, but direct measurement of clinical
samples grown in primary culture is impossible because of the presence of host cells in the sample and
the loss of tumour cells. However, it was found using tumour cell lines that the degree of incorporation
of 3H-thymidine into DNA at different times after addition of paclitaxel, an inhibitor of mitosis and
cell division, was a function of the measured culture doubling time Baguley et al. (1995), as discussed
in Chapter 3. It is assumed by biologists that culture doubling time was similar to culture cycle time
for cell lines (i.e., that cell loss was negligible) and developed an empirical formula that related culture
cycle time to the 3H-thymidine incorporation data.
5.2.3 Determination of the percentage of cells in each phase of the cell division cycle
This was determined for established cell lines by fixing the cells, staining with the DNA stain propid-
ium iodide, and measuring the frequencies of cells with differing DNA content using flow cytometry
Holdaway et al. (1992).
5.3 A simple model for primary culture cell populations evolving into
established cell lines
5.3.1 Two-population age-structured model: solution existence, BEG condition
In accordance with tumour tissue comprising newly arrived tumour stem cells and their progeny, it is
assumed that primary culture cell populations are composed of both ‘rapidly growing’ (ex stem cells)
and ‘slowly growing’ (progeny) sub-populations, and that both are further subdivided by cell cycle
phase. We denote nRG1 (t, τ) to be the number density of rapidly growing sub-population cells in the
G1 phase at time t and age τ and similarly nRS (t, τ) and nRG2 M(t, τ) are the number densities of rapidly
growing sub-population cells in the S and combined G2M phases, respectively. The G2 and M-phases
are combined here because they cannot be separated by flow cytometry as described in Section 1.5.
Here we use the superscript R for the rapidly growing sub-population. Cells progress through the cell
cycle by having a rate of transition probabilitys from one phase to the next according to Figure 5.3
where rRG1→S is that rate of transition from G1-phase to S -phase and other rates have similar form as
specified in Table 5.1. For the slow growing sub-population cells (superscript S) we define nSG1 (t, τ),
nSS (t, τ) and nSG2 M(t, τ) to be the number densities of the slow growing sub-population cells in the G1, S
and G2M phases, respectively. Cell death via apoptosis is achieved by removing cells at a rate rSG1→A
per unit time from the slower growing sub-population G1-phase compartment.
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parameter description units
t time hours
τ age hours
rRG1→S rate transition G1 to S -phase hours
−1
rapid growing cells rRS→G2 M rate transition S to G2M-phase hours
−1
rRG2 M→G1 rate transition G2M to G1-phase hours
−1
ρ differentiation rate hours−1
rSG1→S rate transition G1 to S -phase hours
−1
slowly growing cells rSS→G2 M rate transition S to G2M-phase hours
−1
rSG2 M→G1 rate transition G2M to G1-phase hours
−1
rSG1→A apoptosis rate hours
−1
Table 5.1: Model parameters with descriptions and units. The parameters for the slow growing cells
are similar except the superscript S is added.
The rate of differentiation of the rapidly growing sub-population G1-phase cells to the slower
growing sub-population G1-phase cells is denoted ρ per unit time.
It is assumed that primary culture cell populations are composed of both ‘rapidly growing’ (ex
stem cells) and ‘slowly growing’ (progeny) sub-populations and that both are further subdivided by
cell cycle phase. We denote nR(t, τ) to be the number density vector of rapidly growing sub-population
cells, thus nR(t, τ) = [nRG1 (t, τ) nRS (t, τ) nRG2 M(t, τ)]T . The number densities of slow growing sub-
population cells (superscript S) we define by nS(t, τ) = [nSG1 (t, τ) nSS (t, τ) nSG2 M(t, τ)]T . Similarly to
the age-structure model for one population, as showed in Section 2.2, we define continuous function
n(t, τ) as:
n(t, τ) = [nR(t, τ) nS(t, τ)], (5.3.1)
where vector components are continuous functions on (t, τ) and transition rates are piecewise continu-
ous functions of time t and age τ. The age-structured two-population growth model can be expressed
(just like in Chapter 2) as:
∂
∂t
n(t, τ) + ∂
∂τ
n(t, τ) = −Dout(t, τ)n(t, τ), 0 < t < ∞, 0 < τ < T, (5.3.2)
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Figure 5.3: Scheme of cell-cycle control of a tumour cell population containing slow and rapidly
growing sub-populations of cells. Each sub-population is further subdivided into G1, S and G2M-
phases with the possibility that cells can transfer from one phase to the next according to a transition
rate (see Table 5.1). Rapid sub-population cells differentiate to become slow sub-population cells at
a rate of ρ per hour. Slow sub-population cells are mortal with apoptosis rate from G1 phase denoted
rSG1→A per unit time.
with respective side conditions defined as follows:
n(t = 0, τ) = n0(τ), initial age distribution, (5.3.3)
n(t, τ = 0) =
∫ T
0
Din(t, τ)n(t, τ) dτ, t > 0, renewal distribution. (5.3.4)
The matrix Dout represents the loss of cells from the various phases via death and transfer to other
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phases, and is defined as:
Dout = diagonal

DRout
DSout
 , (5.3.5)
with the following transition rate matrices for rapid and slow compartments:
DRout(t, τ) =

rRG1→S + ρ 0 0
0 rRS→G2M 0
0 0 rRG2M→G1
 (t, τ), (5.3.6)
and
DSout(t, τ) =

rSG1→S + r
S
G1→A 0 0
0 rSS→G2M 0
0 0 rSG2M→G1
 (t, τ). (5.3.7)
The renewal matrix Din represents the gain of cells at age τ = 0 in each phase and is caused by transfer
from other phases. Din is defined as:
Din =
[
DRin 0
C DSin
]
, (5.3.8)
where
DRin(t, τ) =

0 0 2rRG2 M→G1
rRG1→S 0 0
0 rRS→G2M 0
 (t, τ), (5.3.9)
and
DSin(t, τ) =

0 0 2rSG2 M→G1
rSG1→S 0 0
0 rSS→G2M 0
 (t, τ), (5.3.10)
with
C =
ρ 0 00 0 00 0 0
 . (5.3.11)
The solution of the system (5.3.2)-(5.3.4) is still of the form of equation (2.2.21) from Chapter 2.
When solution (2.2.21) is substituted into the renewal condition (5.3.4), the Volterra integral equation
of second kind is as in equation (2.3.1) from Chapter 2, we rewrite it here as:
n(t, 0) = F(t) +
∫ t
0
K(t, s)n(s, 0) ds, (5.3.12)
where
F(t) =
∫ T
t
Din(t, τ) exp
(
−
∫ τ
τ−t
Dout(s + t − τ, s) ds
)
n0(τ − t) dτ, (5.3.13)
and kernel of integro-equation for rapidly growing sub-population is defined as follows:
K(t, s) = DRin(t, t − s) exp
(
−
∫ t−s
0
DRout(ξ + s, ξ) dξ
)
, (5.3.14)
The existence and uniqueness of the solution is given by Theorem 2.3.1 from Chapter 2 with the
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appropriate interpretations for each compartment.
We continue with the proof of BEG existence for the two-population model with transition rates
now only dependent on age τ and the derivation of the characteristic equation for each compartment.
We assume that cell population composed of two sub-populations with different kinetic properties
grows exponentially as follows:
n(t, τ) = eλtn̂(τ), (5.3.15)
same assumption was made for one-compartment model in Section 2.4. When the ansatz (5.3.15) is
substituted into equation (5.3.12), just like in Chapter 2, we obtain the following nonlinear eigenprob-
lem: [
A(λ) − IΛ
]̂
n(0) = 0, (5.3.16)
now I is the 6-dimensional unit matrix, n̂ is the 6-dimensional vector of number density functions,
where the matrix A is as follows:
A =
[
A
R 0
νC AS
]
, (5.3.17)
with AR and AS given by
A
p2 =
∫ T
0
Dp2in (s) exp
(
−
∫ s
0
[Dp2out(s′) + Iλ] ds′
)
ds, with p2 ∈ {R, S}, (5.3.18)
and
ν =
∫ T
0
ρ(s) exp
(
−
∫ s
0
[rRG1→S (ξ) + λ] dξ
)
ds. (5.3.19)
The structure of matrices AR and AS is as follows:
A
p2 =

0 0 κp2G2M
κ
p2
G1 0 0
0 κp2S 0
 , (5.3.20)
for p2 ∈ {R, S}, where κp with p ∈ {G1, S ,G2M} is a positive element and has been defined in equation
(2.4.5) in Chapter 2 with two-population model specific transition rates.
The matrix A is now reducible, as its connected graph shows in Figure 5.4, slow sub-population
makes no contribution to any stage of rapid sub-population, see Appendix for more on reducible
matrices. So previous approach from Chapter 2 is not applicable. However, it can be seen that when
ρ = 0, we have two decoupled algebraic systems. Matrices AR andAS are irreducible and imprimitive.
Hence, Theorem 2.4.1 applies to each of the sub-populations individually. This means, there exists a
Λ = 1 and both, the rapid and slow sub-populations, have one positive eigenvalue each, denoted as λR0
and λS0 , respectively. These solve the characteristic equations (2.4.6) and (2.4.8), derived in Chapter
2, with the appropriate two-population model transition probability rates.
So now let us consider the coupled system again. As stated above, equation (5.3.16) is reducible,
and is of the form [
A
R(λ) − IΛ
]̂
nR(0) = 0, (5.3.21)
Cn̂R(0) +
[
A
S(λ) − IΛ
]̂
nS(0) = 0, (5.3.22)
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G1R S R G2MR G1S S S G2MS
κRG1 κ
R
S
κRG2 M
κSG1 κ
S
S
κSG2 M
ν
Figure 5.4: Reducible matrix A diagram.
then Theorem 2.4.1 applies to the rapid sub-population; therefore, there exists a λR0 , hence Λ = 1 such
that n̂R(0) > 0 (proven with the Perron-Frobenius theorem presented in Section 2.4). Furthermore, if
λ , λS0 , then
[
A
S(λ) − IΛ
]
is not singular, and
n̂S(0) = −
[
A
S(λ) − IΛ
]−1
Cn̂R(0). (5.3.23)
If λ = λS0 , then the Fredholm Alternative theorem applies and Cn̂
R(0) must be orthogonal kernel
of
[
A
S(λ) − IΛ
]
for a solution to exist, see Kantorovich & Akilov (1982). The solution is then a
combination of the eigenvectors n̂R(0) and n̂S(0) of the uncoupled system.
5.3.2 Two-population model ODE
Two-population age-structured model can be reduced to the ODE system, as shown in Section 2.6.
Number of cells in G1-phase for rapid-subpopulation is denoted with variable NRG1 , where N
R
G1(t) =∫ T
0 n
R
G1 (t, τ) dτ, and similar notions have been derived for the rest of the phases. Thus, two-population
dynamics can be modelled by six ordinary differential equations, one for each phase, namely:
dNRG1
dt = 2r
R
G2 M→G1 N
R
G2M − r
R
G1→S N
R
G1 − ρN
R
G1 , (5.3.24)
dNRS
dt = r
R
G1→S N
R
G1 − r
R
S→G2MN
R
S , (5.3.25)
dNRG2M
dt = r
R
S→G2MN
R
S − r
R
G2M→G1 N
R
G2M, (5.3.26)
for the rapidly growing sub-population cells and
dNSG1
dt = ρN
R
G1 + 2r
S
G2 M→G1 N
S
G2M − (rSG1→S + rSG1→A)NSG1 , (5.3.27)
dNSS
dt = r
S
G1→S N
S
G1 − r
S
S→G2MN
S
S , (5.3.28)
dNSG2 M
dt = r
S
S→G2MN
S
S − r
S
G2 M→G1 N
S
G2M , (5.3.29)
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ρ < rRG1→S (λR > 0) rSG1→A < rSG1→S (λS > 0) N(t) → cRvReλRt + cS vSeλSt
ρ < rRG1→S (λR > 0) rSG1→A > rSG1→S (λS < 0) N(t) → cRvReλRt
ρ > rRG1→S (λR < 0) rSG1→A < rSG1→S (λS > 0) N(t) → cS vSeλSt
ρ > rRG1→S (λR < 0) rSG1→A > rSG1→S (λS < 0) N(t) → 0
Table 5.2: Long term behaviour of the solution N(t) (with t ≥ 0) to equations (5.3.24) - (5.3.29) will
depend on the sign of the eigenvalues (λS and λR) of the system.
for the slower growing sub-population cells. These equations are defined on t > 0 with initial condi-
tions specified at t = 0.
If the transition rates between compartments are assumed to be positive constants then it can be
shown that there are at most two positive real eigenvalues to this system that can be found by solving
the characteristic equation for the rapid sub-population:
FR(λ) =
(rRG2M→G1 + λ)(rRS→G2 M + λ)(rRG1→S + ρ + λ)
2rRG1→S r
R
S→G2 Mr
R
G2M→G1
, (5.3.30)
where FR(λ) = 1. The function FR(λ) is a positive cubic and has dominant positive real solution, as
shown in Section 5.3.1, which we call λR.
Similarly, the characteristic equation for the slow sub-population is expressed as
FS(λ) =
(rSG2M→G1 + λ)(rSS→G2 M + λ)(rSG1→S + rSG1→A + λ)
2rSG1→S r
S
S→G2 Mr
S
G2M→G1
. (5.3.31)
The equation FS(λ) = 1 has only one positive real solution, which we call λS.
The asymptotic analytical solution of this system is described in Table 5.2. This solution depends
on the conditions above and can be written in vector form in terms of the positive eigenvalues (λR
and λS) and their corresponding eigenvectors (which we may call vR and vS respectively) and the
constants cR and cS obtained via the initial conditions. The long term proportions in the phases
depend on the eigenvectors vR and vS and the time it takes to reach this asymptotic state will depend
on the transition rates and the initial conditions. The initial state at t = 0 represents the primary culture
and the asymptotic solution represents the established cell line. Experimentally rapid sub-population
cells dominate a cell line so we proceed by running simulations corresponding to parameters chosen
in rows one and two of Table 5.2 where λR > 0.
In Figure 5.5(a), we see a numerical solution of the system obtained using Runge-Kutta methods
supplied by the ode45 function in MatLab. The parameter values are summarized in the caption.
The rates of the transition between phases were chosen based on the transition rates obtained for
unperturbed cell lines in Basse et al. (2005). The remaining have been chosen arbitrarily according
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to the second row of Table 5.2 so that ρ, the differentiation rate, is smaller than rRG1→S , the transition
rate from G1-phase to S -phase for the rapid sub-population cells. Thus λR is positive and the rapid
sub-population of cells increase. In addition the rate to apoptosis in the slow sub-population of cells
(rSG1→A) is bigger than the G1 to S -phase transition rate (rSG1→S ) so λS is negative. However this does
not mean that the slow sub-population cells disappear because there are non-zero slow sub-population
cell components in the eigenvector vR corresponding to λR. Initially, for the primary culture, we
have assumed that the number of slower sub-population cells is higher than the number of rapid sub-
population cells, i.e., 99% of slow sub-population cells, 1% of rapid sub-population cells. In Figure
5.5(a), we see the number of slow sub-population cells first decreasing and then increasing again. The
growth rate of the slow sub-population cells, after a time delay, is eventually the same as the rapid
sub-population cells. This can be explained by looking at row 2 of Table 5.2 where asymptotically the
solution behaves like eλRt. Eventually the proportion of rapidly growing sub-population cells is much
higher than the proportion of slow growing sub-population cells but the slow growing sub-population
cells are still there, that is the slow growing population does not disappear (Figure 5.5(b)). This is
theoretically the established cell line.
For our theoretical established cell line, because the proportion of slow sub-population cells to
rapid sub-population cells is negligible, we may consider the rapid sub-population cells alone. That
is, we set our differentiation rate ρ = 0 and investigate equations (5.3.24) - (5.3.26). We can easily
calculate the proportions in each phase that become asymptotically constant. Constant proportions in
the phases are obtained experimentally in cell lines, in equations (3.2.10). Let ΠRG1 be the proportion
of rapidly growing cells in the G1-phase and similar notation for the other phases then we can show:
ΠRS
ΠRG1
=
rRG1→S
rRS→G2M + λR
, (5.3.32)
ΠRG2M
ΠRS
=
rRS→G2M
rRG2M→G1 + λR
, (5.3.33)
ΠRG1 + Π
R
S + Π
R
G2M = 1. (5.3.34)
We can compute the average cell age in each phase from equations (2.5.42) in Chapter 2 (by taking
aging times τp → 0, for p ∈ {G1, S ,G2M}) as follows:
TRG1 =
ΠRG1
(rRG1→S + λR)
, (5.3.35)
TRS =
ΠRS
(rRS→G2M + λR)
, (5.3.36)
TRG2M =
ΠRG2M
(rRG2M→G1 + λR)
, (5.3.37)
for each of G1, S and G2M-phases, respectively.
The doubling time for the established cell line is related through the λR by
TRd =
ln2
λR
, (5.3.38)
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Figure 5.5: Simulation of the solution to the system equations (5.3.24) - (5.3.29). Initially we assume
there are 10000 cells with 99% slow sub-population cells and 1% rapid sub-population cells. The
proportion of cells in each phase for both slow and rapid sub-populations is initially G1-phase 53%,
S -phase 31% and G2M-phase 16%. The apoptosis rate is constant rSG1→A = 1 per hour. Transition
rates between the phases for the rapid sub-population cells are rRG1→S = 0.052729, r
R
S→G2M = 0.052
and rRG2M→G1 = 1.8 per hour. For the slow sub-population cells, we chose the same transition rates
as the rapid sub-population cells except for rSG1→S which is chosen to be 10% of r
R
G1→S (α = 0.1) in
equation (22). The differentiation rate from rapid sub-population cells to slow sub-population cells is
ρ = 0.00001 per hour.
and an estimate of the corresponding average cell age is just the sum of the proportions in each phase
TRa =
[ ΠRG1
(rRG1→S + λR)
+
ΠRS
(rRS→G2 + λR)
+
ΠRG2M
(rRG2M→G1 + λR)
]
. (5.3.39)
Thus for an established cell line, we have a relationship between proportions in each phase, rate
transitions between phases, population doubling time and cell-age time. Equations (5.3.32)-(5.3.34),
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(5.3.38) and (5.3.39) specify these relationships where λR is determined by solving equation (5.3.30).
Numerical explorations of these six equations using the damped Newton’s method indicate that even
with no cell loss the cell-age time is not equal to the doubling time, demonstrated before in Figure
2.6.
Experimentally, one can determine the proportions in each phase of an established cell line using
flow cytometry and estimate cell-cycle times as described in Section 5.2. In the further calculations,
we assume that experimentally estimated cell-cycle time is equal to what we refer to as the average
cell-age time Ta. We remark here that if we assume that the experimental cell-cycle time is equal
to the removal time, introduced in Section 2.5.6, then the qualitative results obtained by using the
average cell-age time carry-over to the removal time notion. In this chapter, terms average cell-age
and cell-cycle time are interchangeable. One can then obtain all the remaining model parameters
using our equations.
5.4 Time dependent apoptosis
In the previous section, we have described a model of a primary culture cell population composed
of mainly a slower growing sub-population of cells changing over time into an established cell line
composed of mainly rapid sub-population cells and a correspondingly shorter cell-cycle time. We
assumed that model parameters were constant, and now we investigate the case where the apoptosis
of a progeny cell (slow sub-population cell) occurs after a number of successive cell divisions. This
statement is inferred from the kinetics of in vivo human tumours, where the volume doubling time
is much longer than the calculated average cell-cycle time of the individual tumour cells, implying
extensive turnover and therefore death after a number of cell divisions Watson (1991). We do not
track individual cells through successive cell divisions but we can incorporate this phenomenon into
the model by having the apoptosis rate increasing with time. We chose a sigmoid function for the
apoptosis rate
rSG1→A(t) =
µ
1 + β1e−β2t
, (5.4.1)
as depicted in Figure 5.6.
We see in Figure 5.7(a) that the slower sub-population of cells initially keeps growing while
rSG1→A < r
S
G1→S as shown in the first row of Table 5.2. Since the apoptosis rate value is increasing
above rSG1→S , we move to the second row of Table 5.2, where the slow sub-population cells decrease.
Rapid sub-population cells are resistant to apoptosis and they keep growing exponentially at any
apoptosis rate.
5.5 Model applications
5.5.1 Comparing cell-cycle times of primary cultures and established cell lines
In the laboratory experiments, the cell-cycle times of primary cultures are longer than those of estab-
lished cell lines. This can be seen clearly in Figure 5.8 where the experimental estimates of cell-cycle
times (see Table 5.3) of 22 primary cultures and their corresponding cell lines have been plotted. Two
studies, one in ovarian cancer and one in brain cancer, have shown that cell-cycle times are related to
survival Baguley & Marshall (2004); Furneaux et al. (2008); therefore, it is important to understand
the underlying dynamics that might cause this phenomenon. In particular, we ask whether our simple
ODE model with the two - slow and rapid sub-populations of cells can recover the data in Figure 5.8.
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Figure 5.6: The apoptosis rate as a sigmoid function described in equation (5.4.1). Here µ = 1, β1 = e7
and β2 = 130 .
We proceed as follows. For each of 22 established cell lines, we note the experimentally calcu-
lated cell-cycle times and the proportions in each of the G1, S and G2M phases (see Table 5.3). We
assume that the proportion of slow sub-population cells in the established cell line is small compared
to the rapid sub-population cells and we use the six equations (5.3.32)-(5.3.34),(5.3.38), (5.3.39) and
(5.3.30) to find the phase transition rates for the rapid sub-population cells. This in turn can give us
a model estimate of the cell doubling time, TRd , for the rapid sub-population cells. As an interesting
aside we note that even in the absence of cell death the cell line doubling time is longer than the
cell-cycle time for established cell lines, as depicted in Figure 5.9, where we have plotted the model
estimate of the doubling time versus the model input of the experimentally obtained cell-cycle time for
our 22 cell lines. The relationship between the two is described by the non-linear equations mentioned
above but looks almost linear and a least squares regression line has been fitted.
We make the assumption that the difference in cell-cycle times between the slow sub-population
cells and the rapid sub-population cells is caused by a longer G1-phase transit time in the slow sub-
population cells. Thus we set the transition probabilities for the slow sub-population cells to be the
same as for the rapid sub-population cells with the exception of the rate transition from G1-phase. We
assume that the rate transition from G1 to S -phase of the rapid sub-population cells is proportional to
the rate transition from G1 to S -phase of the slow sub-population cells, i.e.,
rSG1→S = αr
R
G1→S , (5.5.1)
where α ∈ [0, 1] is to be determined in such a way as to recover the cycle time of the primary culture.
To obtain the doubling time TSd of the primary culture (slow sub-population cells) where
TSd =
ln2
λS
, (5.5.2)
we use equation (5.3.31) and the same cell-cycle time formula for slow sub-population cells as for
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Figure 5.7: Simulation of the solution to the system equations (5.3.24) - (5.3.29) with parameter
values and initial conditions the same as Figure 5.5 except death via apoptosis from G1-phase of
slowly growing sub-population cells is increasing until it reaches a constant value according to the
sigmoid function of Figure 5.6.
rapid sub-population cells (equation (5.3.39)) with a change from R to S respectively. For the primary
culture there was no experimental data for the proportional distribution among phases given. Propor-
tions in each phase can be expressed through the rate transitions using equations (5.3.32)-(5.3.34).
The two unknown parameters α and λS can be obtained by solving the system of equations (5.3.31)
and (5.3.39) with the damped Newton’s method. Initial guesses of α = 0.1 and λS = 0.005 gave
convergence to positive value parameters.
Using equation (5.5.2), we can now calculate doubling times for each of the 22 primary cultures
as seen in Figure 5.10. We see from this figure and also Figure 5.9 that the model recovers the
experimental data depicted in Figure 5.8.
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Patient code Primary culture Cell line Percentage Percentage
Tc (hours) Tc (hours) G1 phase S phase
NZC01 60 24 57 30
NZEN1 100.8 60 86 8
NZM02 93.6 43.2 62 28
NZM03 93.6 40.8 44 38
NZM04 216 29.8 54 32
NZM09 156 45.6 56 30
NZM12 86.4 25.9 81 11
NZM13 312 76.8 69 16
NZM16 228 50.4 85 7
NZM17 79.2 43.2 66 11
NZM18 163.2 62.5 84 8
NZM19 177.6 63.1 86 10
NZM21 93.6 22.8 84 8
NZM22 213.6 81.4 77 13
NZM24 177.6 39.4 75 13
NZM25 177.6 37.1 80 14
NZM26 105.6 63.1 84 4
NZM28 139.2 38.4 72 24
NZM30 64.8 29.6 69 25
NZM33 132 62.4 64 17
NZM34 105.6 40.8 65 23
NZM56 67.2 33.6 87 12
Table 5.3: Experimentally obtained cell-cycle times (Tc) for 22 primary cultures and their correspond-
ing cell line cell-cycle times. Column 4 and 5 contain data of experimentally obtained percentage
distribution among phases for 22 cell lines. Patient codes starting with the NZM correspond to the
melanoma cells, NZCO stands for the colorectal cancer cells, NZEN - endometrial.
5.5.2 In vivo tumours
A further application of the model is to consider an in vivo tumour, which is sustained by a number
of (rapid sub-population cells) stem cells in a niche. In choosing parameters, we have assumed that
the stem cell population (rapid sub-population cells) has the kinetic properties of the cell line and
that the progeny cells (slow sub-population cells) have the kinetic properties of the corresponding
primary tumour cultures. Because biologically the micro-environment of the niche has a given size,
we set the parameters so that the number of rapid sub-population cells remains constant. This is done
by using the threshold case, where ρ = rRG1→S . Deviations from the threshold condition will result
in population exponential growth or decay according to Table 5.2. In reality, in vivo cell population
dynamics are much more complicated. However, our simple linear model is used here to identify the
essential population dynamics associated with stem cells and their progeny.
Starting with 100% of cells in the rapid sub-population compartment and 0% in the slower sub-
population compartment the entire slow sub-population cell compartment (the tumour cells) is gener-
ated over time from rapid sub-population cell proliferation (the stem cells in the niche). The parame-
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Figure 5.8: Cell-cycle times of 22 primary cultures and corresponding derived cell lines. Recreated
from previously published experimental data Baguley & Marshall (2008).
ters of the sigmoid function for the apoptosis rate were chosen by trial and error so that the initial rate
is small and the horizontal asymptote is approximately equal to rSG1→S . Thus eventually the number
of slow sub-population cells becomes constant, i.e., rSG1→A = r
S
G1→S and λS = 0 (see Table 5.2). Then
the total size of the slow sub-population with time resembles a sigmoid function as depicted in Figure
5.11. This is in accordance with experimental estimates of tumour growth being classified as sigmoid
(including logistic or Gomperzian growth as described in Kozusko & Bourdeau (2007) and references
therein).
The initial number of cells was chosen arbitrarily to be 1000 rapid sub-population cells (stem cells
in the niche) and 0 slow sub-population cells (i.e., no tumour). The emphasis here is on the qualitative
results where eventually the slow sub-population cells dominate showing that the niche sustains the
tumour and results in a sigmoid shaped curve for the number of slow sub-population (tumour) cells. It
is the parameter values and where they are chosen from Table 5.2 that dictate the ‘long’ term behaviour
of the slow sub-population cells not the (non-zero) initial size of the stem cell population.
5.6 Discussion and conclusion
The transition from in vivo tumour to primary culture to established cell line is biologically complex
and not fully understood. In this chapter, we have described a simplistic mathematical model, which
does not address this degree of complexity but aims to capture the essential population dynamics of
these transitions by considering theoretically interacting stem cell and progeny populations. We did
this by formulating six differential equations for a cohort of cells comprising of two sub-populations.
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Figure 5.9: Cell line doubling time vs. cell line cycle time for 22 cell lines. Cell-cycle time on the
horizontal axis are experimental data that are used in addition to experimentally obtained percentage
distributions ΠG1 , ΠS in order to calculate cell line doubling time (vertical axis). Each dot represents
a particular cell line. A least-squares line is fitted through the scatter plot (coefficient of determination
r2 = 0.75).
One exhibiting slow population growth (the ‘slow sub-population cells’) and the other having a faster
population growth rate (the ‘rapid sub-population cells’). Each sub-population is further divided cor-
responding to three distinct phases of the cell cycle (G1, S and G2M phase) with transition rates
between phases. The slow sub-population cells are a mortal population with death via apoptosis from
G1-phase. The rapid sub-population cells can differentiate to become slow sub-population cells ac-
cording to the differentiation rate ρ.
If transition rates are constant then the asymptotic solution of the corresponding differential equa-
tion system are summarised in Table 5.2. The initial condition (t = 0) is chosen to represent a primary
culture and is composed of mainly slow sub-population cells. The asymptotic solution corresponds to
an established cell line and comprises mainly rapid sub-population cells.
We considered the case of rapid sub-population cells alone, i.e., an established cell line. We found
relationships (as described by equations (5.3.32)-(5.3.34), (5.3.38),(5.3.39) and (5.3.30)) between the
proportions in each phase, the rate transitions between phases, the population doubling time and the
average cell age. These relationships confirm that even with no cell loss the average cell age is not
equal to the doubling time. The following simple example illustrates that as soon as synchrony is
broken the average cell age will be different to the cell doubling time. Consider two cells in perfect
synchrony starting the cell age at the same time and each having the same average cell-age. In this
case, the average cell-age is equal to the population doubling time. If this synchrony is broken by
each cell having its own average cell age T 1a and T 2a , respectively, where say that T 1a is slightly smaller
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Figure 5.10: Cell doubling times of 22 primary cultures and corresponding derived cell lines. Dou-
bling time of the cell lines was calculated using experimentally obtained cell-cycle times and propor-
tions in each phase, for primary cultures this was achieved using experimental cell-cycle times and
model derived rapid sub-population cell transition rates.
than T 2a then the population will double at time Td = T 2a and the average cell-age will be (T 1a + T 2a )/2
which will be smaller than the doubling time. Our data has resulted in doubling times being greater
than average cell-age as depicted in Figure 5.9.
In calculations, we assumed that experimentally estimated cell-cycle time is equal to what we
refer to as the average cell-age Ta. We remark here that if we assume that the experimental cell-cycle
time is equal to the average removal time, introduced in Section 2.5.6, then the qualitative results
of the average cell-age time carry-over to the average removal time notion. In this chapter, terms
average cell-age and the experimental cell-cycle time are interchangeable. More importantly, if one
has experimental estimates of the cell-cycle time (or doubling time) and the proportions in any two
phases then one can use the mathematical model equations to estimate the population doubling time
(or the average cell age of the population) for a particular cell line. This model can be easily extended
for the mathematical estimation of the average removal times. We used the model to recover average
cell age of primary cultures given the experimental cell-cycle times of established cell lines.
As a further application of the model we considered an in vivo case of a tumour being sustained
by a niche of (a constant number of) stem cells. We assumed initially no slow sub-population cells
but over time the rapid sub-population cells differentiated to become slow sub-population cells. The
population of the slow sub-population cells was sigmoid that corresponds to empirical estimates of
tumour growth.
The concept that the fraction of stem cells in tumour samples and cell lines is small has been
reported in a number of papers. However, a recent publication has shown that when cells isolated
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Figure 5.11: Simulation of the solution to the system equations (5.3.24) - (5.3.29). Initially we assume
there are 1000 cells with 0% slow sub-population cells and 100% rapid sub-population cells. The
proportion of cells in each phase for rapid sub-populations is initially G1-phase 53%, S -phase 31%
and G2M-phase 16%. Transition rates between the phases for the rapid sub-population cells are
rRG1→S = 0.052729, r
R
S→G2M = 0.052 and r
R
G2 M→G1 = 1.8 per hour. For the slow sub-population cells
we chose the same transition rates as the rapid sub-population cells except for rSG1→S which is chosen
to be 10% of rRG1→S . The differentiation rate from rapid sub-population cells to slow sub-population
cells is ρ = rRG1→S per hour. r
S
G1→A is a sigmoid function, where µ = 0.005528, β1 = e
3.3 and β2 = 1200 .
from human melanomas are grown in host mice with a high degree of immunosuppression, up to 25%
of cells are able to grow into tumours and should thus be defined as tumour stem cells Quintana et al.
(2008).
Stem cells in normal tissue are normally slow growing but this slow growth is maintained by the
niche microenvironment and in response to an appropriate stimulus (e.g. depletion of cells) stem cells
can divide rapidly. The signalling pathways that maintain normal stem cells in a slow growing state
may be defective in tumour stem cells, but definitive evidence is lacking because tumour stem cells
cannot be identified in situ. The range of cycle times determined for the primary cultures is similar to
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that for the bulk of tumour cells reported in vivo.
An understanding of the underlying kinetics of cell lines and the relationship with those of primary
cultures is essential to understanding how human patients with in vivo tumours respond to cancer
therapy. Cell-cycle times of cell lines are related to cell-cycle times of primary culture and our simple
mathematical model goes some way towards explaining that. Since the cell-cycle time of a cell line is
a measure of patient survival it is important to see how this relates back to the in vivo case.
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Chapter 6
Conclusions and Suggestions for Further
Work
In this thesis, investigation of the age-structured models has led to the derivation of biologically sig-
nificant parameters describing the dynamics of an exponentially growing cancer cell population. We
have shown the relationship between the average cell-cycle time (also called the average cell-removal
time) and the population doubling time, where the cell-cycle time of the population is greater or equal
to the population doubling time. This result is of great interest to biologists, as they generally assume
that the cell-cycle time is always equal to the population doubling time.
In Chapter 2, we have proven the existence of the balanced exponential growth state for the age-
structured model with piecewise continuous transition rates. For the case of piecewise constant tran-
sition rates, we have derived analytical formulae for the population distribution among the cell-cycle
phases, the average cell age and the expected (average) removal time for the population in BEG. We
note that the average age of the cells removed from all phases is the average cell-cycle time. Our
expression for the average cell removal time can be found in the literature, where it has been referred
to as the cell-cycle time of the population. However, the formulae in the literature has been assumed
and then verified by using a discrete computational simulation, whereas, in this thesis, it has been
derived from the age-structured model with piecewise constant transition rates. Furthermore, we have
shown that a delay differential equation system can be obtained from the age-structured model with
piecewise constant transition rates. We presented the reduction of the age-structure model to the ordi-
nary differential equation model and thereafter applied it in the analysis of the cancer cell population
response to various cancer treatments. A study of a case of piecewise linear transition rates, would
provide a further generalisation of the model.
In Chapter 3, we have derived an analytical expression for the estimation of the population dou-
bling time from a single experimental observation point using the stathmokinetic method. In the liter-
ature, this method has been proposed from empirical studies. Furthermore, our mathematical model
has provided justification for the stathmokinetic method and presented simple analytical formulae that
could be useful for biologists. A further extension of this model would involve: first, incorporating
the necessary aging times of cells in each phase of the cell cycle to increase biological realism of
the model; and second, deriving expressions to estimate the cell-cycle time from a single experimen-
tal observation of the plateau log reduction value, similar to the ones presented in Table 3.2 for the
doubling time. We aim to elaborate on the model in Chapter 3 and publish this result.
In Chapter 4, we have analysed the effects of the radiotherapy on five melanoma cell lines via
mathematical modelling. Our mathematical model was constructed with the objective of estimating
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the proportion of cells that continue to proliferate after a one-time ionising radiation dose. Flow cy-
tometry profiles of five melanoma cell lines exposed to three types of cancer treatment were utilised in
the optimization routine. This provided the uniqueness of the numerical results. We have concluded
that little apoptosis occurs initially after irradiation. However, this result contradicts the empirical
estimates of the surviving fractions. Therefore, we have reasoned that our high magnitudes of the pro-
liferating cell proportions in each phase at time zero post irradiation suggests that some cells, although
sustaining DNA damage from irradiation, continue to divide several times before undergoing apopto-
sis. A further extension of this study would involve the application of our model to the experimental
data for the same cell lines but with longer observation times, thus providing a better understanding
of the numbers of cells undergoing apoptosis after dividing several times following irradiation.
In Chapter 5, we have proved the existence of the BEG state for the age-structured model depicting
the growth of the cell population composed of two sub-populations with different kinetic parameters.
Furthermore, the age-structured model was reduced to the ordinary differential equation model and
applied to provide an insight into the transition from in vivo tumour to primary culture to established
cell line. The linearity of our mathematical model does not cover the biological complexity of this
problem. However, it provides a small insight into the hypothesis that a cancer tissue is sustained by
a minor population of proliferating stem cells. The extension of the mathematical models presented
in this thesis to describe the dynamics of cells in the primary culture may be of a great interest to
biologists as its dynamics reflect the conditions of malignant tumour dynamics.
108
Appendix A
Appendix
A.1 The existence and uniqueness theorem from Linz (1985)
When the kernel is unbounded (or has some irregular behaviour) it is often convenient to rewrite linear
second kind Volterra equation f (t) = g(t) +
∫ t
0 k(t, s) f (s) ds, as follows:
f (t) = g(t) +
∫ t
0
p(t, s) k(t, s) f (s) ds, (A.1.1)
where p(t, s) represents the part with the non-smooth behaviour.
Theorem A.1.1. Assume that in equation A.1.1
1. g(t) is continuous in 0 ≤ t ≤ T,
2. k(t, s) is continuous in 0 ≤ s ≤ t ≤ T,
3. for each continuous function h and all 0 ≤ τ1 ≤ τ2 ≤ t, the integrals∫ τ2
τ1
p(t, s) k(t, s) h(s) ds (A.1.2)
and ∫ t
0
p(t, s) k(t, s) h(s) ds (A.1.3)
are continuous functions of t,
4. p(t, s) is absolutely integrable with respect to s for all 0 ≤ t ≤ T,
5. there exist points 0 = T0 < T1 < T2 < ... < TN = T such that with t ≥ Ti
K
∫ min(t,Ti+1)
Ti
|p(t, s)| ds ≤ α < 1, (A.1.4)
where
K = max
0≤s≤t≤T
|k(t, s)|, (A.1.5)
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6. for every t ≥ 0
lim
δ→0+
∫ t+δ
t
|p(t + δ, s)| ds = 0. (A.1.6)
Then A.1.1 has a unique continuous solution in 0 ≤ t ≤ T.
A.2 The Perron-Frobenius theorem
The Perron-Frobenius theorem describes the eigenvalues and eigenvectors of a nonnegative matrix A.
Its most important conclusion is that there generally exists one eigenvalue that is greater than or equal
to any of the others in magnitude. Without loss of generality, we can call this eigenvalue λ1; it is called
the dominant eigenvalue of A. The properties of nonnegative matrices have been subdivided into two
cases: reducible and irreducible. Irreducible matrices have been further subdivided into primitive and
imprimitive, Caswell (2001).
A.2.1 Irreducible but imprimitive matrices
A nonnegative matrix is irreducible if and only if its life cycle graph contains a path from every node
to every other node. An imprimitive matrix is said to be cyclic and to have an index of imprimitivity
d equal to the greatest common divisor of the loop lengths in the life cycle graph.
Theorem A.2.1. If the matrix A is irreducible but imprimitive, with index of primitivity d, then there
exists a real positive eigenvalue λ1, which is a simple root of the characteristic equation. The associ-
ated right and left eigenvectors w1 and v1 are positive.
The dominant eigenvalue λ1 is greater than or equal in magnitude to any of the other eigenvalues, i.e.,
λ1 ≥ |λi|, i > 1, (A.2.1)
but the spectrum of A contains d eigenvalues equal in magnitude to λ1. One λ1 itself, and the others
are the d − 1 complex eigenvalues:
λ1 exp 2kpii/d k = 1, 2, ...d − 1. (A.2.2)
A.2.2 Reducible matrices
Theorem A.2.2. Is A is reducible, there exists a real eigenvalue λ1 ≥ 0 with corresponding right and
left eigenvectors w1 ≥ 0 and v1 ≥ 0. This eigenvalue λ1 ≥ |λi|, i > 1.
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B.1 Proof of Theorem 3.2.1 - nonlinear mapping properties
As discussed in Section 3.2.1 in Chapter 3 for an established cell line, we have a relationship between
proportions in each phase, the rate transitions between phases, the population doubling time and
this can be reduced to an implicit relationship involving r = {rG1→S, rS→G2M, rG2M→G1}, and σ =
{ΠG1 ,ΠS , λ}. So it can be shown that the system can be written
G(r,σ) = G(rG1→S, rS→G2M, rG2M→G1 ,ΠG1 ,ΠS, λ) = 0. (B.1.1)
The existence of functional relationships between the variables will be determined by the implicit
function theorem and this is conditional on certain characterisations of the jacobian matrix of G, which
is given by
JG =

−ΠS
Π2G1
1
ΠG1
rG1→S
(rS→G2 M+λ)2
| −1(rS→G2 M+λ)
rG1→S
(rS→G2 M+λ)2
0
−1
ΠS
−ΠG2 M
Π2S
rS→G2 M
(rG2 M→G1+λ)2
| 0 −1(rG2 M→G1+λ)
rS→G2 M
(rG2 M→G1+λ)2
0 0 ∂λF | ∂rG1→S F ∂rS→G2 M F ∂rG2 M→G1 F

=
[
Jσ | Jr
]
Here
∂λF =
1
2rG1→S rS→G2MrG2M→G1
[(rS→G2M + λ)(rG1→S + λ)+
(rG2 M→G1 + rA + λ)(rG1→S + λ) + (rG2 M→G1 + rA + λ)(rS→G2M + λ) ] , (B.1.2a)
∂rG1→S F =
1
2rG1→S rS→G2MrG2M→G1
[(rG2 M→G1 + rA + λ)(rS→G2 M + λ)] − F(λ)rG1→S , (B.1.2b)
∂rS→G2 M F =
1
2rG1→S rS→G2MrG2M→G1
[(rG2 M→G1 + rA + λ)(rG1→S + λ)] − F(λ)rS→G2 M , (B.1.2c)
∂rG2 M→G1 F =
1
2rG1→S rS→G2MrG2M→G1
[(rG1→S + λ)(rS→G2 M + λ)] − F(λ)rG2 M→G1 , (B.1.2d)
with F given by equation (3.2.6). We have partitioned J into the first three columns, and called this
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square matrix Jσ , with the remaining three columns called Jr, and then the implicit function theorem
assures us that the jacobian Jr = dσdr exists locally provided the jacobian Jσ is non singular, i.e.,
det Jσ = ∂λF
(
ΠG2M
ΠSΠG1
+
1
ΠSΠG1
)
> 0. (B.1.3)
This is true if ∂λF > 0 as the proportional of cells in each phase are positive. To see that the condition
on F is true for the domain under consideration here, we note for exponential growth that λ > 0, and
all the rates in equation (B.1.2a) are also positive, so that ∂λF > 0. Hence the map σ = R(r) is locally
unique and determined.
To invert this mapping we must look into the singularity of Jr and this can be determined from
det Jr =
1
(rS→G2 M + λ)
(
rS→G2M∂rG2M→G1 F
(rG2 M→G1 + λ)
+
rS→G2M∂rS→G2 M F
(rG2 M→G1 + λ)2
)
+
∂rG1→S FrG1→S rS→G2M
(rS→G2M + λ)(rG2 M→G1 + λ)2
> 0,
(B.1.4)
so that provided det Jr , 0 anywhere, a local map r(σ) will exist almost everywhere.
To prove this, we first look at equation (B.1.2b) and see this can be written
∂rG1→S F = F(λ)
[
1
(rG1→S + λ)
−
1
rG1→S
]
, (B.1.5)
and in S ′, F(λ) = 1, with λ > 0 so
∂rG1→S F < 0. (B.1.6)
A similar argument applies to the other two derivatives of F in equation (B.1.2). As in S ′ all the
transition probabilities and λ are positive, it follows det Jr < 0 and we have the result.
B.2 Approximate solution of F(λ) − 1 = 0
To enable this, we first look at the dependence of F(λ) = 1 on λ, example of F(λ) = 1 plot shown in
Figure 2.4. So with the understanding of approximating the graph of F(λ), we consider a quadratic
that crosses the x-axis at −β, −α and the y-axis at γ and that is positive for large x. We also assume
that β < α. Then this quadratic is
y(x) = γ
αβ
(x + β)(x + α). (B.2.1)
Again with consideration of equation (3.2.6), we consider the roots of the equation y(x) = 1, and these
are given by
x =
1
2
−(β + α) ±
√
(β + α)2 + 4αβ(β + α)2 (
1
γ
− 1)
 . (B.2.2)
With the assumption 4αβ(β+α)2 ( 1γ − 1) << 1 the positive root is given by
αβ
(β + α) (
1
γ
− 1). (B.2.3)
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When α(β+α) ≈ 1, which is true for |α| large. We then find an approximation to the positive root is
x ≈ β(1
γ
− 1) − O( β
α
)
, β < α. (B.2.4)
We observe that the root found to y(x) = 1 if a linear polynomial is fitted through the x-axis at −β, and
the y-axis at γ, i.e., y(0) = γ is equation (B.2.4) with no error term. So the degree of approximation is
determined by how close α(β+α) ≈ 1. In conclusion, the linear approximation of λ in equation (3.2.6),
when α, β are chosen from rS→G2M , rS→G2M depending on which is larger, and the y-axis crossing is
1/2, is given by equation (3.3.14). This is because
α = max
(
|rG1→S |, |rS→G2M |
)
, β = min
(
|rG1→S |, |rS→G2M |
)
, (B.2.5)
and γ = 2.
B.3 Phase solutions with no division in Chapter 3
We consider the solution when the system is not exhibiting BEG. Solving equations (3.2.1), when
the transition rates between compartments are assumed to be positive constants and rG2M→G1 is set to
zero, gives us analytical formulas for the number of cells Np, p ∈ {G1, S ,G2M}, in each of the phases.
We can subdivide the solution of the ODE system into two cases. Firstly, let rG1→S , rS→G2 M, then
the system of differential equations (3.2.1) can be solved analytically as follows:
NG1(t) = NG1(0)e−rG1→S t, (B.3.1a)
NS (t) = NG1(0)
rG1→S
rS→G2 M − rG1→S
(
e−rG1→S t − e−rS→G2 M t
)
+ NS (0)e−rS→G2 M t, (B.3.1b)
NG2M(t) =
(
rG1→S rS→G2M
(rA − rG1→S )(rA − rS→G2M)
NG1(0) +
rS→G2M
rS→G2M − rA
NS (0) + NG2M(0)
)
e−rAt (B.3.1c)
+
rS→G2M
rA − rS→G2M
(
NS (0) −
rG1→S
rS→G2M − rG1→S
NG1(0)
)
e−rS→G2 M t (B.3.1d)
+
rG1→S rS→G2M
(rS→G2M − rG1→S )(rA − rG1→S )
NG1(0)e−rG1→S t. (B.3.1e)
Secondly, when rG1→S = rS→G2M , the analytical solution of the system (3.2.1) is:
NG1(t) = NG1(0)e−rG1→S t, (B.3.2a)
NS (t) = [NS (0) + tNG1(0)rG1→S ]e−rG1→S t, (B.3.2b)
NG2M(t) =
(
NG2M(0) −
1
rA − rG1→S
NS (0)
)
e−rAt +
1
rA − rG1→S
(
NS (0) + rG1→S NG1(0)t
)
e−rG1→S t.
(B.3.2c)
But solution (B.3.2) will occur with probability of zero when running a Monte Carlo simulation such
as in Section 3.3.3 so it is not considered further.
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